a10579464.s3	NRA0160 NN B-noun.person	has VBZ B-verb.possession	negligible JJ B-adj.all	affinity NN B-noun.attribute	for IN 0	the DT 0	human NN B-noun.person	cloned VBD B-verb.contact	dopamine NN B-noun.person	D3 : 0	receptor NN B-noun.person	( ( 0	Ki=39 FW 0	nM LS 0	) ) 0	, , 0	rat VBD B-verb.contact	serotonin NN B-noun.person	( ( 0	5-HT)2A JJ 0	receptors NNS B-noun.person	( ( 0	Ki=180 FW 0	nM LS 0	) ) 0	and CC 0	rat VBD B-verb.stative	alpha1 JJ B-adj.all	adrenoceptor NN B-noun.person	( ( 0	Ki=237 FW 0	nM LS 0	) ) 0	. . 0	. . 0
a1147734.s1	This DT 0	report NN B-noun.communication	presents VBZ B-verb.creation	the DT 0	clinical JJ B-adj.all	, , 0	laboratory NN B-noun.person	, , 0	and CC 0	light NN B-noun.person	and CC 0	electron NN B-noun.person	microscopic JJ B-adj.all	observations NNS B-noun.act	on IN 0	a DT 0	patient NN B-noun.person	with IN 0	chronic_active_(aggressive)_hepatitis NNS 0	caused VBN B-verb.communication	by IN 0	the DT 0	administration NN B-noun.time	of IN 0	propylthiouracil NN B-noun.person	. . 0	. . 0
a20588063.s3	METHODS NNS B-noun.attribute	, , 0	Using VBG B-verb.consumption	immune JJ B-adj.all	stainings NNS B-noun.artifact	, , 0	semiquantitative JJ B-adj.all	measurement NN B-noun.attribute	was VBD 0	performed VBN B-verb.change	under IN 0	the DT 0	electron NN B-noun.person	microscope NN B-noun.person	. . 0	. . 0
a15325671.s4	Analysis NN B-noun.person	was VBD 0	performed VBN B-verb.social	on IN 0	61 CD 0	women NNS B-noun.person	with IN 0	chemotherapy NN B-noun.act	- : 0	responsive JJ B-adj.all	metastatic JJ B-adj.all	breast_cancer NN B-noun.person	receiving VBG B-verb.communication	96-h JJ B-adj.all	infusional JJ B-adj.all	cyclophosphamide NN 0	as IN 0	part NN 0	of IN 0	a DT 0	triple JJ B-adj.all	sequential JJ B-adj.all	high JJ B-noun.group	- : 0	dose NN B-noun.person	regimen NNS B-noun.person	to TO 0	assess VB B-verb.cognition	association NN I-verb.cognition	between IN 0	presence NN B-noun.person	of IN 0	peritransplant JJ B-adj.all	congestive_heart_failure NN B-noun.cognition	( ( 0	CHF NNP 0	) ) 0	and CC 0	the DT 0	following VBG 0	pretreatment JJ B-noun.person	characteristics NNS I-noun.person	, , 0	presence NN B-noun.person	of IN 0	electrocardiogram NN B-noun.cognition	( ( 0	EKG NNP 0	) ) 0	abnormalities NNS B-noun.animal	, , 0	age NN B-noun.person	, , 0	hypertension NN 0	, , 0	prior RB B-adj.all	cardiac JJ B-adj.pert	history NN B-noun.cognition	, , 0	smoking NN B-verb.consumption	, , 0	diabetes_mellitus NN B-noun.other	, , 0	prior RB 0	use NN 0	of IN 0	anthracyclines NNS B-noun.object	, , 0	and CC 0	left VBD B-verb.motion	- : 0	sided VBD B-verb.contact	chest JJS B-adj.all	irradiation NN B-noun.person	. . 0	. . 0
a11532387.s0	Withdrawal NN B-noun.person	- : 0	emergent_rabbit_syndrome NN 0	during IN 0	dose DT 0	reduction NN B-noun.act	of IN 0	risperidone NN 0	. . 0	. . 0
a9495837.s4	10 SYM B-adj.all	- : 0	30 CD B-adj.all	micrograms NNS B-noun.quantity	/ : 0	mouse NN B-noun.person	i.c.v NNP I-noun.person	. . 0	) ) 0	. . 0
a18464113.s10	Of IN 0	our PRP$ 0	control NN B-noun.location	group NN 0	( ( 0	n= $ 0	50 CD B-adj.all	) ) 0	, , 0	21 CD B-adj.all	patients NNS B-noun.person	( ( 0	42 CD 0	% NN 0	) ) 0	were VBD 0	established VBN B-verb.creation	hepatitis NN 0	. . 0	. . 0
a20067456.s1	OBJECTIVE NNP B-noun.group	, , 0	To TO 0	determine VB B-verb.communication	the DT 0	safety NN B-noun.artifact	and CC 0	efficacy NN B-noun.person	of IN 0	adjunctive JJ B-adj.all	bupropion NN B-noun.person	sustained VBD B-verb.communication	- : 0	release NN B-noun.communication	( ( 0	SR NNP 0	) ) 0	on IN 0	male JJ B-adj.all	sexual_dysfunction NN B-noun.act	( ( 0	SD NNP 0	) ) 0	induced VBN B-verb.creation	by IN 0	a DT 0	selective_serotonin_reuptake_inhibitor NN B-noun.person	( ( 0	SSRI NNP B-noun.group	) ) 0	, , 0	as IN 0	SD NNP 0	is VBZ B-verb.stative	a DT 0	common JJ B-adj.all	side NN B-noun.attribute	- : 0	effect NN B-noun.cognition	of IN 0	SSRIs NNP B-noun.location	and CC 0	the DT 0	most RBS 0	effective JJ B-adj.all	treatments NNS B-noun.plant	have VBP 0	yet RB 0	to TO 0	be VB 0	determined VBN B-verb.communication	. . 0	. . 0
a11752354.s4	An DT 0	analysis NN B-noun.communication	for IN 0	factor NN B-noun.person	V NNP I-noun.person	Leiden NNP I-noun.person	and CC 0	the DT 0	G20210A JJ B-adj.all	mutation NN B-noun.act	in IN 0	the DT 0	prothrombin NN B-noun.person	gene NN B-noun.person	was VBD 0	conducted VBN B-verb.creation	in IN 0	217 CD 0	patients NNS B-noun.person	and CC 0	763 CD 0	controls NNS B-noun.group	RESULTS NNS B-noun.other	, , 0	The DT 0	odds NNS B-noun.artifact	ratio NN B-noun.person	for IN 0	myocardial_infarction NN B-noun.act	among IN 0	women NNS B-noun.person	who WP 0	used VBD B-verb.consumption	any DT 0	type NN B-noun.person	of IN 0	combined VBN B-verb.change	oral_contraceptive JJ I-verb.change	, , 0	as IN 0	compared VBN B-verb.creation	with IN 0	nonusers NNS B-noun.person	, , 0	was VBD B-verb.stative	2.0 CD B-noun.quantity	( ( 0	95 CD 0	percent NN B-noun.quantity	confidence NN B-noun.relation	interval NN I-noun.relation	, , 0	1.5 CD 0	to TO 0	2.8 CD 0	) ) 0	. . 0	. . 0
a7234705.s7	In IN 0	the DT 0	seventh JJ B-adj.all	patient NN B-noun.person	, , 0	a DT 0	permanent JJ B-adj.all	ventricular NN B-noun.artifact	pacemaker NN B-noun.artifact	was VBD 0	inserted VBN B-verb.contact	and CC 0	, , 0	despite IN 0	continuation NN B-noun.cognition	of IN 0	procainamide NN B-noun.person	therapy NN B-noun.person	, , 0	polymorphous JJ B-adj.all	ventricular_tachycardia NNS B-noun.artifact	did VBD 0	not RB B-adv.all	reoccur VB B-verb.change	. . 0	. . 0
a17437408.s3	By IN 0	using VBG B-verb.consumption	this DT 0	strategy NN B-noun.attribute	to TO 0	study VB B-verb.cognition	the DT 0	involvement NN B-noun.person	of IN 0	MRP2 NNP B-noun.person	in IN 0	brain NN 0	access NN 0	of IN 0	antiepileptic JJ B-adj.all	drugs NNS B-noun.artifact	( ( 0	AEDs NNP B-noun.group	) ) 0	, , 0	we PRP 0	recently RB B-adv.all	reported VBD B-verb.communication	that DT 0	phenytoin NN B-noun.person	is VBZ B-verb.stative	a DT 0	substrate NN B-noun.person	for IN 0	MRP2 NNP B-noun.person	in IN 0	the DT 0	BBB NNP B-noun.group	. . 0	. . 0
a16740173.s12	High JJ B-adj.all	doses NNS B-noun.attribute	of IN 0	atropine NN B-noun.phenomenon	( ( 0	up IN 0	to TO 0	50 CD B-adj.all	mg NN B-noun.quantity	per IN 0	24 CD B-adj.all	hours NNS B-noun.artifact	) ) 0	, , 0	adrenaline NN B-noun.person	and CC 0	dopamine NN B-noun.act	were VBD B-verb.stative	necessary JJ B-adj.all	. . 0	. . 0
a8741744.s5	We PRP 0	conclude VBP B-verb.cognition	that IN 0	the DT 0	interpeduncular JJ B-adj.all	nucleus NN B-noun.group	mediates VBZ B-verb.change	nicotinic JJ B-adj.pert	depression NN B-noun.state	of IN 0	locomotor NN B-noun.phenomenon	activity NN B-noun.process	and CC 0	dampens VBZ B-verb.change	nicotinic JJ B-adj.all	arousal NN B-noun.body	mechanisms NNS I-noun.body	located VBN B-verb.possession	elsewhere RB B-adv.all	in IN 0	the DT 0	brain NN B-noun.person	. . 0	. . 0
a15009014.s3	An DT 0	experimental JJ B-adj.all	model NN B-noun.person	was VBD 0	developed VBN B-verb.creation	in IN 0	the DT 0	rat NN 0	to TO 0	measure VB B-verb.change	changes NNS B-noun.relation	in IN 0	lacrimation NN B-noun.act	and CC 0	intracranial JJ B-adj.all	blood NN B-noun.attribute	flow NN B-noun.process	following VBG B-verb.motion	noxious JJ B-adj.all	chemical NN B-noun.communication	stimulation NN B-noun.cognition	of IN 0	facial JJ B-adj.all	mucosa NN B-noun.act	. . 0	. . 0
a8372922.s0	Neuroplasticity NN B-noun.person	of IN 0	the DT 0	adult NN B-noun.person	primate NN B-noun.person	auditory NN B-noun.artifact	cortex NN I-noun.artifact	following VBG B-verb.stative	cochlear JJ B-adj.all	hearing_loss NN B-noun.location	. . 0	. . 0
a11587867.s6	A DT 0	review NN B-noun.act	of IN 0	all DT 0	reported VBD B-verb.communication	cases NNS B-noun.person	in IN 0	the DT 0	literature NN B-noun.act	is VBZ 0	given VBN B-verb.possession	. . 0	. . 0
a8092427.s14	PG NNP 0	was VBD B-verb.stative	well RB 0	tolerated VBN 0	by IN 0	all DT 0	54 CD B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a18162529.s4	Chronic NNP B-adj.pert	hyperprolactinemia NN B-noun.feeling	induced VBN B-verb.creation	by IN 0	the DT 0	dopamine NN 0	antagonist JJ B-adj.all	sulpiride NN B-noun.person	caused VBD B-verb.communication	a DT 0	40 CD B-adj.all	% NN 0	reduction NN B-noun.group	LH NNP 0	pulse JJ B-adj.all	frequency NN B-noun.person	in IN 0	ovariectomized VBN B-verb.consumption	rats NNS I-verb.consumption	, , 0	but CC 0	only RB B-adv.all	in IN 0	the DT 0	presence NN B-noun.person	of IN 0	chronic JJ B-adj.all	low JJ B-adj.all	levels NNS B-noun.state	of IN 0	estradiol NN B-noun.act	. . 0	. . 0
a20196116.s0	Antituberculosis DT 0	therapy NN B-noun.act	- : 0	induced VBN B-verb.creation	acute_liver_failure NN B-noun.quantity	, , 0	magnitude NN B-noun.person	, , 0	profile NN B-noun.person	, , 0	prognosis NN B-noun.person	, , 0	and CC 0	predictors NNS B-noun.person	of IN 0	outcome NN 0	. . 0	. . 0
a19729346.s2	Seventy NNP B-noun.person	- : 0	one NN 0	participants NNS B-noun.person	completed VBN B-verb.change	2 CD B-adj.all	separate JJ B-adj.all	study NN B-noun.artifact	days NNS B-noun.artifact	and CC 0	were VBD B-verb.stative	blind JJ 0	to TO 0	medication NN 0	condition NN 0	( ( 0	placebo NN B-noun.substance	, , 0	10-mg JJ 0	oxycodone NN 0	) ) 0	. . 0	. . 0
a19346865.s2	MATERIALS NNS B-noun.artifact	AND CC 0	METHODS NNS B-noun.attribute	, , 0	From IN 0	November NNP B-noun.communication	2005 CD 0	to TO 0	September NNP B-noun.other	2007 CD I-noun.other	, , 0	8 CD B-adj.all	patients NNS B-noun.person	( ( 0	5 CD B-adj.all	men NNS B-noun.person	and CC 0	3 CD B-adj.all	women NNS B-noun.person	) ) 0	were VBD 0	diagnosed VBN B-verb.communication	as IN 0	having VBG 0	metronidazole NN B-noun.attribute	- : 0	induced VBN B-verb.creation	encephalopathy JJ B-adj.all	( ( 0	age NN 0	range NN B-noun.location	, , 0	43 CD 0	- : 0	78 CD 0	years NNS B-noun.quantity	) ) 0	. . 0	. . 0
a7834920.s4	Other JJ 0	possible JJ B-adj.all	causes NNS B-noun.event	of IN 0	rapidly RB B-adv.all	progressive JJ B-adj.all	glomerulonephritis NNS B-noun.food	were VBD 0	investigated VBN B-verb.communication	and CC 0	ruled VBD B-verb.stative	out RP 0	. . 0	. . 0
a15130900.s1	OBJECTIVE NNP B-noun.group	, , 0	To TO 0	assess VB B-verb.communication	and CC 0	characterise VB B-verb.change	the DT 0	risk NN 0	of IN 0	bladder_cancer NN B-noun.object	, , 0	and CC 0	its PRP$ 0	relation NN B-noun.motive	to TO 0	cyclophosphamide VB B-verb.social	, , 0	in IN 0	patients NNS B-noun.person	with IN 0	Wegener's_granulomatosis NN B-noun.food	. . 0	. . 0
a424937.s6	The DT 0	drug NN B-noun.person	was VBD 0	withdrawn VBN B-verb.contact	on IN 0	presentation NN B-noun.person	to TO 0	hospital NN B-noun.artifact	in IN 0	11 CD B-adj.all	patients NNS B-noun.person	, , 0	with IN 0	rapid JJ B-adj.all	clinical JJ B-adj.all	improvement NN B-noun.state	in IN 0	9 CD B-adj.all	. . 0	. . 0
a17562951.s4	The DT 0	primary JJ B-adj.all	outcome NN B-noun.person	was VBD B-verb.stative	a DT 0	postdose JJ B-adj.all	SCr NNP B-noun.other	increase NN B-noun.event	> : 0	or CC 0	= $ 0	0.5 CD 0	mg PRP B-noun.quantity	/ : 0	dL PRP 0	( ( 0	44.2 CD 0	micromol NN B-noun.quantity	/ '' 0	L NNP 0	) ) 0	over IN 0	baseline NN B-noun.person	. . 0	. . 0
a19889778.s0	Differential JJ B-adj.all	impact NN B-noun.state	of IN 0	immune JJ B-adj.all	escape NN B-noun.act	mutations NNS B-noun.act	G145R NNP I-noun.act	and CC 0	P120 NNP B-noun.group	T NNP 0	on IN 0	the DT 0	replication NN B-noun.act	of IN 0	lamivudine NN B-noun.act	- : 0	resistant JJ B-adj.all	hepatitis_B_virus_e_antigen NNP B-noun.person	- : 0	positive JJ B-adj.all	and CC 0	-negative JJ B-noun.body	strains NNS I-noun.body	. . 0	. . 0
a2484011.s1	The DT 0	effect NN B-noun.cognition	of IN 0	amantadine_hydrochloride JJ B-noun.other	, , 0	injected VBN B-verb.change	i.p NNP 0	. . 0	. . 0
a9672936.s0	Pethidine NNP B-noun.person	- : 0	associated VBN B-verb.cognition	seizure NN B-noun.act	in IN 0	a DT 0	healthy JJ B-adj.all	adolescent NN B-noun.person	receiving VBG B-verb.communication	pethidine NN B-noun.person	for IN 0	postoperative_pain JJ B-adj.all	control NN B-noun.act	. . 0	. . 0
a12369736.s0	Effects NNS B-noun.phenomenon	of IN 0	5-HT1B JJ B-adj.all	receptor NN B-noun.person	ligands NNS B-noun.person	microinjected VBN B-verb.social	into IN 0	the DT 0	accumbal JJ B-adj.all	shell NN B-noun.animal	or CC 0	core NN B-noun.quantity	on IN 0	the DT 0	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	locomotor_hyperactivity NN B-noun.feeling	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a15515654.s9	Subjects NNS B-noun.person	with IN 0	SNHL NNP B-noun.group	were VBD 0	submitted VBN B-verb.cognition	to TO 0	DFO NNP 0	reduction NN B-noun.process	or CC 0	temporary JJ B-adj.all	withdrawal NN B-noun.person	. . 0	. . 0
a19211690.s3	In IN 0	contrast NN 0	to TO 0	the DT 0	systemic JJ B-adj.all	renin NN B-noun.act	- : 0	angiotensin NN B-noun.cognition	system NN I-noun.cognition	, , 0	which WDT 0	is VBZ 0	suppressed VBN B-verb.social	in IN 0	response NN B-noun.communication	to TO 0	HS NNP 0	in IN 0	male NN 0	DS NNP 0	, , 0	intrarenal JJ B-adj.all	angiotensinogen NN 0	expression NN B-noun.communication	is VBZ 0	increased VBN B-verb.change	, , 0	and CC 0	intrarenal JJ B-adj.all	levels NNS B-noun.state	of IN 0	ANG NNP 0	II NNP 0	are VBP 0	not RB B-adv.all	suppressed VBN B-verb.social	. . 0	. . 0
a10683478.s5	Moreover RB B-adv.all	, , 0	test NN B-adj.all	conditions NNS B-noun.person	can MD 0	impact VB B-verb.change	upon IN 0	other JJ 0	physiological JJ B-adj.pert	responses NNS B-noun.act	to TO 0	apomorphine VB B-verb.social	such JJ 0	as IN 0	drug NN B-noun.person	- : 0	induced VBN B-verb.creation	hypothermia NN 0	. . 0	. . 0
a20080419.s6	The DT 0	density NN B-noun.state	of IN 0	hippocampal JJ B-adj.all	neurons NNS B-noun.person	in IN 0	the DT 0	brains NNS B-noun.group	of IN 0	animals NNS B-noun.person	treated VBN B-verb.social	with IN 0	BMCs NNP B-noun.person	was VBD B-verb.stative	markedly RB B-adv.all	preserved VBN B-verb.possession	. . 0	. . 0
a11250767.s3	Serologic JJ B-adj.all	testing NN B-noun.communication	and CC 0	immunologic JJ B-adj.all	studies NNS B-noun.group	were VBD 0	done VBN B-verb.social	, , 0	and CC 0	a DT 0	pericardial JJ B-adj.all	biopsy NN B-noun.cognition	was VBD 0	performed VBN B-verb.social	. . 0	. . 0
a11135224.s10	After IN 0	154 CD 0	courses NNS B-noun.act	of IN 0	therapy NN B-noun.act	, , 0	the DT 0	median NN B-noun.artifact	dose NN I-noun.artifact	intensity NN B-noun.possession	was VBD B-verb.stative	131 CD 0	mg NN B-noun.quantity	/ : 0	m(2 LS 0	) ) 0	for IN 0	paclitaxel NN B-noun.artifact	( ( 0	97.3 CD 0	% NN 0	) ) 0	, , 0	117 CD 0	mg NN B-noun.quantity	/ : 0	m(2 LS 0	) ) 0	for IN 0	cisplatin NN B-noun.substance	( ( 0	97.3 CD 0	% NN 0	) ) 0	, , 0	and CC 0	1378 CD 0	mg NN B-noun.quantity	/ : 0	m(2 LS 0	) ) 0	for IN 0	gemcitabine NN 0	( ( 0	86.2 CD 0	% NN 0	) ) 0	. . 0	. . 0
a2802551.s2	In IN 0	salt NN B-noun.act	- : 0	depleted VBN B-verb.creation	rats NNS B-noun.animal	, , 0	amphotericin NN 0	B NNP 0	decreased VBD B-verb.change	creatinine JJ B-adj.all	clearance NN B-noun.person	linearly RB B-adv.all	with IN 0	time NN B-noun.time	, , 0	with IN 0	an DT 0	85 CD 0	% NN 0	reduction NN B-noun.act	by IN 0	week NN B-noun.communication	3 CD 0	. . 0	. . 0
a16740173.s2	We PRP 0	report VBP B-verb.communication	an DT 0	interesting JJ B-noun.artifact	case NN I-noun.artifact	investigating VBG B-verb.stative	a DT 0	( ( 0	near IN 0	) ) 0	fatal JJ B-adj.pert	poisoning NN B-noun.state	. . 0	. . 0
a8372922.s5	Following VBG 0	recovery NN B-noun.communication	, , 0	the DT 0	monkeys NNS B-noun.person	were VBD B-verb.stative	selectively RB B-adv.all	deafened VBN B-verb.cognition	for IN 0	high JJ B-adj.all	frequencies NNS B-noun.person	using VBG B-verb.consumption	kanamycin NN B-noun.food	and CC 0	furosemide NN B-noun.artifact	. . 0	. . 0
a16337777.s0	Investigation NNP B-noun.person	of IN 0	mitochondrial JJ B-adj.all	involvement NN B-noun.person	in IN 0	the DT 0	experimental JJ B-adj.all	model NN B-noun.person	of IN 0	epilepsy NN B-noun.communication	induced VBN B-verb.creation	by IN 0	pilocarpine NN B-noun.person	. . 0	. . 0
a18020536.s2	METHODS NNS B-noun.attribute	, , 0	A DT 0	non NN B-noun.person	- : 0	randomised VBD B-verb.communication	clinical JJ B-adj.all	study NN B-noun.artifact	of IN 0	patients NNS B-noun.person	aged VBN B-verb.communication	> : 0	or CC 0	= $ 0	65 CD 0	years NNS 0	admitted VBN B-verb.social	to TO 0	acute VB B-verb.consumption	hospital NN B-noun.animal	wards NNS B-noun.location	during IN 0	1 CD B-adj.all	month NN B-noun.quantity	. . 0	. . 0
a9390208.s13	Median JJ B-adj.all	progression NN B-noun.act	- : 0	free JJ B-adj.all	survival NN B-noun.location	was VBD B-verb.stative	5 CD B-adj.all	months NNS B-noun.person	. . 0	. . 0
a6209318.s0	International JJ B-adj.all	mexiletine NN B-noun.person	and CC 0	placebo VB B-verb.creation	antiarrhythmic JJ B-adj.all	coronary JJ B-adj.all	trial NN B-noun.act	, , 0	I. NNP B-noun.person	Report NNP I-noun.person	on IN 0	arrhythmia NN B-noun.person	and CC 0	other JJ 0	findings NNS B-noun.act	. . 0	Impact NNP B-noun.person	Research NNP I-noun.person	Group NNP I-noun.person	. . 0	. . 0
a1085609.s3	The DT 0	fits NNS B-noun.person	ceased VBD B-verb.stative	within IN 0	4 CD B-adj.all	hours NNS B-noun.time	of IN 0	administering VBG B-verb.change	intramuscular JJ B-adj.all	pyridoxine NN B-noun.artifact	, , 0	suggesting VBG B-verb.communication	an DT 0	aetiology NN B-noun.attribute	of IN 0	pyridoxine JJ B-adj.all	deficiency NN B-noun.attribute	secondary JJ B-adj.all	to TO 0	isoniazid VB B-verb.change	medication NN B-noun.feeling	. . 0	. . 0
a20196116.s6	In IN 0	44 CD 0	( ( 0	62.8 CD 0	% NN 0	) ) 0	patients NNS B-noun.person	, , 0	ATT NNP 0	was VBD 0	prescribed VBN B-verb.communication	empirically RB B-adv.all	without IN 0	definitive JJ B-adj.all	evidence NN B-noun.attribute	of IN 0	tuberculosis NN B-noun.food	. . 0	. . 0
a2266990.s9	Mazindol NNP B-noun.person	doses VBZ I-noun.person	not RB B-adv.all	slow VB B-verb.change	the DT 0	progression NN B-noun.act	of IN 0	weakness NN B-noun.state	in IN 0	Duchenne_dystrophy NN 0	. . 0	. . 0
a15804801.s0	Coronary_aneurysm NN B-noun.artifact	after IN 0	implantation NN B-noun.time	of IN 0	a DT 0	paclitaxel NN B-noun.person	- : 0	eluting VBG B-verb.communication	stent NN B-noun.communication	. . 0	. . 0
a8595686.s8	The DT 0	VAS NNP B-noun.other	scores NNS B-noun.cognition	for IN 0	recall NN B-noun.act	of IN 0	pain NN B-noun.cognition	in IN 0	the DT 0	recovery NN B-noun.artifact	room NN I-noun.artifact	were VBD 0	correlated VBN B-verb.stative	with IN 0	the DT 0	VAS NNP B-noun.other	scores NNS B-noun.artifact	during IN 0	induction NN B-noun.cognition	( ( 0	r NN 0	= SYM 0	0.7045 CD 0	, , 0	P NNP 0	< $ 0	0.0001 CD 0	) ) 0	. . 0	. . 0
a9406968.s4	Plasma NNP B-noun.person	sodium NN B-noun.artifact	concentrations NNS B-noun.artifact	were VBD 0	found VBN B-verb.perception	to TO 0	be VB B-verb.stative	slightly RB B-adv.all	increased VBN B-verb.change	in IN 0	the DT 0	Li SYM 0	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	compared VBN B-verb.change	with IN 0	those DT 0	in IN 0	controls NNS B-noun.artifact	. . 0	. . 0
a11135224.s11	World NNP B-noun.group	Health NNP I-noun.group	Organization NNP I-noun.group	Grade NNP I-noun.group	3 SYM 0	- : 0	4 CD B-adj.all	neutropenia NN B-noun.person	and CC 0	thrombocytopenia NN B-noun.person	occurred VBD B-verb.cognition	in IN 0	39.9 CD 0	% NN 0	and CC 0	11.4 CD 0	% NN 0	of IN 0	patients NNS B-noun.person	, , 0	respectively RB B-adv.all	. . 0	. . 0
a9495837.s6	+ SYM 0	/-)-PG-9 JJ B-adj.all	antinociception NN B-noun.person	peaked VBD B-verb.contact	15 CD B-adj.all	min NN B-noun.communication	after IN 0	injection NN B-noun.act	and CC 0	then RB B-adv.all	slowly RB B-adv.all	diminished VBN B-verb.change	. . 0	. . 0
a8864707.s2	Five CD 0	females NNS B-noun.person	and CC 0	6 CD B-adj.all	males NNS B-noun.animal	, , 0	21 CD 0	- : 0	59 CD 0	years NNS B-noun.time	of IN 0	age NN B-noun.time	, , 0	were VBD 0	examined VBN B-verb.communication	with IN 0	a DT 0	1.5-T NNP B-noun.person	whole WP B-verb.communication	- : 0	body NN 0	system NN 0	using VBG B-verb.consumption	a DT 0	circular JJ B-adj.all	polarized JJ B-adj.all	head NN B-noun.location	coil NN B-noun.person	. . 0	. . 0
a15859940.s8	Three CD 0	cases NNS B-noun.state	were VBD 0	related VBN B-verb.communication	to TO 0	cyclosporine VB B-verb.social	, , 0	and CC 0	1 CD B-adj.all	case NN B-noun.state	was VBD B-verb.stative	secondary JJ B-adj.all	to TO 0	both DT 0	cyclosporine NN B-noun.person	and CC 0	tacrolimus NN B-noun.person	. . 0	. . 0
a17261653.s0	Direct JJ 0	inhibition NN 0	of IN 0	cardiac JJ B-adj.all	hyperpolarization NN B-noun.person	- : 0	activated VBN B-verb.creation	cyclic_nucleotide JJ 0	- : 0	gated VBN B-verb.contact	pacemaker NN B-noun.artifact	channels NNS B-noun.artifact	by IN 0	clonidine NN B-noun.person	. . 0	. . 0
a10901305.s10	Ninety CD 0	- : 0	nine CD B-adj.all	percent NN B-noun.person	( ( 0	sixty RB B-adv.all	- : 0	eight CD 0	) ) 0	of IN 0	the DT 0	sixty CD 0	- : 0	nine CD B-adj.all	parents NNS B-noun.person	present JJ B-adj.all	during IN 0	the DT 0	reduction NN B-noun.group	were VBD 0	pleased VBN B-verb.emotion	with IN 0	the DT 0	sedation NN B-noun.act	and CC 0	would MD 0	allow VB B-verb.communication	it PRP 0	to TO 0	be VB 0	used VBN B-verb.consumption	again RB B-adv.all	in IN 0	a DT 0	similar JJ B-adj.all	situation NN B-noun.state	. . 0	. . 0
a10737864.s4	Therefore RB 0	, , 0	in IN 0	the DT 0	present JJ B-adj.all	experiment NN B-noun.person	, , 0	the DT 0	effects NNS B-noun.phenomenon	of IN 0	clonidine JJ B-adj.all	administration NN B-noun.time	( ( 0	0.5 CD 0	mg PRP B-noun.quantity	/ : 0	kg LS 0	) ) 0	on IN 0	cardiac JJ B-adj.all	rate NN B-noun.time	and CC 0	ultrasound JJ B-adj.all	production NN B-noun.artifact	were VBD 0	examined VBN B-verb.communication	in IN 0	2- : 0	, , 0	8- UH 0	, , 0	15- UH 0	, , 0	and CC 0	20-day JJ B-noun.time	- : 0	old JJ B-adj.all	rats NNS B-noun.person	. . 0	. . 0
a8590259.s7	Upper JJ B-adj.all	lid NN B-noun.body	retraction NN I-noun.body	was VBD B-verb.stative	frequently RB B-adv.all	noted VBN B-verb.perception	. . 0	. . 0
a15338796.s8	In IN 0	another DT 0	series NN B-noun.event	of IN 0	measurements NNS B-noun.attribute	, , 0	reproducibility NN B-noun.person	and CC 0	reference NN B-noun.act	values NNS B-noun.attribute	of IN 0	the DT 0	tremor NN B-noun.plant	was VBD 0	assessed VBN B-verb.cognition	in IN 0	65 CD 0	healthy JJ B-adj.all	subjects NNS B-noun.person	in IN 0	three CD 0	sessions NNS B-noun.time	, , 0	at IN 0	9 CD B-adj.all	a.m. NN B-noun.time	, , 0	4 CD B-adj.all	p.m. RB B-noun.time	and CC 0	9 CD B-adj.all	a.m. NN B-noun.time	, , 0	respectively RB B-adv.all	, , 0	1 CD B-adj.all	week NN 0	later RB B-adv.all	. . 0	. . 0
a15275829.s1	Binding NNP B-noun.person	of IN 0	nicotine NN B-noun.person	to TO 0	nicotinic JJ B-adj.pert	acetylcholine NN B-noun.person	receptors NNS B-noun.person	( ( 0	nAChRs NNS 0	) ) 0	elicits VBZ B-verb.stative	a DT 0	series NN B-noun.communication	of IN 0	dose NN B-noun.act	- : 0	dependent JJ B-adj.all	behaviors NNS B-noun.person	that WDT 0	go VBP B-verb.stative	from IN 0	altered JJ B-adj.all	exploration NN B-noun.person	, , 0	sedation NN B-noun.act	, , 0	and CC 0	tremors NNS B-noun.person	, , 0	to TO 0	seizures NNS B-noun.act	and CC 0	death NN B-noun.person	. . 0	. . 0
a7083920.s0	Further JJ B-adj.all	observations NNS B-noun.act	on IN 0	the DT 0	electrophysiologic JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	oral JJ B-adj.all	amiodarone NN 0	therapy NN 0	. . 0	. . 0
a20080983.s1	OBJECTIVE NNP B-noun.group	, , 0	The DT 0	purpose NN B-noun.attribute	of IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	to TO 0	determine VB B-verb.communication	the DT 0	effect NN B-noun.cognition	of IN 0	morning NN B-noun.act	- : 0	dosed VBN B-adj.all	modafinil NN B-noun.artifact	on IN 0	sleep NN B-noun.food	and CC 0	daytime_sleepiness NN B-noun.person	in IN 0	chronic JJ B-adj.all	cocaine NN B-noun.event	users NNS B-noun.person	. . 0	. . 0
a88336.s7	It PRP 0	is VBZ 0	suggested VBN B-verb.communication	that IN 0	in IN 0	both DT 0	situations NNS B-noun.person	disturbed VBD B-verb.contact	reticulo NN B-noun.person	- : 0	thalamic JJ B-noun.person	interactions NNS I-noun.person	are VBP B-verb.stative	important JJ B-adj.all	in IN 0	the DT 0	pathogenesis NN B-noun.location	of IN 0	alpha NN B-noun.animal	coma NN I-noun.animal	. . 0	. . 0
a11745184.s12	RESULTS NNS B-noun.artifact	, , 0	Forty NNP B-noun.person	- : 0	four CD 0	patients NNS B-noun.person	were VBD 0	enrolled VBN B-verb.social	in IN 0	the DT 0	study NN B-noun.artifact	of IN 0	which WDT 0	7 CD 0	( ( 0	16 CD B-adj.all	% NN 0	) ) 0	were VBD B-verb.stative	ineligible JJ B-adj.all	. . 0	. . 0
a19889778.s1	Immune NNP B-noun.person	escape NN B-noun.artifact	variants NNS B-noun.artifact	of IN 0	the DT 0	hepatitis NN 0	B NNP 0	virus NN B-noun.animal	( ( 0	HBV NNP 0	) ) 0	represent VBP B-verb.social	an DT 0	emerging VBG B-verb.change	clinical JJ B-adj.all	challenge NN B-noun.communication	, , 0	because IN 0	they PRP 0	can MD 0	be VB 0	associated VBN B-verb.cognition	with IN 0	vaccine NN B-noun.artifact	escape NN B-noun.act	, , 0	HBV NNP 0	reactivation NN B-noun.process	, , 0	and CC 0	failure NN B-noun.person	of IN 0	diagnostic JJ B-adj.all	tests NNS B-noun.cognition	. . 0	. . 0
a19473225.s5	There EX 0	was VBD B-verb.stative	no DT 0	significant JJ B-adj.all	difference NN B-noun.cognition	in IN 0	the DT 0	frequency NN B-noun.person	of IN 0	signs NNS B-noun.communication	or CC 0	symptoms NNS B-noun.body	between IN 0	the DT 0	two CD 0	groups NNS 0	although IN 0	neurotoxicity NN B-noun.person	symptoms NNS B-noun.person	presented VBD B-verb.communication	mostly RB B-adv.all	with IN 0	lower JJR B-adj.all	scores NNS B-noun.cognition	of IN 0	severity NN B-noun.attribute	in IN 0	group NN B-noun.person	G. NNP I-noun.person	However NNP I-noun.person	, , 0	this DT 0	difference NN B-noun.communication	reached VBD B-verb.communication	statistical JJ B-adj.all	significance NN B-noun.communication	only RB B-adv.all	with IN 0	regard NN B-noun.act	to TO 0	reported VBN B-verb.communication	pain NN B-noun.person	sensation NN B-noun.person	( ( 0	P UH 0	= SYM 0	0.011 CD 0	) ) 0	. . 0	. . 0
a11875660.s7	It PRP 0	was VBD 0	found VBN B-verb.cognition	that IN 0	the DT 0	transformation NN B-noun.act	of IN 0	exencephalic JJ B-adj.all	tissue NN B-noun.body	was VBD B-verb.stative	not RB B-adv.all	simply RB B-adv.all	size VB B-verb.perception	- : 0	dependent JJ B-adj.all	, , 0	and CC 0	all DT 0	cases NNS B-noun.event	of IN 0	anencephaly RB B-adv.all	at IN 0	E18.5 NNP B-noun.location	resulted VBD B-verb.stative	from IN 0	embryos NNS B-noun.person	with IN 0	a DT 0	large JJ B-adj.all	amount NN B-noun.quantity	of IN 0	exencephalic JJ B-adj.all	tissue NN B-noun.substance	at IN 0	E13.5 NNP B-noun.location	. . 0	. . 0
a7582165.s3	The DT 0	purpose NN B-noun.attribute	of IN 0	our PRP$ 0	study NN B-noun.artifact	was VBD 0	to TO 0	determine VB B-verb.communication	the DT 0	cause NN B-noun.act	of IN 0	the DT 0	patients NNS B-noun.person	' POS 0	reactions NNS B-noun.act	, , 0	the DT 0	immunological JJ B-adj.all	mechanisms NNS B-noun.person	involved VBN B-verb.stative	and CC 0	whether IN 0	these DT 0	patients NNS B-noun.person	would MD 0	be VB B-verb.stative	able JJ B-adj.all	to TO 0	tolerate VB B-verb.cognition	any DT 0	kind NN 0	of IN 0	corticoid JJ B-adj.all	. . 0	. . 0
a16904497.s13	She PRP 0	was VBD B-verb.stative	unable JJ B-adj.all	to TO 0	urinate VB B-verb.communication	. . 0	. . 0
a11250767.s8	CONCLUSION NN B-noun.group	, , 0	Pericarditis NNP B-noun.person	may MD 0	be VB B-verb.stative	the DT 0	initial JJ B-adj.all	manifestation NN B-noun.act	of IN 0	drug NN B-noun.person	- : 0	induced VBN B-verb.creation	vasculitis RBR B-adv.all	attributable JJ B-adj.all	to TO 0	propylthio-_uracil VB B-verb.motion	therapy NN I-verb.motion	. . 0	. . 0
a18083142.s7	In IN 0	experiments NNS B-noun.animal	using VBG B-verb.consumption	specific JJ B-adj.all	adrenergic JJ B-adj.all	antagonists NNS B-noun.person	, , 0	we PRP 0	found VBD B-verb.cognition	that IN 0	pretreatment NN B-noun.person	with IN 0	the DT 0	beta NN B-noun.body	- : 0	adrenergic JJ B-adj.all	receptor NN B-noun.person	antagonist JJ B-adj.all	propranolol NN B-noun.person	blocked VBD B-verb.contact	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	anxiety NN 0	- : 0	like IN 0	behavior NN B-noun.attribute	in IN 0	Dbh NNP 0	+ ( 0	/- : 0	and CC 0	wild JJ B-noun.person	- : 0	type NN B-noun.person	C57BL6/J JJ B-adj.all	mice NNS B-noun.animal	, , 0	while IN 0	the DT 0	alpha(1 NNP B-noun.location	) ) 0	antagonist NN 0	prazosin NN B-noun.person	and CC 0	the DT 0	alpha(2 NNP B-noun.location	) ) 0	antagonist VBP B-verb.communication	yohimbine PRP 0	had VBD 0	no DT 0	effect NN B-noun.phenomenon	. . 0	. . 0
a15145918.s4	Three CD 0	time NN 0	domain NN B-noun.person	indexes NNS I-noun.person	of IN 0	hemodynamic JJ B-adj.all	variability NN B-noun.attribute	were VBD 0	employed VBN B-verb.consumption	, , 0	the DT 0	standard JJ B-adj.all	deviation NN B-noun.event	of IN 0	mean JJ B-adj.all	arterial JJ B-adj.all	pressure NN B-noun.act	as IN 0	a DT 0	measure NN B-noun.attribute	of IN 0	blood NN B-noun.phenomenon	pressure NN I-noun.phenomenon	variability NN B-noun.phenomenon	and CC 0	the DT 0	standard JJ B-adj.all	deviation NN B-noun.event	of IN 0	beat NN B-noun.food	- : 0	to TO 0	- : 0	beat NN B-noun.cognition	intervals NNS I-noun.cognition	( ( 0	SDRR NNP B-noun.group	) ) 0	and CC 0	the DT 0	root NN B-noun.location	mean JJ B-adj.all	square NN B-noun.cognition	of IN 0	successive JJ B-adj.all	differences NNS B-noun.event	in IN 0	R SYM 0	- : 0	wave NN B-noun.attribute	- : 0	to TO 0	- : 0	R SYM 0	- : 0	wave NN B-noun.cognition	intervals NNS I-noun.cognition	as IN 0	measures NNS B-noun.person	of IN 0	heart NN B-noun.body	rate NN B-noun.time	variability NN B-noun.attribute	. . 0	. . 0
a10683478.s6	In IN 0	mice NNS B-noun.animal	, , 0	apomorphine NN B-noun.person	produced VBD B-verb.creation	qualitatively RB B-adv.all	different JJ B-adj.all	responses NNS B-noun.act	under IN 0	novel NN B-noun.communication	conditions NNS B-noun.artifact	when WRB 0	compared VBN B-verb.cognition	to TO 0	those DT 0	behaviors NNS B-noun.person	elicited VBN B-verb.emotion	in IN 0	the DT 0	home NN 0	test NN 0	cage NN B-noun.state	. . 0	. . 0
a17241784.s7	These DT 0	observations NNS B-noun.act	suggest VBP B-verb.communication	that IN 0	statins NNS B-noun.animal	may MD 0	initiate VB B-verb.cognition	an DT 0	immune JJ B-noun.person	- : 0	mediated VBN B-verb.cognition	myopathy NN I-verb.cognition	that WDT 0	persists VBZ B-verb.creation	after IN 0	withdrawal NN B-noun.person	of IN 0	the DT 0	drug NN B-noun.artifact	and CC 0	responds VBZ B-verb.social	to TO 0	immunosuppressive JJ B-adj.all	therapy NN B-noun.person	. . 0	. . 0
a11334364.s9	GSPE+drug NN 0	exposed VBN B-verb.perception	tissues NNS B-noun.body	exhibited VBD B-verb.perception	minor JJ B-adj.all	residual JJ B-adj.pert	damage NN B-noun.act	or CC 0	near IN 0	total JJ B-adj.all	recovery NN B-noun.process	. . 0	. . 0
a1549199.s2	The DT 0	physician NN B-noun.communication	should MD 0	also RB B-adv.all	determine VB B-verb.communication	the DT 0	proper JJ B-adj.all	use NN B-noun.attribute	of IN 0	any DT 0	adjunctive JJ B-adj.all	medications NNS B-noun.person	, , 0	such JJ 0	combined VBN B-verb.stative	therapy NN 0	has VBZ 0	become VBN B-verb.stative	the DT 0	standard JJ B-adj.all	approach NN B-noun.act	to TO 0	treatment NN B-noun.communication	. . 0	. . 0
a15899738.s3	Thyroid_disorders NNS B-noun.person	, , 0	illicit JJ B-adj.all	drug NN B-noun.person	or CC 0	stimulant JJ B-adj.all	use NN B-noun.person	, , 0	and CC 0	acute_alcohol_intoxication NN B-noun.act	are VBP B-verb.stative	among IN 0	these DT 0	causes NNS B-noun.event	. . 0	. . 0
a7930386.s5	For IN 0	both DT 0	experiments NNS B-noun.group	the DT 0	drug NN B-noun.artifact	intake NN B-noun.person	led VBD B-verb.motion	to TO 0	significant JJ B-adj.all	increases NNS B-noun.event	in IN 0	PRL NNP 0	secretion NN 0	, , 0	acting VBG B-verb.body	preferentially RB B-adv.all	on IN 0	tonic JJ B-adj.all	secretion NN B-noun.act	as IN 0	pulse JJ B-adj.all	amplitude NN B-noun.person	and CC 0	frequency NN B-noun.person	did VBD 0	not RB B-adv.all	differ VB B-verb.cognition	significantly RB B-adv.all	from IN 0	corresponding VBG B-verb.social	control NN B-noun.act	values NNS B-noun.attribute	. . 0	. . 0
a8423889.s0	Increase NNP B-noun.other	of IN I-noun.other	Parkinson_disability NN I-noun.other	after IN 0	fluoxetine JJ B-adj.all	medication NN B-noun.artifact	. . 0	. . 0
a8590259.s6	Conjunctival_blanching VBG B-verb.communication	and CC 0	mydriasis NN B-noun.person	were VBD 0	commonly RB B-adv.all	found VBN B-verb.possession	. . 0	. . 0
a20084309.s3	METHOD NNP B-noun.attribute	, , 0	prospective JJ B-adj.all	study NN B-noun.artifact	with IN 0	137 CD 0	patients NNS B-noun.person	that WDT 0	underwent VBD B-verb.stative	TEE NNP 0	with IN 0	MZ NNP 0	associated VBN B-verb.cognition	to TO 0	moderate JJ B-adj.all	sedation NN B-noun.person	. . 0	. . 0
a2445283.s3	The DT 0	average JJ B-adj.all	time NN B-noun.time	of IN 0	death NN B-noun.phenomenon	was VBD 0	delayed VBN B-verb.change	. . 0	. . 0
a9869257.s8	The DT 0	maximal JJ B-adj.all	NGF NNP B-noun.group	contents NNS B-noun.group	obtained VBN B-verb.social	by IN 0	PG-9 NNP B-noun.person	were VBD B-verb.stative	17.6-fold JJ 0	of IN 0	the DT 0	control NN B-noun.possession	value NN B-noun.possession	. . 0	. . 0
a12707296.s5	Crossover NNP B-noun.person	studies NNS I-noun.person	were VBD 0	performed VBN B-verb.consumption	2 CD B-adj.all	weeks NNS B-noun.time	apart RB B-adv.all	. . 0	. . 0
a8372922.s10	The DT 0	region NN B-noun.act	of IN 0	cortex NN B-noun.communication	that WDT 0	represents VBZ B-verb.stative	the DT 0	low JJ B-adj.all	frequencies NNS B-noun.person	was VBD B-verb.stative	not RB B-adv.all	obviously RB B-adv.all	affected VBN B-verb.change	by IN 0	the DT 0	cochlear NN 0	hearing_loss NN 0	. . 0	. . 0
a7352670.s0	Rebound VB B-verb.change	hypertensive JJ I-verb.change	after IN 0	sodium_nitroprusside RB 0	prevented VBN B-verb.creation	by IN 0	saralasin NN B-noun.person	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a14513889.s4	This DT 0	case NN B-noun.state	illustrates VBZ B-verb.change	the DT 0	need NN B-noun.object	for IN 0	close JJ B-adj.all	vigilance NN B-noun.person	in IN 0	adverse_drug_reactions NNS 0	, , 0	particularly RB B-adv.all	in IN 0	the DT 0	elderly JJ B-adj.all	. . 0	. . 0
a1835291.s1	The DT 0	bronchodilator NN 0	effects NNS B-noun.phenomenon	of IN 0	a DT 0	single JJ B-adj.all	dose NN B-noun.event	of IN 0	ipratropium_bromide JJ 0	aerosol NN B-noun.phenomenon	( ( 0	36 CD 0	micrograms NNS B-noun.quantity	) ) 0	and CC 0	short JJ B-noun.body	- : 0	acting VBG B-verb.stative	theophylline NN 0	tablets NNS B-noun.artifact	( ( 0	dose RB 0	titrated VBN 0	to TO 0	produce VB B-verb.cognition	serum NN B-noun.state	levels NNS B-noun.attribute	of IN 0	10 CD B-adj.all	- : 0	20 CD B-adj.all	micrograms NNS B-noun.quantity	/ : 0	mL LS 0	) ) 0	were VBD 0	compared VBN B-verb.change	in IN 0	a DT 0	double JJ B-adj.all	- : 0	blind NN B-noun.person	, , 0	placebo NN B-noun.person	- : 0	controlled JJ B-verb.social	crossover NN B-adj.all	study NN B-noun.artifact	in IN 0	21 CD B-adj.all	patients NNS B-noun.person	with IN 0	stable JJ B-adj.all	, , 0	chronic_obstructive_pulmonary_disease NNP 0	. . 0	. . 0
a3564823.s2	Intense JJ B-adj.all	vasospasm NN B-noun.artifact	with IN 0	threatened VBN B-verb.communication	gangrene NN B-noun.person	arose VBD B-verb.creation	in IN 0	the DT 0	arm NN 0	used VBN B-verb.consumption	for IN 0	the DT 0	infusion NN B-noun.cognition	. . 0	. . 0
a3101906.s3	An DT 0	analysis NN B-noun.communication	of IN 0	the DT 0	75 CD 0	cases NNS B-noun.quantity	that WDT 0	had VBD 0	been VBN 0	adequately RB B-adv.all	followed VBD B-verb.stative	up RP 0	suggested VBD B-verb.communication	that IN 0	16 CD B-adj.all	, , 0	including VBG B-verb.stative	three CD B-adj.all	deaths NNS B-noun.time	, , 0	were VBD B-verb.stative	probably RB B-adv.all	related VBN B-verb.cognition	to TO 0	treatment NN B-noun.person	with IN 0	the DT 0	drug NN B-noun.artifact	. . 0	. . 0
a3425586.s4	Although IN 0	the DT 0	AE NNP B-noun.person	RBCs NNP I-noun.person	from IN 0	an DT 0	individual NN 0	not RB 0	taking VBG 0	dapsone NN B-noun.person	had VBD 0	increased VBN B-verb.change	incubated VBN B-verb.stative	Heinz NNP 0	body NN 0	formation NN B-noun.act	, , 0	the DT 0	GSH NNP B-noun.other	content NN B-noun.artifact	and CC 0	GSH NNP 0	stability NN 0	were VBD B-verb.stative	normal JJ B-adj.all	. . 0	. . 0
a150790.s4	A DT 0	placebo NN B-noun.person	had VBD 0	no DT 0	effect NN B-noun.cognition	, , 0	but CC 0	niacinamide NN B-noun.person	was VBD B-verb.stative	as IN 0	effective JJ 0	as IN 0	pyridoxine NN 0	. . 0	. . 0
a20084309.s2	OBJECTIVE NNP B-noun.group	, , 0	to TO 0	analyze VB B-verb.cognition	aspects NNS B-noun.attribute	of IN 0	TEE NNP B-noun.group	safety NN B-noun.artifact	associated VBN B-verb.cognition	to TO 0	the DT 0	use NN 0	of IN 0	Midazolan NNP B-noun.person	( ( 0	MZ NNP 0	) ) 0	and CC 0	Flumazenil NNP B-noun.person	( ( 0	FL NNP 0	) ) 0	and CC 0	the DT 0	influence NN B-noun.cognition	of IN 0	the DT 0	clinical JJ B-adj.all	variables NNS B-noun.cognition	on IN 0	the DT 0	event NN B-adj.pert	rate NN B-noun.time	. . 0	. . 0
a18809400.s2	We PRP 0	used VBD B-verb.consumption	an DT 0	in IN 0	vitro NN 0	model NN 0	of IN 0	chemotherapy NN B-noun.communication	induced VBN B-verb.creation	peripheral_neuropathy JJ 0	that IN 0	closely RB B-adv.all	mimic VB B-verb.change	the DT 0	in FW 0	vivo FW 0	condition NN 0	by IN 0	exposing VBG B-verb.change	primary JJ B-adj.all	cultures NNS B-noun.act	of IN 0	dorsal JJ B-adj.all	root NN 0	ganglion NN 0	( ( 0	DRG NNP 0	) ) 0	sensory NN B-noun.location	neurons NNS B-noun.person	to TO 0	paclitaxel VB B-verb.contact	and CC 0	cisplatin NN B-noun.person	, , 0	two CD 0	widely RB B-adv.all	used VBN B-verb.consumption	and CC 0	highly RB B-adv.all	effective JJ B-adj.all	chemotherapeutic JJ B-adj.all	drugs NNS B-noun.artifact	. . 0	. . 0
a18308784.s8	The DT 0	electrophysiological JJ B-adj.all	recording NN B-noun.act	in IN 0	vitro NN B-noun.person	showed VBD B-verb.communication	that IN 0	Rg1 NNP B-noun.person	restored VBD B-verb.social	the DT 0	LTP NNP B-noun.group	in IN 0	slices NNS B-noun.act	from IN 0	the DT 0	rats NNS B-noun.plant	treated VBN B-verb.change	with IN 0	morphine NN B-noun.person	, , 0	but CC 0	not RB B-adv.all	changed VBN B-verb.change	LTP NNP 0	in IN 0	the DT 0	slices NNS B-noun.artifact	from IN 0	normal JJ B-adj.all	saline- NN B-noun.act	or CC 0	morphine JJR B-noun.quantity	/ : 0	Rg1-treated VBN B-verb.emotion	rats NNS I-verb.emotion	, , 0	this DT 0	restoration NN B-noun.act	could MD 0	be VB 0	inhibited VBN B-verb.change	by IN 0	N NNP 0	- : 0	methyl NN B-noun.attribute	- : 0	D SYM 0	- : 0	aspartate NN B-noun.person	( ( 0	NMDA NNP 0	) ) 0	receptor NN B-noun.person	antagonist NN B-noun.person	MK801 NN B-noun.person	. . 0	. . 0
a11263551.s6	Pain NNP B-noun.person	was VBD B-verb.stative	not RB B-adv.all	explained VBN B-verb.communication	by IN 0	other JJ 0	diseases NNS B-noun.person	causing VBG B-verb.creation	foot NN B-noun.body	pain NN I-noun.body	, , 0	like IN 0	reflex_sympathetic_dystrophy NN B-noun.food	, , 0	polyneuropathy JJ B-adj.all	, , 0	Morton's_neuralgia NNP B-noun.person	, , 0	gout NN B-noun.person	, , 0	osteoporosis NN B-noun.person	, , 0	avascular_necrosis NN B-noun.location	, , 0	intermittent_claudication NN 0	, , 0	orthopaedic JJ B-adj.all	foot_deformities NNS B-noun.food	, , 0	stress_fractures NNS B-noun.artifact	, , 0	and CC 0	hyperparathyroidism NN B-noun.artifact	. . 0	. . 0
a20528871.s5	Our PRP$ 0	experience NN B-noun.cognition	supports VBZ B-verb.cognition	the DT 0	safety NN B-noun.person	of IN 0	giving VBG B-verb.possession	AraG RP 0	as IN 0	salvage NN B-noun.act	therapy NN B-noun.act	in IN 0	synchrony NN 0	with IN 0	etoposide NN B-noun.artifact	and CC 0	cyclophosphamide NN B-noun.person	, , 0	although IN 0	neurological_toxicity NN B-noun.person	must MD 0	be VB B-verb.stative	closely RB B-adj.all	monitored VBN I-adj.all	. . 0	. . 0
a20633755.s1	Suxamethonium NNP B-noun.person	causes VBZ B-verb.communication	prolonged JJ B-adj.all	apnea NN B-noun.person	in IN 0	patients NNS B-noun.person	in IN 0	whom WP 0	pseudocholinesterase VBP B-verb.cognition	enzyme NN B-noun.person	gets VBZ 0	deactivated VBN B-verb.cognition	by IN 0	organophosphorus_(OP)_poisons NNS B-noun.act	. . 0	. . 0
a7420681.s5	Five CD 0	of IN 0	33 CD 0	( ( 0	15 CD B-adj.all	% NN 0	) ) 0	of IN 0	the DT 0	tobramycin NN B-noun.person	- : 0	treated VBN B-verb.communication	patients NNS B-noun.person	and CC 0	16 CD B-adj.all	of IN 0	29 CD B-noun.quantity	( ( 0	55.2 CD 0	% NN 0	) ) 0	of IN 0	the DT 0	gentamicin NN B-noun.communication	- : 0	treated VBN B-verb.communication	patients NNS B-noun.person	had VBD 0	renal_failure NN B-noun.other	. . 0	. . 0
a9390208.s9	One CD 0	patient NN B-noun.person	had VBD 0	complete JJ B-adj.all	response NN B-noun.communication	, , 0	seven CD 0	had VBD 0	stable JJ B-adj.all	disease NN B-noun.person	, , 0	none NN 0	had VBD 0	partial JJ B-adj.all	response NN B-noun.communication	and CC 0	five CD 0	had VBD 0	progressive JJ B-adj.all	disease NN B-noun.state	. . 0	. . 0
a15572383.s15	This DT 0	supports VBZ B-verb.social	the DT 0	assumption NN B-noun.cognition	that IN 0	differences NNS B-noun.state	in IN 0	renal JJ B-adj.all	ACE NNP B-noun.person	activity NN I-noun.person	predispose VBP B-verb.cognition	to TO 0	a DT 0	less RBR B-adv.all	favourable JJ B-adj.all	course NN B-noun.location	of IN 0	renal_damage NN B-noun.act	. . 0	. . 0
a12789195.s3	Pseudoacromegaly NNP B-noun.person	, , 0	on IN 0	the DT 0	other JJ B-adj.all	hand NN B-noun.communication	, , 0	is VBZ B-verb.stative	the DT 0	presence NN B-noun.person	of IN 0	similar JJ B-adj.all	acromegaloid NN B-noun.body	features NNS B-noun.body	in IN 0	the DT 0	absence NN B-noun.act	of IN 0	elevated JJ B-adj.all	growth NN 0	hormone NN 0	or CC 0	insulin NN B-noun.substance	- : 0	like IN 0	growth NN B-noun.process	factor NN B-noun.location	levels NNS B-noun.state	. . 0	. . 0
a8649546.s4	This DT 0	study NN B-noun.communication	suggests VBZ B-verb.communication	that IN 0	administration NN B-noun.time	of IN 0	low JJ B-adj.all	doses NNS B-noun.event	of IN 0	beta JJ B-adj.pert	- : 0	blockers NNS B-noun.person	may MD 0	improve VB B-verb.possession	levodopa NN B-noun.attribute	- : 0	induced VBN B-verb.creation	ballistic JJ B-adj.all	and CC 0	choreic JJ B-adj.all	dyskinesia NN B-noun.state	in IN 0	PD NNP 0	. . 0	. . 0
a9100294.s2	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	designed VBN B-verb.creation	to TO 0	investigate VB B-verb.communication	the DT 0	hypothesis NN B-noun.communication	that WDT 0	calcium VBP B-verb.stative	channel NN 0	blockers NNS B-verb.weather	in IN 0	general JJ B-adj.all	induce NN B-noun.communication	cardiovascular_malformations NNS B-noun.communication	indicating VBG B-verb.creation	a DT 0	pharmacologic JJ B-adj.all	class NN B-noun.person	effect NN B-noun.cognition	. . 0	. . 0
a8638206.s4	We PRP 0	report VBP B-verb.communication	a DT 0	case NN B-noun.state	of IN 0	atracurium NN B-noun.person	- : 0	related JJ B-adj.all	paralysis NN B-noun.person	persisting VBG B-verb.social	for IN 0	approximately RB B-adv.all	50 CD B-adj.all	hours NNS B-noun.person	in IN 0	a DT 0	patient NN B-noun.person	who WP 0	was VBD B-verb.stative	not RB B-adv.all	treated VBN B-verb.change	with IN 0	corticosteroids NNS B-noun.food	. . 0	. . 0
a11532387.s4	The DT 0	symptom NN B-noun.communication	was VBD 0	treated VBN B-verb.change	successfully RB B-adv.all	with IN 0	trihexyphenidyl RBR B-adj.all	anticholinergic JJ B-adj.pert	therapy NN B-noun.act	. . 0	. . 0
a6640832.s13	The DT 0	beneficial JJ B-adj.all	effect NN B-noun.cognition	of IN 0	Adriamycin NNP B-noun.person	appears VBZ B-verb.communication	obvious JJ B-adj.all	and CC 0	might MD 0	be VB 0	related VBN B-verb.cognition	to TO 0	the DT 0	drug NN B-noun.person	itself PRP 0	, , 0	the DT 0	early JJ B-adj.all	and CC 0	repeated VBD B-verb.communication	instillations NNS B-noun.communication	after IN 0	TUR NNP B-noun.group	, , 0	or CC 0	both DT 0	. . 0	. . 0
a18442015.s3	Additionally RB B-adv.all	, , 0	the DT 0	protective JJ B-adj.all	effect NN B-noun.cognition	of IN 0	verapamil NN B-noun.artifact	on IN 0	this DT 0	ulcer NN B-adj.all	model NN B-noun.person	was VBD 0	evaluated VBN B-verb.change	. . 0	. . 0
a19473225.s4	Patients NNS B-noun.person	were VBD 0	evaluated VBN B-verb.communication	by IN 0	neurological JJ B-noun.person	examinations NNS I-noun.person	, , 0	questionnaires NNS B-noun.person	and CC 0	sensory JJ B-noun.person	- : 0	motor NN B-verb.creation	nerve NN B-noun.attribute	conduction NN B-noun.process	studies NNS B-noun.artifact	. . 0	. . 0
a17344566.s0	Simvastatin NNP B-noun.person	- : 0	induced VBN B-verb.creation	bilateral JJ B-adj.all	leg NN B-noun.act	compartment_syndrome NN I-noun.act	and CC 0	myonecrosis NN B-noun.cognition	associated VBN B-verb.cognition	with IN 0	hypothyroidism NN B-noun.artifact	. . 0	. . 0
a8752018.s3	This DT 0	report NN B-noun.communication	summarizes VBZ B-verb.communication	our PRP$ 0	experience NN B-noun.cognition	in IN 0	switching VBG B-verb.change	bipolar JJ B-adj.all	patients NNS B-noun.person	from IN 0	lithium NN B-noun.animal	to TO 0	divalproex_sodium NN 0	to TO 0	alleviate VB B-verb.possession	such JJ B-adj.all	cognitive_and_functional_impairments NNS B-noun.person	. . 0	. . 0
a17439425.s13	6 CD B-adj.all	. . 0	. . 0
a15338796.s3	Aim NN 0	of IN 0	the DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	determine VB B-verb.communication	sensitivity NN B-noun.feeling	, , 0	reproducibility NN B-noun.person	, , 0	reference NN B-noun.phenomenon	values NNS B-noun.attribute	and CC 0	the DT 0	agreement NN B-noun.person	with IN 0	a DT 0	questionnaire NN B-noun.communication	. . 0	. . 0
a11379838.s4	RESULTS NNS B-noun.artifact	, , 0	Switches VBZ B-verb.motion	to TO 0	hypomania NN B-noun.person	or CC 0	mania NN B-noun.location	occurred VBD B-verb.stative	in IN 0	27 CD B-adj.all	% NN 0	of IN 0	all DT 0	patients NNS B-noun.person	( ( 0	N NNP 0	= SYM 0	12 CD B-adj.all	) ) 0	( ( 0	and CC 0	in IN 0	24 CD B-adj.all	% NN 0	of IN 0	the DT 0	subgroup NN B-noun.group	of IN 0	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	SSRIs NNP B-noun.other	[ POS I-noun.other	8/33 CD I-noun.other	] LS 0	) ) 0	, , 0	16 CD B-adj.all	% NN 0	( ( 0	N NNP 0	= SYM 0	7 CD B-adj.all	) ) 0	experienced VBD B-verb.perception	manic JJ B-adj.pert	episodes NNS B-noun.communication	, , 0	and CC 0	11 CD B-adj.all	% NN 0	( ( 0	N NNP 0	= SYM 0	5 CD B-adj.all	) ) 0	experienced VBD B-verb.perception	hypomanic JJ B-adj.all	episodes NNS B-noun.communication	. . 0	. . 0
a16330293.s10	Five CD B-adj.all	hundred CD 0	fifty JJ B-adj.all	- : 0	three CD 0	patients NNS B-noun.person	, , 0	264 CD 0	taking VBG B-verb.possession	the DT 0	lozenge NN B-noun.artifact	and CC 0	289 CD 0	taking VBG B-verb.possession	the DT 0	gum NN B-noun.person	, , 0	used VBD B-verb.consumption	the DT 0	study NN B-noun.artifact	product NN B-noun.artifact	for IN 0	> CD 0	or CC 0	= $ 0	4 CD B-adj.all	days NNS B-noun.phenomenon	per IN 0	week NN B-noun.animal	during IN 0	the DT 0	first JJ B-verb.competition	2 CD B-adj.all	weeks NNS B-noun.time	( ( 0	evaluable JJ B-adj.all	population NN B-noun.attribute	) ) 0	. . 0	. . 0
a17612891.s3	RESULTS NNS B-noun.artifact	, , 0	A DT 0	20-year JJ 0	- : 0	old JJ B-adj.all	male NN B-noun.person	with IN 0	schizophrenia NN B-noun.person	developed VBD B-verb.creation	a DT 0	sudden JJ B-adj.all	onset NN B-noun.event	of IN 0	myocarditis NN B-noun.food	after IN 0	commencement NN B-noun.person	of IN 0	clozapine NN B-noun.phenomenon	. . 0	. . 0
a2224762.s0	A DT 0	phase NN B-noun.time	I PRP 0	study NN B-verb.cognition	of IN 0	4'-0-tetrahydropyranyladriamycin NNP B-noun.person	. . 0	Clinical NNP B-noun.person	pharmacology NN I-noun.person	and CC 0	pharmacokinetics NNS B-noun.person	. . 0	. . 0
a15188772.s2	In IN 0	contrast NN 0	, , 0	reports NNS B-noun.communication	of IN 0	myocardial_dysfunction CD 0	due JJ 0	to TO 0	acute VB B-verb.change	iatrogenic JJ B-adj.all	overdose NN B-noun.state	are VBP B-verb.stative	rare JJ B-adj.all	. . 0	. . 0
a11007689.s6	With IN 0	the DT 0	more RBR B-noun.quantity	widespread JJ B-adj.all	application NN B-noun.act	of IN 0	tacrolimus NN B-noun.food	in IN 0	organ NN B-noun.artifact	transplantation NN I-noun.artifact	, , 0	tacrolimus NN B-noun.person	- : 0	associated VBN B-verb.cognition	TMA NNP B-noun.group	has VBZ 0	also RB B-adv.all	been VBN 0	recognized VBN B-verb.cognition	. . 0	. . 0
a11279304.s10	On IN 0	the DT 0	other JJ B-adj.all	hand NN B-noun.communication	, , 0	BNP NNP B-noun.group	did VBD 0	not RB B-adv.all	increase VB B-verb.change	in IN 0	the DT 0	patients NNS B-noun.person	without IN 0	heart_failure NN B-noun.act	given VBN B-verb.possession	DNR NNP 0	, , 0	even RB B-adv.all	at IN 0	more JJR B-noun.quantity	than IN 0	700 CD 0	mg PRP 0	/ : 0	m(2 LS 0	) ) 0	. . 0	. . 0
a10579464.s6	NRA0160 NN B-noun.artifact	and CC 0	clozapine NN B-noun.person	significantly RB B-adv.all	induced VBN B-verb.creation	catalepsy NN B-noun.artifact	in IN 0	rats NNS B-noun.animal	, , 0	although IN 0	their PRP$ 0	effects NNS B-noun.phenomenon	did VBD 0	not RB B-adv.all	exceed VB B-verb.stative	50 CD B-adj.all	% NN 0	induction NN B-noun.time	even RB B-adv.all	at IN 0	the DT 0	highest JJS B-adj.all	dose NN B-noun.act	given VBN B-verb.possession	. . 0	. . 0
a17919553.s12	Recurrence NN B-noun.act	of IN 0	hepatitis NN B-noun.artifact	attack NN B-noun.artifact	might MD 0	have VB 0	been VBN 0	avoided VBN B-verb.social	if IN 0	the DT 0	initial JJ B-adj.all	incident NN B-noun.person	had VBD 0	been VBN 0	communicated VBN B-verb.communication	to TO 0	the DT 0	attending VBG B-verb.stative	physician NN 0	who WP 0	prescribed VBD B-verb.communication	telithromycin NN B-noun.communication	the DT 0	second JJ B-adj.all	time NN B-noun.time	. . 0	. . 0
a983936.s1	A DT 0	reproducible JJ B-adj.all	model NN B-noun.person	for IN 0	producing VBG B-verb.communication	diffuse NN B-noun.communication	myocardial_injury NN I-noun.communication	( ( 0	epinephrine NN 0	infusion NN 0	) ) 0	has VBZ 0	been VBN 0	developed VBN B-verb.creation	to TO 0	study VB B-verb.cognition	the DT 0	cardioprotective JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	agents NNS B-noun.person	or CC 0	maneuvers NNS B-noun.substance	which WDT 0	might MD 0	alter VB B-verb.change	the DT 0	evolution NN B-noun.time	of IN 0	acute JJ B-adj.all	myocardial_infarction NN B-noun.person	. . 0	. . 0
a8595686.s9	Recovery NN B-noun.artifact	room NN I-noun.artifact	discharge NN B-noun.phenomenon	times NNS B-noun.event	were VBD B-verb.stative	similar JJ B-adj.all	, , 0	C NNP 0	( ( 0	75.9 CD 0	+ : 0	/- $ 0	19.4 CD 0	min NN B-noun.quantity	) ) 0	, , 0	L NNP 0	73.6 CD 0	+ : 0	/- $ 0	21.6 CD 0	min NN 0	) ) 0	, , 0	T NNP 0	( ( 0	77.1 CD 0	+ : 0	/- $ 0	18.9 CD 0	min NN B-noun.quantity	) ) 0	. . 0	. . 0
a9766615.s2	Thus RB 0	, , 0	clinicians NNS B-noun.person	should MD 0	address VB B-verb.communication	patients NNS B-noun.person	' POS 0	concerns NNS B-noun.possession	about IN 0	adverse JJ B-adj.all	effects NNS B-noun.phenomenon	and CC 0	attempt NN B-noun.act	to TO 0	choose VB B-verb.cognition	medications NNS B-noun.person	that WDT 0	will MD 0	improve VB B-verb.creation	their PRP$ 0	patients NNS B-noun.person	' POS 0	quality NN B-noun.cognition	of IN 0	life NN B-noun.phenomenon	as RB 0	well RB 0	as IN 0	overall JJ B-adj.all	health NN B-noun.person	. . 0	. . 0
a12536034.s2	Despite IN 0	the DT 0	underlying JJ B-adj.all	diseases NNS B-noun.person	, , 0	the DT 0	prognosis NN B-noun.person	for IN 0	drug NN B-noun.person	- : 0	induced VBN B-verb.creation	de IN 0	novo RB B-adj.all	absence_seizure JJ B-noun.relation	is VBZ B-verb.stative	good JJ 0	because IN 0	it PRP 0	subsides VBZ B-verb.possession	rapidly RB B-adv.all	after IN 0	discontinuing VBG B-verb.motion	the DT 0	use NN 0	of IN 0	the DT 0	offending VBG B-noun.artifact	drugs NNS I-noun.artifact	. . 0	. . 0
a14596845.s2	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	examined VBD B-verb.communication	whether IN 0	female NN B-noun.person	rats NNS B-noun.person	on IN 0	various JJ B-adj.all	regimens NNS B-noun.location	of IN 0	sugar NN B-noun.phenomenon	access NN B-noun.artifact	would MD 0	show VB B-verb.communication	behavioral_cross JJ B-noun.person	- : 0	sensitization NN B-noun.time	to TO 0	a DT 0	low JJ B-adj.all	dose NN B-noun.quantity	of IN 0	amphetamine NN B-noun.person	. . 0	. . 0
a1867351.s5	The DT 0	incidence NN B-noun.communication	calculation NN B-noun.communication	revealed VBD B-verb.communication	that IN 0	one CD 0	of IN 0	215 CD 0	therapeutic JJ B-adj.pert	users NNS B-noun.person	had VBD 0	reactions NNS B-noun.motive	, , 0	compared VBN B-verb.cognition	with IN 0	one CD 0	of IN 0	13,000 CD 0	in IN 0	the DT 0	prophylaxis NN B-noun.location	group NN 0	, , 0	making VBG B-verb.social	the DT I-verb.social	risk NN I-verb.social	of IN 0	neuropsychiatric JJ B-noun.act	reactions NNS I-noun.act	after IN 0	mefloquine JJ B-adj.all	treatment NN B-noun.communication	60 CD B-adj.all	times NNS B-noun.event	higher JJR B-adj.all	than IN 0	after IN 0	prophylaxis NNS B-noun.person	. . 0	. . 0
a9522143.s7	None NN 0	of IN 0	the DT 0	patients NNS B-noun.person	complained VBD B-verb.stative	of IN 0	subjective JJ B-adj.all	hearing_loss NN B-noun.process	. . 0	. . 0
a12536034.s7	By IN 0	understanding VBG B-verb.cognition	the DT 0	underlying VBG 0	mechanism NN B-noun.attribute	of IN 0	absence_epilepsy JJ B-noun.artifact	, , 0	we PRP 0	can MD 0	avoid VB B-verb.social	the DT 0	inappropriate JJ B-adj.all	use NN 0	of IN 0	anticonvulsants NNS B-noun.person	in IN 0	children NNS B-noun.animal	with IN 0	epilepsy NN B-noun.artifact	and CC 0	prevent VB B-verb.possession	drug NN B-noun.person	- : 0	induced VBN B-verb.creation	absence_seizures NNS B-noun.artifact	. . 0	. . 0
a9862868.s5	We PRP 0	used VBD B-verb.consumption	rat NN 0	models NNS 0	of IN 0	intrahepatic_cholestasis NN B-noun.food	by IN 0	ethinyl_estradiol NN 0	( ( 0	EE NNP 0	) ) 0	treatment NN B-noun.communication	and CC 0	extrahepatic_cholestasis NN B-noun.act	by IN 0	bile JJ B-adj.all	duct NN B-noun.substance	ligation NN B-noun.relation	( ( 0	BDL NNP 0	) ) 0	to TO 0	precisely RB B-adv.all	determine VB B-verb.cognition	the DT 0	site NN B-noun.location	of IN 0	TJ NNP 0	damage NN 0	. . 0	. . 0
a16867021.s16	reduced VBN B-verb.change	locomotor NN 0	time NN B-noun.time	, , 0	distance NN B-noun.person	traveled VBN B-verb.motion	and CC 0	average JJ B-adj.all	speed NN B-noun.person	( ( 0	P NNP 0	< $ 0	0.05 CD 0	) ) 0	. . 0	. . 0
a16755009.s5	DCE NNP 0	( ( 0	200 CD 0	, , 0	400 CD 0	mg NN B-noun.quantity	/ : 0	kg PRP 0	, , 0	p.o RB 0	. . 0	) ) 0	. . 0
a16867021.s18	could MD 0	partially RB B-adv.all	reverse VB B-verb.communication	such JJ B-adj.all	effects NNS B-noun.phenomenon	of_THP RB 0	( ( 0	3.75 CD 0	mg FW B-noun.quantity	/ FW 0	kg FW 0	i.p FW 0	. . 0	) ) 0	. . 0	. . 0
a9721172.s0	Drug NN B-noun.person	- : 0	associated JJ B-adj.all	acute NN B-noun.person	- : 0	onset JJ B-adj.all	vanishing_bile_duct NNP B-noun.other	and CC 0	Stevens NNP B-noun.person	- : 0	Johnson_syndromes NNS B-noun.act	in IN 0	a DT 0	child NN B-noun.person	. . 0	. . 0
a9100294.s5	A DT 0	low JJ B-adj.all	incidence NN B-noun.event	of IN 0	cardiovascular_malformations NNS B-noun.artifact	was VBD 0	observed VBN B-verb.perception	after IN 0	exposure NN B-noun.person	to TO 0	each DT 0	of IN 0	the DT 0	four CD 0	calcium NN 0	channel NN 0	blockers NNS B-noun.person	, , 0	but CC 0	this DT 0	incidence NN B-noun.event	was VBD B-verb.stative	statistically RB B-adv.all	significant JJ 0	only RB B-adv.all	for IN 0	verapamil NN B-noun.artifact	and CC 0	nifedipine NN B-noun.person	. . 0	. . 0
a6534871.s2	The DT 0	rats NNS B-noun.plant	were VBD 0	trained VBN B-verb.cognition	to TO 0	swim VB B-verb.motion	for IN 0	a DT 0	specific JJ B-adj.all	duration NN B-noun.attribute	and CC 0	for IN 0	a DT 0	particular JJ B-adj.all	period NN B-noun.person	. . 0	. . 0
a17400887.s6	Immunohistochemical JJ B-adj.all	studies NNS B-noun.person	showed VBD B-verb.communication	that IN 0	administration NN B-noun.time	of IN 0	terbutaline NN B-noun.artifact	on IN 0	PN NNP 0	2 CD 0	to TO 0	5 CD 0	produced VBD B-verb.creation	a DT 0	robust JJ B-adj.all	increase NN B-noun.event	in IN 0	microglial JJ B-adj.all	activation NN B-noun.act	on IN 0	PN $ 0	30 CD B-adj.all	in IN 0	the DT 0	cerebral JJ B-noun.body	cortex NN I-noun.body	, , 0	as RB 0	well RB 0	as IN 0	in IN 0	cerebellar JJ B-adj.all	and CC 0	cerebrocortical JJ B-adj.all	white JJ B-adj.all	matter NN B-noun.cognition	. . 0	. . 0
a7234705.s2	In IN 0	four CD 0	patients NNS B-noun.person	, , 0	polymorphous JJ B-adj.all	ventricular_tachycardia NNS B-noun.location	appeared VBD B-verb.communication	after IN 0	intravenous JJ B-adj.all	administration NN B-noun.time	of IN 0	200 CD 0	to TO 0	400 CD 0	mg NN B-noun.quantity	of IN 0	procainamide NN B-noun.person	for IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	sustained VBN B-verb.contact	ventricular_tachycardia NNP B-noun.person	. . 0	. . 0
a17439425.s11	Dex NNP B-noun.person	increased_SBP NNP I-noun.person	( ( 0	110 CD 0	+ : 0	/- # 0	2 SYM 0	- : 0	126 CD 0	+ . 0	/- $ 0	3 CD B-adj.all	mmHg CD B-noun.quantity	, , 0	P NNP 0	< $ 0	0.001 CD 0	) ) 0	and CC 0	decreased_thymus_(P_<_0.001)_and_bodyweights NNS B-noun.attribute	( ( 0	P NNP 0	" : 0	< $ 0	0.01 CD 0	) ) 0	. . 0	. . 0
a9522143.s2	Up RB 0	until IN 0	now RB 0	, , 0	the DT 0	only JJ B-adj.all	factor NN B-noun.person	studied VBD B-verb.cognition	has VBZ 0	been VBN B-verb.stative	the DT 0	effect NN B-noun.cognition	of IN 0	the DT 0	diameter NN B-noun.attribute	of IN 0	the DT 0	spinal JJ B-adj.all	needle NN B-noun.artifact	on IN 0	post NN B-noun.act	- : 0	operative JJ B-adj.all	sensorineural_hearing_loss NN B-noun.person	. . 0	. . 0
a8372922.s9	The DT 0	results NNS B-noun.communication	indicate VBP B-verb.communication	that IN 0	the DT 0	deprived VBN B-adj.all	area NN B-noun.cognition	of IN 0	A1 JJ B-adj.all	undergoes NNS B-noun.artifact	extensive JJ B-adj.all	reorganization NN B-noun.act	and CC 0	becomes VBZ B-verb.stative	responsive JJ B-adj.all	to TO 0	intact JJ B-adj.all	cochlear NN 0	frequencies NNS B-noun.relation	. . 0	. . 0
a9869257.s7	PG-9 NN B-noun.artifact	was VBD B-verb.stative	also RB B-adv.all	able JJ B-adj.all	to TO 0	increase VB B-verb.change	the DT 0	amount NN B-noun.possession	of IN 0	NGF NNP 0	secreted VBN B-verb.communication	in IN 0	vitro NN B-noun.animal	by IN 0	astrocytes NNS B-noun.person	in IN 0	a DT 0	dose NN B-noun.person	- : 0	dependent JJ B-adj.all	manner NN B-noun.person	. . 0	. . 0
a1664218.s7	1 CD B-adj.all	patient NN B-noun.person	with IN 0	squamous_cell_carcinoma NNP B-noun.group	achieved VBD B-verb.social	a DT 0	partial JJ B-adj.all	response NN B-noun.communication	lasting JJ B-verb.stative	5 CD B-adj.all	months NNS B-noun.person	. . 0	. . 0
a8739323.s6	Following VBG 0	polytherapy NN 0	according VBG 0	to TO 0	the DT 0	CMF NNP B-noun.person	regimen NNS I-noun.person	, , 0	a DT 0	statistically RB B-adv.all	significant JJ B-adj.all	decrease NN B-noun.state	( ( 0	p IN 0	= SYM 0	0.0343 CD 0	) ) 0	in IN 0	creatinine NN 0	clearance NN B-noun.person	was VBD 0	found VBN B-verb.possession	, , 0	but CC 0	creatinine NN 0	concentration NN B-noun.artifact	did VBD 0	not RB B-adv.all	increase VB B-verb.change	significantly RB B-adv.all	compared VBN B-verb.cognition	to TO 0	controls NNS B-noun.cognition	. . 0	. . 0
a6209318.s6	The DT 0	incidence NN B-noun.relation	of IN 0	coronary JJ B-adj.all	events NNS B-noun.person	was VBD B-verb.stative	similar JJ B-adj.all	in IN 0	both DT 0	groups NNS B-noun.group	. . 0	. . 0
a15338796.s12	RESULTS NNS B-noun.artifact	, , 0	Salbutamol NNP B-noun.person	significantly RB B-adv.all	increased VBN B-verb.change	tremor NN 0	severity NN 0	in IN 0	patients NNS B-noun.person	in IN 0	a DT 0	dose NN B-noun.person	- : 0	dependent JJ B-adj.all	way NN B-noun.state	. . 0	. . 0
a18020536.s11	Two CD 0	or CC 0	three CD 0	BZDs NNP B-noun.other	/ NNP I-noun.other	RDs NNP I-noun.other	were VBD B-verb.stative	concomitantly RB B-adv.all	taken VBN B-verb.cognition	by IN 0	26 CD B-adj.all	% NN 0	of IN 0	users NNS B-noun.person	( ( 0	n UH 0	= $ 0	20 CD B-adj.all	) ) 0	. . 0	. . 0
a11279304.s11	The DT 0	plasma NN B-noun.attribute	level NN I-noun.attribute	of IN 0	ANP NNP B-noun.group	did VBD 0	not RB B-adv.all	always RB B-adv.all	increase VB B-verb.body	in IN 0	all PDT 0	the DT 0	patients NNS B-noun.person	with IN 0	clinical JJ B-adj.all	and CC 0	subclinical JJ B-adj.all	heart_failure NN B-noun.state	. . 0	. . 0
a6640832.s11	In IN 0	patients NNS B-noun.artifact	that WDT 0	were VBD B-verb.stative	free JJ B-noun.relation	of IN 0	recurrence NN B-noun.act	during IN 0	the DT 0	first JJ B-adj.all	year NN B-noun.time	, , 0	80 CD B-adj.all	% NN 0	remained VBD B-verb.communication	tumor NN B-noun.feeling	- : 0	free JJ B-verb.social	during IN 0	the DT 0	2- ( 0	to TO 0	3-year JJ 0	follow NN B-noun.shape	- : 0	up IN 0	period NN B-noun.person	. . 0	. . 0
a12584269.s1	BACKGROUND NN 0	, , 0	Sirolimus NNP B-noun.person	( ( 0	SRL NNP 0	) ) 0	may MD 0	supplement VB B-verb.possession	calcineurin NN B-noun.communication	inhibitors NNS B-noun.attribute	in IN 0	clinical JJ B-adj.all	organ NN B-noun.artifact	transplantation NN I-noun.artifact	. . 0	. . 0
a16740173.s6	Carbachol NN B-noun.person	concentrations NNS I-noun.person	in IN 0	serum NN B-noun.body	and CC 0	urine NN B-noun.act	on IN 0	day NN 0	1 CD 0	and CC 0	2 CD 0	of IN 0	hospital NN B-noun.phenomenon	admission NN I-noun.phenomenon	were VBD 0	analysed VBN B-verb.cognition	by IN 0	HPLC NNP B-noun.person	- : 0	mass NN B-noun.act	spectrometry NN B-noun.possession	. . 0	. . 0
a12905102.s1	BACKGROUND NN 0	, , 0	Incidence NNP B-noun.person	and CC 0	risk NN B-noun.plant	factors NNS B-noun.person	for IN 0	delirium NN 0	during IN 0	clozapine NN B-noun.phenomenon	treatment NN B-noun.process	require VBP B-verb.consumption	further JJ B-adj.all	clarification NN B-noun.person	. . 0	. . 0
a19037603.s6	Baseline NNP B-noun.person	, , 0	liver NN 0	function NN B-noun.act	tests NNS B-noun.person	were VBD 0	elevated VBN B-verb.social	in IN 0	two CD 0	patients NNS B-noun.person	( ( 0	fourth JJ B-adj.all	patient NN B-noun.person	, , 0	ALT,122 NNP B-noun.person	IU NNP I-noun.person	/ , 0	l PRP 0	, , 0	AST,111 JJ 0	IU NNP 0	/ , 0	l PRP 0	, , 0	tenth JJ B-adj.all	patient NN B-noun.person	, , 0	ALT,294 NNP B-noun.person	IU NNP I-noun.person	/ , 0	l PRP 0	, , 0	AST,274 JJ 0	IU NNP 0	/ , 0	l PRP 0	, , 0	with IN 0	minimal JJ B-adj.all	changes NNS B-noun.relation	in IN 0	the DT 0	liver NN B-noun.possession	biopsy NN I-noun.possession	in IN 0	both DT 0	) ) 0	. . 0	. . 0
a11250767.s6	Propylthiouracil NNP B-noun.person	therapy NN I-noun.person	was VBD 0	withdrawn VBN B-verb.contact	, , 0	and CC 0	she PRP 0	was VBD 0	treated VBN B-verb.change	with IN 0	a DT 0	1-month JJ B-adj.all	course NN B-noun.attribute	of IN 0	prednisone NN B-noun.person	, , 0	which WDT 0	alleviated VBD B-verb.possession	her PRP$ 0	symptoms NNS B-noun.body	. . 0	. . 0
a18560792.s10	Severity NNP B-noun.person	of IN 0	regurgitation NN B-noun.act	was VBD B-verb.stative	not RB B-adv.all	correlated VBN B-verb.stative	with IN 0	pergolide JJ B-adj.all	cumulative JJ B-adj.all	dose NN B-noun.person	. . 0	. . 0
a3970039.s8	There EX 0	have VBP 0	been VBN 0	several JJ 0	long RB 0	- : 0	term NN B-noun.time	studies NNS B-noun.act	of IN 0	patients NNS B-noun.person	with IN 0	rheumatoid_arthritis NN 0	treated VBN B-verb.change	with IN 0	azathioprine NN B-noun.person	and CC 0	cyclophosphamide NN B-noun.person	and CC 0	the DT 0	incidence NN B-noun.event	of IN 0	most JJS 0	of IN 0	the DT 0	common JJ B-noun.person	cancers NNS I-noun.person	is VBZ B-verb.stative	not RB B-adv.all	increased VBN B-verb.change	. . 0	. . 0
a8387218.s10	Peripheral_neuropathy JJ B-noun.relation	occurred VBD B-verb.stative	in IN 0	12 CD B-adj.all	patients NNS B-noun.person	and CC 0	pancreatitis NN B-noun.location	in IN 0	six CD 0	. . 0	. . 0
a19346865.s4	Initial JJ B-adj.all	brain NN B-noun.communication	magnetic JJ B-adj.all	resonance NN B-noun.phenomenon	imaging NN B-noun.attribute	( ( 0	MRI NNP 0	) ) 0	were VBD 0	obtained VBN B-verb.possession	after IN 0	the DT 0	hospitalization NN B-noun.artifact	, , 0	including VBG B-verb.change	DWI NNP 0	( ( 0	8/8 CD 0	) ) 0	, , 0	apparent JJ B-adj.all	diffusion NN B-noun.relation	coefficient NN I-noun.relation	( ( 0	ADC NNP B-noun.group	) ) 0	map NN 0	( ( 0	4/8 CD 0	) ) 0	, , 0	FLAIR NNP B-noun.person	( ( 0	7/8 CD 0	) ) 0	, , 0	and CC 0	T2-weighted JJ B-adj.all	image NN B-noun.attribute	( ( 0	8/8 CD 0	) ) 0	. . 0	. . 0
a12617329.s5	It PRP 0	could MD 0	be VB 0	inferred VBN B-verb.cognition	that IN 0	gum_Arabic JJ B-adj.all	treatment NN B-noun.plant	has VBZ 0	induced VBN B-verb.creation	a DT 0	modest JJ B-adj.all	amelioration NN B-noun.person	of IN 0	some DT 0	of IN 0	the DT 0	histological JJ B-adj.all	and CC 0	biochemical JJ B-adj.all	indices NNS B-noun.act	of IN 0	GM NNP 0	nephrotoxicity NN 0	. . 0	. . 0
a18951540.s4	However RB 0	, , 0	comparison NN B-noun.person	with IN 0	the DT 0	baseline NN B-noun.person	showed VBD B-verb.communication	small JJ B-noun.person	but CC 0	significant JJ B-adj.all	reduction NN B-noun.cognition	in IN 0	dyskinesia NN 0	severity NN 0	following VBG B-verb.stative	real JJ B-adj.all	rTMS NNS B-noun.attribute	but CC 0	not RB 0	placebo NN 0	. . 0	. . 0
a20588063.s7	The DT 0	amount NN B-noun.possession	of IN 0	nephrin NN B-noun.person	was VBD 0	reduced VBN B-verb.change	in IN 0	both DT 0	diseased JJ B-adj.all	and CC 0	normal JJ B-adj.all	areas NNS B-noun.location	. . 0	. . 0
a12653683.s5	The DT 0	time NN B-noun.time	courses NNS B-noun.act	of IN 0	urinary JJ B-adj.all	sodium NN B-noun.artifact	excretion NN B-noun.act	, , 0	plasma NN 0	aldosterone NN 0	concentration NN B-noun.event	and CC 0	proteinuria NNS B-noun.person	were VBD 0	studied VBN B-verb.cognition	in IN 0	male NN 0	Sprague NNP B-noun.person	- : 0	Dawley NN B-noun.person	rats NNS B-noun.person	treated VBN B-verb.social	with IN 0	a DT 0	single JJ B-adj.all	dose NN B-noun.event	of IN 0	either DT 0	PAN NNP B-noun.location	or CC 0	vehicle NN B-noun.communication	. . 0	. . 0
a15859940.s9	The DT 0	fifth JJ B-noun.artifact	case NN I-noun.artifact	had VBD 0	features NNS B-noun.cognition	of IN 0	thrombotic_microangiopathy JJ 0	related VBN B-verb.communication	to TO 0	an DT 0	antiphospholipid_syndrome JJ B-adj.all	in IN 0	a DT 0	patient NN B-noun.person	with IN 0	systemic_lupus_erythematosus NN 0	. . 0	. . 0
a20067456.s6	RESULTS NNS B-noun.artifact	, , 0	After IN 0	12 CD B-adj.all	weeks NNS B-noun.time	of IN 0	treatment NN B-noun.communication	, , 0	the DT 0	mean NN B-noun.attribute	( ( 0	sd NN 0	) ) 0	scores NNS B-noun.cognition	for IN 0	CGI NNP B-noun.group	- : 0	SF NNP 0	were VBD 0	significantly RB B-adv.all	lower JJR B-adj.all	, , 0	i.e. FW B-adv.all	better RBR I-adv.all	, , 0	in IN 0	patients NNS B-noun.person	on IN 0	bupropion NN 0	SR NNP 0	, , 0	at IN 0	2.4 CD 0	( ( 0	1.2 CD 0	) ) 0	, , 0	than IN 0	in IN 0	the DT 0	placebo NN B-noun.location	group NN 0	, , 0	at IN 0	3.9 CD 0	( ( 0	1.1 CD 0	) ) 0	( ( 0	P= $ 0	0.01 CD 0	) ) 0	. . 0	. . 0
a19346865.s8	High NNP B-noun.group	- : 0	signal NN B-noun.communication	intensity NN B-noun.attribute	lesions NNS B-noun.quantity	on IN 0	DWI NNP B-noun.group	tended VBD B-verb.social	to TO 0	show VB B-verb.communication	low JJ B-adj.all	signal NN B-noun.phenomenon	intensity NN B-noun.attribute	on IN 0	ADC NNP B-noun.group	map NN B-noun.person	( ( 0	3/4 CD 0	) ) 0	, , 0	but CC 0	in IN 0	one CD 0	patient NN B-noun.person	, , 0	high JJ B-adj.all	signal NN B-noun.phenomenon	intensity NN B-noun.attribute	was VBD 0	shown VBN B-verb.perception	at IN 0	bilateral JJ B-adj.all	dentate NN B-noun.person	nuclei NN B-noun.person	on IN 0	not RB B-adv.all	only RB B-adv.all	DWI NNP 0	but CC 0	also RB B-adj.all	ADC NNP B-noun.group	map NN B-noun.person	. . 0	. . 0
a1835291.s5	While IN 0	side JJ B-adj.all	effects NNS B-noun.phenomenon	were VBD B-verb.stative	rare JJ B-adj.all	, , 0	those DT 0	experienced VBN B-verb.perception	after IN 0	theophylline DT 0	use NN B-noun.attribute	did VBD 0	involve VB B-verb.stative	the DT 0	cardiovascular_and_gastrointestinal_systems NNS B-noun.communication	. . 0	. . 0
a7890216.s10	In IN 0	conclusion NN 0	, , 0	octreotide RB 0	induced VBN B-verb.creation	gall_stones NNS B-noun.artifact	are VBP B-verb.stative	generally RB B-adj.all	small JJ B-noun.person	, , 0	multiple JJ B-adj.all	, , 0	and CC 0	cholesterol NN B-noun.person	rich JJ I-noun.person	although IN 0	, , 0	in IN 0	common JJ 0	with IN 0	spontaneous JJ B-adj.all	gall_stone_disease NN B-noun.act	, , 0	at IN 0	presentation NN B-noun.communication	some DT 0	patients NNS B-noun.person	will MD 0	have VB B-verb.stative	a DT 0	blocked VBN B-verb.body	cystic JJ B-adj.all	duct NN B-noun.state	and CC 0	some DT 0	gall_stones NNS B-noun.artifact	containing VBG B-verb.stative	calcium NN B-noun.substance	. . 0	. . 0
a19957053.s0	Phenylephrine NN B-noun.person	but CC 0	not RB B-adv.all	ephedrine JJ B-adj.all	reduces_frontal_lobe_oxygenation NN B-noun.artifact	following VBG B-verb.stative	anesthesia NNS B-noun.person	- : 0	induced VBN B-verb.creation	hypotension NN 0	. . 0	. . 0
a11745184.s14	Six CD 0	partial JJ B-adj.all	responses NNS B-noun.act	were VBD 0	observed VBN B-verb.perception	for IN 0	an DT 0	overall JJ B-adj.all	response NN B-noun.communication	rate NN B-noun.time	of IN 0	16 CD B-adj.all	% NN 0	. . 0	. . 0
a983936.s11	Evidence NN B-noun.time	of IN 0	microscopic JJ B-adj.all	damage NN B-noun.event	was VBD 0	graded VBN B-verb.possession	as IN 0	less RBR 0	severe JJ 0	in IN 0	the DT 0	three CD 0	treatment NN B-adj.all	groups NNS B-noun.group	. . 0	. . 0
a220563.s5	The DT 0	underlying VBG 0	mechanism NN 0	causing VBG B-verb.communication	the DT 0	neuropathy NN B-noun.person	is VBZ B-verb.stative	not RB I-verb.stative	yet RB 0	fully RB B-adj.all	known VBN I-adj.all	, , 0	although IN 0	some DT 0	evidence NN B-noun.communication	indicates VBZ B-verb.communication	that IN 0	it PRP 0	may MD 0	be VB B-verb.stative	a DT 0	lipid NN B-noun.body	storage NN B-noun.act	process NN I-noun.act	. . 0	. . 0
a11807648.s8	FINDINGS NNS B-noun.act	, , 0	FS NNP 0	containing VBG B-verb.communication	tAMCA NNP B-noun.person	caused VBD B-verb.communication	paroxysmal JJ B-adj.all	brain NN B-noun.group	activity NN B-noun.state	which WDT 0	was VBD 0	associated VBN B-verb.cognition	with IN 0	distinct JJ B-adj.all	convulsive JJ B-adj.all	behaviours NNS B-noun.person	. . 0	. . 0
a1835291.s4	The DT 0	mean JJ B-adj.all	duration NN 0	of IN 0	action NN B-noun.person	was VBD B-verb.stative	3.8 CD 0	hours NNS B-noun.person	with IN 0	ipratropium NN B-noun.artifact	and CC 0	2.4 CD 0	hours NNS B-noun.quantity	with IN 0	theophylline PRP 0	. . 0	. . 0
a16904497.s6	Spread NNP B-noun.person	of IN 0	the DT 0	contrast NN B-noun.group	medium NN B-noun.person	within IN 0	the DT 0	epidural JJ B-adj.all	space NN B-noun.location	was VBD 0	determined VBN B-verb.communication	by IN 0	radiographic JJ B-adj.all	imaging NN B-noun.attribute	. . 0	. . 0
a18754075.s5	This DT 0	report NN B-noun.communication	demonstrates VBZ B-verb.communication	that IN 0	not RB B-adv.all	only RB B-adv.all	intravenous JJ B-adj.all	, , 0	but CC 0	also RB B-adv.all	oral JJ B-adj.all	bisphosphonates NNS B-noun.person	can MD 0	aggravate VB B-verb.communication	proteinuria NNS B-noun.person	and CC 0	acute_renal_failure NN B-noun.act	. . 0	. . 0
a11279304.s8	Five CD 0	patients NNS B-noun.person	were VBD 0	diagnosed VBN B-verb.communication	as IN 0	having VBG B-verb.communication	subclinical JJ B-noun.phenomenon	heart_failure NN I-noun.phenomenon	after IN 0	the DT 0	completion NN B-noun.act	of IN 0	chemotherapy NN B-noun.communication	. . 0	. . 0
a20080983.s9	Comparison NNP B-noun.person	of IN 0	slow JJ B-adj.all	- : 0	wave VBP B-verb.stative	sleep JJ B-adj.all	time NN B-noun.time	, , 0	total JJ B-adj.all	sleep JJ B-adj.all	time NN B-noun.time	, , 0	and CC 0	sleep JJ B-adj.all	latency NN B-noun.person	in IN 0	cocaine NN 0	- : 0	dependent JJ B-adj.all	and CC 0	healthy JJ B-adj.all	participants NNS B-noun.person	revealed VBD B-verb.perception	a DT 0	normalizing JJ B-adj.all	effect NN B-noun.cognition	of IN 0	modafinil NN B-noun.person	in IN 0	cocaine NN 0	- : 0	dependent JJ B-adj.all	participants NNS B-noun.person	. . 0	. . 0
a16574712.s3	Fifteen JJ B-adj.all	polydrug NN B-noun.person	ecstasy NN B-noun.person	users NNS B-noun.person	and CC 0	15 CD B-adj.all	polydrug NN B-noun.person	non NN B-noun.person	- : 0	ecstasy NN 0	user NN 0	controls NNS B-noun.artifact	completed VBD B-verb.change	a DT 0	general JJ B-adj.all	drug NN 0	use NN 0	questionnaire NN B-noun.communication	, , 0	the DT 0	Brixton NNP B-noun.location	Spatial NNP I-noun.location	Anticipation NNP I-noun.location	task NN 0	( ( 0	set VBN 0	shifting VBG B-verb.body	) ) 0	, , 0	Backward NNP B-noun.person	Digit NNP I-noun.person	Span NNP I-noun.person	procedure NN B-noun.person	( ( 0	memory NN B-noun.person	updating VBG B-verb.social	) ) 0	, , 0	Inhibition NNP B-noun.person	of IN 0	Return NNP B-noun.person	( ( 0	inhibition NN B-noun.attribute	) ) 0	, , 0	an DT 0	emotional JJ B-adj.all	intelligence NN B-noun.act	scale NN B-noun.event	, , 0	the DT 0	Tromso NNP B-noun.group	Social NNP I-noun.group	Intelligence NNP I-noun.group	Scale NNP I-noun.group	and CC 0	the DT 0	Dysexecutive NNP B-noun.other	Questionnaire NNP I-noun.other	( ( 0	DEX NNP B-noun.group	) ) 0	. . 0	. . 0
a3856631.s3	Leucovorin NNP B-noun.person	rescue NN I-noun.person	was VBD 0	initiated VBN B-verb.consumption	12 CD B-adj.all	hours NNS B-noun.person	after IN 0	the DT 0	end NN B-noun.time	of IN 0	the DT 0	infusion NN B-noun.cognition	with IN 0	a DT 0	loading NN B-noun.possession	dose NN B-noun.quantity	of IN 0	200 CD 0	mg NN B-noun.quantity	/ : 0	m2 CC 0	followed VBN B-verb.stative	by IN 0	12 CD B-adj.all	mg NN B-noun.quantity	/ : 0	m2 CC 0	every DT 0	three CD 0	hours NNS 0	for IN 0	six CD B-adj.all	doses NNS B-noun.act	and CC 0	then RB B-adv.all	every DT 0	six CD 0	hours NNS 0	until IN 0	the DT 0	plasma NN B-noun.substance	methotrexate NN B-noun.state	level NN I-noun.state	decreased VBD B-verb.change	to TO 0	less JJR B-noun.quantity	than IN 0	1 CD B-adj.all	X NNP B-noun.other	10(-7 NNP I-noun.other	) ) 0	mol NN 0	/ ( 0	L. NNP 0	The DT 0	mean JJ B-adj.all	steady JJ B-noun.artifact	- : 0	state NN B-adj.all	plasma NN B-noun.person	and CC 0	CSF NNP 0	methotrexate NN B-noun.location	concentrations NNS B-noun.person	achieved VBN B-verb.social	were VBD B-verb.stative	1.1 CD 0	X NNP B-noun.group	10(-3 NNP I-noun.group	) ) 0	mol NN 0	/ '' 0	L NNP 0	and CC 0	3.6 CD 0	X NNP B-noun.group	10(-5 NNP I-noun.group	) ) 0	mol NN 0	/ '' 0	L NNP 0	, , 0	respectively RB B-adv.all	. . 0	. . 0
a8386779.s4	papaverine NN B-noun.person	, , 0	100 CD 0	micrograms NNS B-noun.quantity	. . 0	. . 0
a17879945.s13	E2 PRP 0	did VBD 0	, , 0	however RB 0	, , 0	significantly RB B-adv.all	suppress VB B-verb.social	CD36 JJ 0	protein NN B-adj.all	levels NNS B-noun.state	as IN 0	measured VBN B-verb.cognition	by IN 0	fluorescent JJ B-adj.all	immunocytochemistry NN B-noun.artifact	. . 0	. . 0
a17147461.s10	Although IN 0	these DT 0	adverse JJ B-adj.all	effects NNS B-noun.phenomenon	occur VBP B-verb.stative	in IN 0	some DT 0	patients NNS B-noun.person	, , 0	their PRP$ 0	occurrence NN B-noun.state	could MD 0	be VB 0	minimised VBN B-verb.communication	by IN 0	knowledge NN B-noun.person	of IN 0	the DT 0	molecular JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	sirolimus NN B-noun.animal	on IN 0	the DT 0	kidney NN B-noun.person	, , 0	the DT 0	use NN 0	of IN 0	sirolimus NN B-noun.food	in IN 0	appropriate JJ B-adj.all	patient NN B-noun.person	populations NNS B-noun.person	, , 0	close JJ B-adj.all	monitoring NN B-noun.person	of IN 0	proteinuria NN B-noun.person	and CC 0	renal JJ B-adj.all	function NN B-noun.act	, , 0	use NN 0	of IN 0	angiotensin NN B-noun.person	- : 0	converting VBG B-verb.communication	enzyme JJ B-adj.all	inhibitors NNS B-noun.person	or CC 0	angiotensin_II JJ B-adj.all	receptor NN B-noun.person	blockers NNS B-noun.person	if IN 0	proteinuria NNS B-noun.person	occurs VBZ B-verb.competition	and CC 0	withdrawal NN B-noun.person	if IN 0	needed VBN B-verb.consumption	. . 0	. . 0
a20477932.s2	Nuclear JJ B-adj.pert	factor NN B-noun.person	kappa NN B-noun.group	B NNP 0	( ( 0	NFkappaB NNP 0	) ) 0	is VBZ B-verb.stative	a DT 0	sensor NN B-noun.person	of IN 0	oxidative JJ B-adj.all	stress NN B-noun.state	and CC 0	participates NNS B-noun.person	in IN 0	memory NN B-noun.food	formation NN B-noun.act	that WDT 0	could MD 0	be VB 0	involved VBN B-verb.stative	in IN 0	drug NN 0	toxicity NN B-noun.attribute	and CC 0	addiction NN B-noun.person	mechanisms NNS B-noun.person	. . 0	. . 0
a19269743.s10	Correlation NN B-noun.person	with IN 0	rating NN B-noun.act	recall NN B-noun.act	after IN 0	one CD B-adj.all	week NN B-noun.time	was VBD 0	best RB 0	when WRB 0	first RB B-adv.all	- DT 0	time NN B-noun.time	ratings NNS B-noun.time	were VBD 0	requested VBN B-verb.communication	as IN 0	late RB 0	as IN 0	one CD 0	day NN 0	after IN 0	injection NN B-noun.time	( ( 0	R(2)=0.79 NN 0	) ) 0	indicating VBG B-verb.communication	that IN 0	both DT 0	rating NN B-noun.group	retrievals NNS B-noun.person	utilized VBD B-verb.consumption	similar JJ B-adj.all	memory NN B-noun.artifact	traces NNS I-noun.artifact	. . 0	. . 0
a10193204.s8	These DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	antithrombosis NN B-noun.attribute	of IN 0	TET NNP B-noun.group	and CC 0	FAN NNP B-noun.person	in IN 0	mice NNS B-noun.animal	may MD 0	be VB B-verb.stative	mainly RB B-adv.all	related VBN B-verb.cognition	to TO 0	the DT 0	antiplatelet NN B-noun.phenomenon	aggregation NN I-noun.phenomenon	activities NNS B-noun.person	. . 0	. . 0
a19445921.s9	The DT 0	protective JJ B-adj.all	role NN B-noun.attribute	of IN 0	salvianolic_acid NN B-noun.group	A DT 0	against IN 0	isoproterenol NN B-noun.person	- : 0	induced VBN B-verb.creation	myocardial_damage NN B-noun.artifact	was VBD B-verb.stative	further RB B-adv.all	confirmed VBN B-verb.cognition	by IN 0	histopathological JJ B-adj.all	examination NN B-noun.act	. . 0	. . 0
a11334364.s8	Histopathological JJ B-adj.all	examination NN B-noun.act	of IN 0	kidney NN B-noun.person	, , 0	heart NN B-noun.body	and CC 0	lung NN B-noun.body	sections NNS B-noun.object	revealed VBD B-verb.perception	moderate JJ B-adj.all	to TO 0	massive JJ B-adj.all	tissue_damage NN B-noun.food	with IN 0	a DT 0	variety NN B-noun.cognition	of IN 0	morphological JJ B-adj.all	aberrations NNS B-noun.act	by IN 0	all PDT 0	the DT 0	three CD 0	drugs NNS B-noun.artifact	in IN 0	the DT 0	absence NN B-noun.act	of IN 0	GSPE NNP B-noun.group	preexposure NN B-noun.attribute	than IN 0	in IN 0	its PRP$ 0	presence NN B-noun.person	. . 0	. . 0
a15188772.s0	Severe JJ 0	reversible JJ B-adj.all	left_ventricular_systolic_and_diastolic_dysfunction NN B-noun.event	due JJ 0	to TO 0	accidental JJ B-adj.all	iatrogenic JJ B-adj.pert	epinephrine NN B-noun.body	overdose NN I-noun.body	. . 0	. . 0
a11532387.s3	The DT 0	patient NN B-noun.person	developed VBD B-verb.body	RS NNP 0	during IN 0	dose DT 0	reduction NN B-noun.act	of IN 0	risperidone NN 0	. . 0	. . 0
a17931375.s10	RESULTS NNS B-noun.artifact	, , 0	The DT 0	percentage NN B-noun.possession	of IN 0	bruising VBG B-verb.contact	occurrence NN B-noun.state	was VBD B-verb.stative	64 CD B-adj.all	% NN 0	with IN 0	the DT 0	injection NN B-noun.act	of IN 0	10 CD B-adj.all	seconds NNS B-noun.time	duration NN B-noun.act	and CC 0	42 CD 0	% NN 0	in IN 0	the DT 0	30-second JJ 0	injection NN B-noun.act	. . 0	. . 0
a11135224.s16	This DT 0	treatment NN B-noun.animal	merits NNS I-noun.animal	further JJ B-adj.all	comparison NN B-noun.person	with IN 0	other JJ 0	cisplatin NN B-noun.person	- : 0	based VBN B-verb.cognition	regimens NNS 0	. . 0	. . 0
a10737864.s2	Previous JJ B-adj.all	investigations NNS B-noun.artifact	have VBP 0	determined VBN B-verb.communication	that IN 0	, , 0	in IN 0	response NN B-noun.communication	to TO 0	clonidine VB B-verb.social	, , 0	ultrasound JJ B-adj.all	production NN B-noun.artifact	increases NNS B-noun.artifact	through IN 0	the DT 0	2nd SYM 0	- : 0	week NN B-noun.time	postpartum NN 0	and CC 0	decreases VBZ B-verb.change	thereafter RB 0	. . 0	. . 0
a7088431.s1	Two CD 0	cases NNS B-noun.quantity	of IN 0	clear_cell_adenocarcinoma_of_the_vagina NNP B-noun.person	detected VBD B-verb.perception	at IN 0	follow NN B-noun.act	- : 0	up RB B-adv.all	in IN 0	young JJ B-adj.all	women NNS B-noun.person	exposed VBN B-verb.communication	in IN 0	utero NN 0	to TO 0	diethylstilbestrol NN B-noun.act	are VBP 0	reported VBN B-verb.communication	. . 0	. . 0
a3564823.s1	Following VBG 0	major JJ B-adj.all	intracranial JJ B-noun.possession	surgery NN I-noun.possession	in IN 0	a DT 0	35-year JJ B-noun.other	- : 0	old JJ B-noun.person	man NN I-noun.person	, , 0	sodium_pentothal JJ B-noun.person	was VBD B-verb.stative	intravenously RB B-adv.all	infused VBN B-verb.communication	to TO 0	minimize VB B-verb.consumption	cerebral_ischaemia NN I-verb.consumption	. . 0	. . 0
a21029050.s5	We PRP 0	determined VBD B-verb.communication	the DT 0	BChE JJ 0	activity NN B-noun.state	and CC 0	the DT 0	BCHE NNP B-noun.group	genotype NN B-noun.person	using VBG B-verb.consumption	molecular JJ B-adj.all	genetic JJ B-adj.all	methods NNS B-noun.attribute	, , 0	the DT 0	duration NN 0	of IN 0	apnea NN B-noun.person	, , 0	time NN 0	to TO 0	sufficient JJ B-adj.all	spontaneous JJ B-adj.all	ventilation NN B-noun.communication	and CC 0	whether IN 0	neuromuscular JJ B-adj.all	monitoring NN B-noun.person	was VBD 0	used VBN B-verb.consumption	. . 0	. . 0
a11807648.s3	Recently RB B-adv.all	, , 0	synthetic JJ B-adj.all	fibrinolysis NN B-noun.event	inhibitors NNS 0	such JJ 0	as IN 0	tranexamic_acid JJ 0	( ( 0	tAMCA JJ B-noun.attribute	) ) 0	have VBP 0	been VBN 0	considered VBN B-verb.cognition	as IN 0	substitutes NNS B-noun.person	for IN 0	aprotinin NN B-noun.person	. . 0	. . 0
a19445921.s0	Cardioprotective JJ B-adj.all	effect NN B-noun.cognition	of IN 0	salvianolic_acid NN B-noun.group	A DT 0	on IN 0	isoproterenol NN B-noun.act	- : 0	induced VBN B-verb.creation	myocardial_infarction NN B-noun.process	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a6640832.s10	Of IN 0	these DT 0	recurrences NNS B-noun.artifact	, , 0	27 CD 0	were VBD B-verb.stative	T1 JJ B-adj.all	tumors NNS B-noun.person	while IN 0	five CD 0	progressed VBN B-verb.cognition	to TO 0	more RBR B-adv.all	highly RB B-adv.all	invasive JJ B-adj.all	lesions NNS B-noun.person	. . 0	. . 0
a8558192.s4	VNB NNP 0	was VBD 0	administered VBN B-verb.emotion	weekly RB I-verb.emotion	as IN 0	a DT 0	25-mg JJ 0	/ : 0	m2 CC 0	short RB B-noun.body	intravenous JJ I-noun.body	( ( 0	i.v FW 0	. . 0	) ) 0	. . 0
a17147461.s2	Sirolimus NNP B-noun.person	represents VBZ B-verb.communication	a DT 0	major JJ B-adj.all	therapeutic JJ B-adj.pert	advance NN B-noun.act	in IN 0	the DT 0	prevention NN B-noun.relation	of IN 0	acute JJ B-adj.all	renal JJ B-adj.all	allograft NN B-noun.animal	rejection NN I-noun.animal	and CC 0	chronic JJ B-adj.all	allograft NN B-noun.artifact	nephropathy NN I-noun.artifact	. . 0	. . 0
a9855119.s4	RESULTS NNS B-noun.artifact	, , 0	The DT 0	main JJ B-adj.all	pathologic JJ B-adj.all	diagnoses NNS B-noun.attribute	( ( 0	some DT 0	overlap NN B-noun.event	) ) 0	were VBD B-verb.stative	acute JJ B-adj.all	rejection NN B-noun.cognition	( ( 0	AR NNP 0	, , 0	n UH 0	= : 0	4 LS 0	) ) 0	, , 0	chronic JJ B-adj.all	rejection NN B-noun.relation	( ( 0	CR NNP 0	, , 0	n=5 NNP 0	) ) 0	, , 0	AR+CR NNP B-noun.person	( ( 0	n UH 0	= : 0	4 LS 0	) ) 0	, , 0	recurrent VB B-verb.communication	IgA_nephropathy JJ I-verb.communication	( ( 0	n UH 0	= $ 0	5 CD B-adj.all	) ) 0	, , 0	normal JJ B-adj.all	findings NNS B-noun.act	( ( 0	n UH 0	= : 0	2 LS 0	) ) 0	, , 0	minimal JJ B-adj.pert	- : 0	type NN B-noun.person	chronic NN B-adj.all	FK506 NNP B-noun.other	nephropathy JJ B-adj.all	( ( 0	n UH 0	= $ 0	9 CD B-adj.all	) ) 0	, , 0	and CC 0	mild JJ B-noun.person	- : 0	type RB B-adv.all	FK506 JJ B-adj.all	nephropathy JJ B-adj.all	( ( 0	n UH 0	= $ 0	11 CD 0	) ) 0	. . 0	. . 0
a18951540.s5	The DT 0	major JJ B-adj.all	effect NN B-noun.cognition	was VBD B-verb.stative	on IN 0	dystonia NN B-noun.artifact	subscore NN B-noun.person	. . 0	. . 0
a15602202.s1	A DT 0	14-year JJ 0	- : 0	old JJ B-adj.all	girl NN B-noun.person	is VBZ 0	reported VBN B-verb.communication	with IN 0	recurrent NN B-noun.person	, , 0	azithromycin NN B-noun.person	- : 0	induced VBN B-verb.creation	, , 0	acute VB B-verb.possession	interstitial_nephritis NNP I-verb.possession	. . 0	. . 0
a20080983.s0	Normalizing JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	modafinil NN B-noun.artifact	on IN 0	sleep NN B-noun.food	in IN 0	chronic JJ B-adj.all	cocaine NN B-noun.event	users NNS B-noun.person	. . 0	. . 0
a17639754.s1	Warfarin NNP B-noun.person	is VBZ B-verb.stative	the DT 0	most RBS 0	widely RB B-adv.all	used VBN B-verb.consumption	oral JJ B-adj.all	anticoagulant NN B-noun.attribute	and CC 0	is VBZ 0	indicated VBN B-verb.communication	for IN 0	many JJ 0	clinical JJ B-adj.all	conditions NNS B-noun.communication	. . 0	. . 0
a15859940.s10	CONCLUSIONS NNS B-noun.artifact	, , 0	In IN 0	the DT 0	literature NN B-noun.act	, , 0	the DT 0	most JJS 0	- : 0	frequent JJ B-adj.all	cause NN B-noun.act	of IN 0	hemolytic_uremic_syndrome NNP B-noun.location	in IN 0	patients NNS B-noun.artifact	following VBG B-verb.stative	renal JJ B-adj.all	transplantation NN B-noun.act	is VBZ B-verb.stative	recurrence NN B-noun.act	of IN 0	the DT 0	hemolytic_uremic_syndrome NN B-noun.location	. . 0	. . 0
a12523465.s5	None NN 0	of IN 0	the DT 0	patients NNS B-noun.person	had VBD 0	experienced VBN B-verb.perception	visual_hallucinations NNS B-noun.artifact	before IN 0	this DT 0	event NN B-noun.event	. . 0	. . 0
a11426838.s7	In IN 0	contrast NN 0	to TO 0	the DT 0	protection NN B-noun.communication	provided VBN B-verb.communication	by IN 0	the DT 0	putative JJ B-adj.all	antagonists NNS B-noun.person	, , 0	the DT 0	well UH 0	- : 0	characterized VBN B-verb.communication	sigma NN B-noun.person	receptor NN B-noun.person	agonist NN B-noun.person	di SYM 0	- : 0	o SYM 0	- : 0	tolylguanidine NN 0	( ( 0	DTG NNP 0	) ) 0	and CC 0	the DT 0	novel JJ B-adj.all	sigma NN 0	receptor NN 0	agonist JJ B-adj.pert	BD1031 NN B-noun.person	( ( 0	3R-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane NN 0	) ) 0	each DT 0	worsened VBD B-verb.creation	the DT 0	behavioral JJ B-adj.all	toxicity NN B-noun.attribute	of IN 0	cocaine NN 0	. . 0	. . 0
a3970039.s9	Data NNS B-noun.cognition	on IN 0	the DT 0	possible JJ B-adj.all	increased VBN B-verb.change	risk NN 0	of IN 0	malignancy NN B-noun.person	in IN 0	rheumatoid_arthritis NN 0	are VBP B-verb.stative	still RB 0	being VBG 0	collected VBN B-verb.possession	, , 0	and CC 0	until IN 0	further JJ B-adj.all	information NN B-noun.cognition	is VBZ B-verb.stative	available JJ B-adj.all	, , 0	the DT 0	use NN 0	of IN 0	immunosuppressive JJ B-adj.all	drugs NNS B-noun.artifact	, , 0	particularly RB B-adj.all	alkylating_agents NNS B-noun.person	, , 0	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	rheumatoid_arthritis NN B-noun.location	should MD 0	be VB 0	reserved VBN B-verb.cognition	for IN 0	patients NNS B-noun.person	with IN 0	severe JJ B-adj.all	progressive JJ B-adj.all	disease NN B-noun.state	or CC 0	life NN B-noun.person	- : 0	threatening JJ B-verb.communication	complications NNS B-noun.person	. . 0	. . 0
a3101906.s0	Hepatic JJ B-adj.all	reactions NNS B-noun.motive	associated VBN B-verb.cognition	with IN 0	ketoconazole NN B-noun.person	in IN 0	the DT 0	United NNP B-noun.person	Kingdom NNP I-noun.person	. . 0	. . 0
a15515654.s0	Long JJ 0	term NN 0	audiological JJ B-adj.all	evaluation NN B-noun.act	of IN 0	beta JJ B-adj.pert	- : 0	thalassemic JJ 0	patients NNS B-noun.person	. . 0	. . 0
a15009014.s10	Similar JJ B-adj.all	mechanisms NNS B-noun.Tops	may MD 0	be VB 0	involved VBN B-verb.stative	in IN 0	the DT 0	pathogenesis NN B-noun.location	of IN 0	cluster_headache NNP B-noun.group	. . 0	. . 0
a12464714.s4	Faster NNP B-adj.all	relief NN B-noun.time	of IN 0	headache NN B-noun.state	was VBD B-verb.stative	the DT 0	most RBS 0	important JJ B-adj.all	reason NN B-noun.communication	for IN 0	preference NN B-noun.person	, , 0	cited VBN B-verb.communication	by IN 0	67.3 CD 0	% NN 0	of IN 0	patients NNS B-noun.person	preferring VBG B-verb.competition	rizatriptan JJ I-verb.competition	and CC 0	54.2 CD 0	% NN 0	of IN 0	patients NNS B-noun.person	who WP 0	preferred VBD B-verb.emotion	ergotamine NN I-verb.emotion	/ : 0	caffeine NN B-noun.person	. . 0	. . 0
a10721819.s5	Bromocriptine SYM 0	- : 0	induced VBN B-verb.creation	hypotension NN B-noun.person	was VBD B-verb.stative	unaffected JJ B-adj.all	by IN 0	isoproterenol NN B-noun.relation	pretreatment NN I-noun.relation	, , 0	while IN 0	tachycardia NN B-noun.person	was VBD 0	reversed VBN B-verb.change	to TO 0	significant JJ B-adj.all	bradycardia NNS B-noun.person	, , 0	an DT 0	effect NN B-noun.cognition	that WDT 0	was VBD B-verb.stative	partly RB B-adv.all	reduced VBN B-verb.change	by IN 0	i.v NNP B-noun.person	. . 0	. . 0
a16274958.s1	We PRP 0	report VBP B-verb.communication	the DT 0	case NN B-noun.state	of IN 0	a DT 0	woman NN B-noun.person	complaining VBG B-verb.communication	of IN 0	dysphonia NN B-noun.location	while IN 0	she PRP 0	was VBD 0	treated VBN B-verb.change	by IN 0	acitretin NN B-noun.person	. . 0	. . 0
a15859940.s12	We PRP 0	found VBD B-verb.cognition	that IN 0	the DT 0	most JJS 0	- : 0	frequent JJ B-adj.all	cause NN B-noun.act	of IN 0	thrombotic_microangiopathy JJ 0	was VBD B-verb.stative	drug NN B-noun.person	related VBN B-verb.communication	, , 0	secondary JJ B-adj.all	mainly RB B-adv.all	to TO 0	cyclosporine VB B-verb.social	. . 0	. . 0
a18162529.s13	They PRP 0	also RB B-adv.all	provide VB B-verb.possession	evidence NN B-noun.attribute	for IN 0	estradiol NN B-noun.act	- : 0	dependent JJ B-adj.all	and CC 0	brain NN B-noun.food	region NN B-noun.act	- : 0	specific JJ B-adj.all	regulation NN B-noun.relation	of IN 0	PRL NNP B-noun.group	- : 0	R NN 0	expression NN B-noun.communication	and CC 0	signaling VBG B-verb.social	responses NNS B-noun.act	by IN 0	prolactin NN B-noun.person	. . 0	. . 0
a8590259.s3	The DT 0	ocular_hypotensive JJ B-adj.all	effects NNS B-noun.phenomenon	were VBD B-verb.stative	statistically RB B-adv.all	significant JJ B-adj.all	for IN 0	apraclonidine JJ B-noun.act	- : 0	treated JJ B-adj.all	eyes NNS B-noun.body	throughout IN 0	the DT 0	study NN B-noun.artifact	and CC 0	also RB B-adv.all	statistically RB B-adv.all	significant JJ B-adj.all	for IN 0	contralateral JJ B-adj.all	eyes NNS B-noun.body	from IN 0	three CD 0	hours NNS 0	after IN 0	topical JJ B-adj.all	administration NN B-noun.time	of IN 0	1 CD B-adj.all	% NN 0	apraclonidine NN B-noun.attribute	. . 0	. . 0
a20722491.s6	It PRP 0	has VBZ 0	shown VBN B-verb.perception	promising JJ B-adj.all	results NNS B-noun.phenomenon	alone RB B-adv.all	or CC 0	in IN 0	combination NN 0	with IN 0	other JJ 0	chemotherapeutic JJ B-adj.all	agents NNS B-noun.person	in IN 0	colorectal,_breast,_pancreaticobiliary,_gastric,_renal_cell_and_head_and_neck_cancers NNS B-noun.person	. . 0	. . 0
a16867021.s0	Antipsychotic JJ B-adj.all	- : 0	like IN 0	profile NN B-noun.quantity	of IN 0	thioperamide NN 0	, , 0	a DT 0	selective JJ B-adj.all	H3-receptor NN B-noun.person	antagonist NN B-noun.person	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a1527456.s4	In IN 0	one CD 0	patient NN B-noun.person	, , 0	the DT 0	tinnitus NN B-noun.artifact	was VBD B-verb.stative	almost RB B-adv.all	completely RB B-adv.all	abolished VBN B-verb.contact	, , 0	but CC 0	in IN 0	all PDT 0	the DT 0	nine CD B-adj.all	patients NNS B-noun.person	the DT 0	decompensated JJ B-adj.all	tinnitus NN B-noun.artifact	changed VBD B-verb.change	to TO 0	a DT 0	compensated VBN B-verb.creation	one CD 0	. . 0	. . 0
a9495837.s3	10 SYM B-adj.all	- : 0	30 CD 0	mg PRP$ 0	kg-1 JJ B-noun.person	i.v NNP I-noun.person	. . 0	, , 0	. . 0
a12589964.s23	Although IN 0	there EX 0	was VBD B-verb.stative	a DT 0	discrepancy NN B-noun.person	between IN 0	the DT 0	amount NN B-noun.possession	of IN 0	cTnI NNP B-noun.person	and CC 0	cTnT JJ 0	after IN 0	DOX NNP B-noun.group	, , 0	probably RB 0	due JJ 0	to TO 0	heterogeneity NN 0	in IN 0	cross NN B-noun.animal	- : 0	reactivities NNS B-noun.person	of IN 0	mAbs NNS 0	to TO 0	various JJ B-adj.all	cTnI NNS B-noun.location	and CC 0	cTnT JJ B-adj.all	forms NNS B-noun.body	, , 0	it PRP 0	is VBZ B-verb.stative	likely JJ B-adj.all	that IN 0	cTnT JJ 0	in IN 0	rats NNS B-noun.animal	after IN 0	DOX NNP B-noun.group	indicates VBZ B-verb.communication	cell NN B-noun.body	damage NN 0	determined VBN B-verb.communication	by IN 0	the DT 0	magnitude NN B-noun.person	of IN 0	injury NN B-noun.communication	induced VBN B-verb.creation	and CC 0	that DT 0	cTnT NN B-noun.location	should MD 0	be VB B-verb.stative	a DT 0	useful JJ B-adj.all	marker NN B-noun.person	for IN 0	the DT 0	prediction NN B-noun.person	of IN 0	experimentally RB B-adv.all	induced VBN B-verb.creation	cardiotoxicity NN B-noun.feeling	and CC 0	possibly RB B-adj.all	for IN 0	cardioprotective JJ B-adj.all	experiments NNS B-noun.person	. . 0	. . 0
a17343925.s10	Mean NNP B-noun.person	TEOAEs NNP I-noun.person	responses NNS I-noun.person	of IN 0	highly RB B-adv.all	exposed VBN B-verb.perception	newborns NNS B-noun.artifact	were VBD B-verb.stative	also RB B-adv.all	significantly RB B-adv.all	lower JJR B-adj.all	in IN 0	comparison NN 0	to TO 0	our PRP$ 0	control NN B-noun.act	group NN I-noun.act	. . 0	. . 0
a11263551.s8	The DT 0	Calcineurin NNP B-noun.person	- : 0	inhibitor NN B-noun.person	Induced NNP I-noun.person	Pain NNP I-noun.person	Syndrome NNP I-noun.person	( ( 0	CIPS NNS B-noun.group	) ) 0	is VBZ B-verb.stative	a DT 0	rare JJ B-adj.all	but CC 0	severe JJ B-adj.all	side NN 0	effect NN 0	of IN 0	cyclosporine NN B-noun.state	or CC 0	tacrolimus NN B-noun.animal	and CC 0	is VBZ B-verb.stative	accurately RB B-adv.all	diagnosed VBN B-verb.communication	by IN 0	its PRP$ 0	typical JJ B-adj.all	presentation NN B-noun.person	, , 0	magnetic JJ B-adj.all	resonance NN B-noun.act	imaging NN I-noun.act	and CC 0	bone NN 0	scans NNS B-noun.person	. . 0	. . 0
a18004067.s1	BACKGROUND NN 0	, , 0	The DT 0	possible JJ B-adj.all	role NN B-noun.attribute	of IN 0	alcohol NN B-noun.food	in IN 0	the DT 0	development NN B-noun.process	of IN 0	hepatotoxicity NN B-noun.attribute	associated VBN B-verb.cognition	with IN 0	therapeutic JJ B-adj.all	doses NNS B-noun.event	of IN 0	paracetamol NN B-noun.cognition	( ( 0	acetaminophen NN 0	) ) 0	is VBZ B-verb.stative	currently RB B-adv.all	debated VBN B-verb.change	. . 0	. . 0
a11431197.s0	Ranitidine SYM 0	- : 0	induced VBN B-verb.creation	acute JJ B-adj.all	interstitial_nephritis NN B-noun.food	in IN 0	a DT 0	cadaveric JJ B-adj.all	renal JJ B-adj.all	allograft NN B-noun.act	. . 0	. . 0
a17020434.s2	Pooled VBN B-verb.contact	data NNS B-noun.cognition	from IN 0	trials NNS B-noun.person	comparing VBG B-verb.change	antithrombotic JJ B-adj.all	treatment NN B-noun.plant	with IN 0	placebo NN B-noun.plant	have VBP 0	shown VBN B-verb.cognition	that DT 0	warfarin NN B-noun.act	reduces VBZ B-verb.change	the DT 0	risk NN 0	of IN 0	stroke NN B-noun.phenomenon	by IN 0	62 CD 0	% NN 0	, , 0	and CC 0	that DT 0	aspirin NN B-noun.state	alone RB 0	reduces VBZ B-verb.social	the DT I-verb.social	risk NN I-verb.social	by IN 0	22 CD B-adj.all	% NN 0	. . 0	. . 0
a19843802.s1	Twenty CD 0	- : 0	three CD 0	hours NNS 0	after IN 0	heart NN B-noun.body	transplantation NN B-noun.act	, , 0	life NN B-noun.person	- : 0	threatening VBG B-verb.communication	acute JJ B-adj.all	right_heart_failure NN B-noun.body	was VBD 0	diagnosed VBN B-verb.communication	in IN 0	a DT 0	patient NN B-noun.person	requiring VBG B-verb.body	continuous JJ B-adj.all	venovenous JJ B-adj.pert	hemodiafiltration NN B-noun.location	( ( 0	CVVHDF NNP B-noun.group	) ) 0	. . 0	. . 0
a19767176.s8	A DT 0	significant JJ B-adj.all	decrease NN B-noun.state	in IN 0	neuronal JJ B-adj.all	density NN B-noun.process	of IN 0	the DT 0	hippocampal JJ B-adj.all	hilar JJ B-adj.all	formation NN B-noun.act	was VBD 0	identified VBN B-verb.cognition	in IN 0	vehicle- JJ 0	and CC 0	PDTC NNP B-noun.group	- : 0	treated VBN B-verb.communication	rats NNS B-noun.substance	following VBG B-verb.stative	status_epilepticus NN 0	. . 0	. . 0
a19299179.s1	Pneumocystis_pneumonia NN 0	( ( 0	PCP NNP 0	) ) 0	, , 0	a DT 0	common JJ B-noun.person	opportunistic_infection NN B-noun.person	in IN 0	HIV NNP 0	- : 0	infected JJ B-adj.all	individuals NNS B-noun.person	, , 0	is VBZ 0	generally RB B-adv.all	treated VBN B-verb.change	with IN 0	high JJ B-adj.all	doses NNS B-noun.attribute	of IN 0	co SYM 0	- : 0	trimoxazole NN B-noun.communication	. . 0	. . 0
a17879945.s5	In IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	, , 0	we PRP 0	have VBP 0	investigated VBN B-verb.communication	the DT 0	molecular JJ B-adj.all	mechanisms NNS B-noun.person	by IN 0	which WDT 0	female JJ B-adj.all	hormones NNS B-noun.communication	influence VBP B-verb.emotion	cholesterol NN I-verb.emotion	metabolism NN B-noun.artifact	in IN 0	macrophages NNS B-noun.person	in IN 0	response NN B-noun.communication	to TO 0	the DT 0	HIV NNP 0	protease NN 0	inhibitor NN 0	ritonavir NN B-noun.person	. . 0	. . 0
a424937.s4	Biochemical JJ B-adj.all	liver NN 0	function NN B-noun.act	tests NNS B-noun.person	indicated VBD B-verb.communication	hepatocellular JJ B-adj.all	necrosis NN B-noun.food	and CC 0	correlated VBD B-verb.stative	with IN 0	histopathological JJ B-adj.all	evidence NN B-noun.attribute	of IN 0	hepatic_injury NNP B-noun.person	, , 0	the DT 0	spectrum NN B-noun.artifact	of IN 0	which WDT 0	ranged VBD B-verb.stative	from IN 0	fatty_change NN B-noun.location	and CC 0	focal JJ B-adj.all	hepatocellular JJ B-adj.all	necrosis NN B-noun.motive	to TO 0	massive_hepatic_necrosis NNP B-noun.other	. . 0	. . 0
a6466532.s5	Bradycardia NNP B-noun.person	( ( 0	defined VBN B-verb.stative	as IN 0	a DT 0	decrease NN B-noun.event	in IN 0	heart NN 0	rate NN B-noun.time	to TO 0	less JJR B-noun.quantity	than IN 0	50 CD B-adj.all	beat VBD B-verb.body	min-1 JJ 0	) ) 0	was VBD 0	prevented VBN B-verb.creation	when WRB 0	the DT 0	larger JJR B-adj.all	dose NN B-noun.person	of IN 0	either DT 0	active JJ B-adj.all	drug NN B-noun.person	was VBD 0	used VBN B-verb.consumption	. . 0	. . 0
a19387625.s5	Our PRP$ 0	findings NNS B-noun.act	, , 0	showing VBG B-verb.perception	no DT 0	interaction NN B-noun.act	between IN 0	capsaicin NN B-noun.communication	treatment NN B-noun.communication	and CC 0	attentional JJ B-adj.all	modulation NN B-noun.person	suggest VBP B-verb.communication	that IN 0	capsaicin NN B-noun.person	- : 0	induced VBN B-verb.creation	secondary JJ B-adj.all	hyperalgesia NN B-noun.person	and CC 0	attention NN 0	might MD 0	affect VB B-verb.change	mechanical JJ B-adj.all	pain NN B-noun.quantity	through IN 0	independent JJ B-adj.all	mechanisms NNS B-noun.person	. . 0	. . 0
a15649445.s0	Acute NNP B-noun.person	reserpine NN I-noun.person	and CC 0	subchronic JJ B-adj.all	haloperidol NN B-noun.person	treatments NNS B-noun.plant	change VBP B-verb.change	synaptosomal JJ B-adj.all	brain NN B-noun.person	glutamate NN B-noun.person	uptake NN B-noun.person	and CC 0	elicit VB B-verb.emotion	orofacial_dyskinesia NNP B-noun.group	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a6640832.s8	Of IN 0	the DT 0	82 CD 0	patients NNS B-noun.person	studied VBD B-verb.cognition	after IN 0	1 CD B-adj.all	year NN B-noun.time	, , 0	23 CD 0	had VBD 0	primary JJ B-noun.person	and CC 0	59 CD B-adj.all	recurrent NN B-noun.act	disease NN B-noun.state	. . 0	. . 0
a10791295.s2	once RB B-adv.all	daily JJ I-adv.all	) ) 0	aggressive_behavior JJ 0	of IN 0	adult NN B-noun.person	male NN B-noun.person	and CC 0	female JJ B-noun.person	Wistar NNP I-noun.person	rats NNS B-noun.communication	obtained VBN B-verb.communication	from IN 0	the DT 0	same JJ B-adj.all	breeder NN B-noun.person	was VBD 0	studied VBN B-verb.cognition	in IN 0	two CD 0	consecutive JJ B-adj.all	sets NNS B-noun.artifact	. . 0	. . 0
a10901305.s1	BACKGROUND NN 0	, , 0	There EX 0	recently RB B-adv.all	has VBZ 0	been VBN B-verb.stative	a DT 0	resurgence NN B-noun.act	in IN 0	the DT 0	utilization NN B-noun.act	of IN 0	ketamine NN B-noun.person	, , 0	a DT 0	unique JJ B-adj.all	anesthetic JJ B-adj.all	, , 0	for IN 0	emergency NN B-noun.person	- : 0	department NN B-noun.person	procedures NNS B-noun.person	requiring VBG B-verb.stative	sedation NN B-noun.act	. . 0	. . 0
a20196116.s3	The DT 0	current JJ B-adj.all	study NN B-noun.artifact	prospectively RB B-adv.all	evaluated VBD B-verb.communication	the DT 0	magnitude NN B-noun.person	, , 0	clinical JJ B-adj.all	course NN B-noun.location	, , 0	outcome NN 0	, , 0	and CC 0	prognostic JJ B-adj.all	factors NNS B-noun.person	in IN 0	ATT NNP 0	- : 0	ALF NNP B-noun.group	. . 0	. . 0
a10835440.s10	16 CD B-adj.all	, , 0	95 CD 0	% NN 0	CI $ 0	1.02 CD 0	to TO 0	101.74 CD 0	) ) 0	and CC 0	death NN 0	alone RB 0	( ( 0	n FW 0	/ FW 0	N=9/26 FW 0	, , 0	OR CC 0	4.336 CD 0	, , 0	95 CD 0	% NN 0	CI $ 0	1.131 CD 0	16.619 CD 0	) ) 0	compared VBN B-verb.stative	with IN 0	all DT 0	placebo NN B-noun.location	patients NNS B-noun.person	( ( 0	n UH 0	/ : 0	N=62/92 NN B-noun.other	and CC I-noun.other	14/92 CD I-noun.other	, , 0	respectively RB B-adv.all	) ) 0	. . 0	. . 0
a16740173.s17	On IN 0	the DT 0	next JJ B-adj.all	day NN B-noun.event	he PRP 0	died VBD B-verb.change	, , 0	probably RB 0	as IN 0	a DT 0	result NN B-noun.act	of IN 0	heart_failure NN B-noun.state	. . 0	. . 0
a7088431.s3	In IN 0	both DT 0	instances NNS B-noun.group	, , 0	suspicion NN 0	of IN 0	the DT 0	presence NN B-noun.person	of IN 0	carcinoma NN B-noun.food	was VBD 0	aroused VBN B-verb.emotion	by IN 0	the DT 0	palpation NN B-noun.act	of IN 0	a DT 0	small JJ B-adj.all	nodule NN B-noun.quantity	in IN 0	the DT 0	vaginal JJ B-adj.all	fornix NN B-noun.attribute	. . 0	. . 0
a20588063.s12	CONCLUSIONS NNS B-noun.artifact	, , 0	PAN NNP 0	glomeruli NNS 0	already RB B-adv.all	showed VBD B-verb.communication	significant JJ B-adj.all	pathology NN B-noun.attribute	by IN 0	day NN 0	4 CD 0	, , 0	despite IN 0	relatively RB B-adv.all	mild JJ B-adj.all	proteinuria NNS B-noun.person	. . 0	. . 0
a12063090.s7	Acute NNP B-noun.person	antinociceptive JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	the DT 0	combination NN B-noun.person	were VBD B-verb.stative	partially RB B-adv.all	prevented VBN B-verb.creation	by IN 0	3.2 CD 0	mg FW B-noun.quantity	/ FW 0	kg FW 0	naloxone FW 0	s.c FW 0	. . 0	( ( 0	. . 0
a3503576.s5	Since IN 0	18 CD 0	of IN 0	the DT 0	22 CD B-adj.all	patients NNS B-noun.person	were VBD 0	initially RB B-adv.all	receiving VBG B-verb.perception	deferoxamine NN I-verb.perception	doses NNS B-noun.event	in IN 0	excess NN 0	of IN 0	the DT 0	commonly RB B-adv.all	recommended VBN B-verb.communication	50 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	per FW 0	dose NN B-noun.animal	, , 0	therapy NN B-noun.person	was VBD 0	restarted VBN B-verb.social	with IN 0	lower JJR B-adj.all	doses NNS B-noun.person	, , 0	usually RB B-verb.consumption	50 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	per FW 0	dose NN B-noun.animal	or CC 0	less JJR B-noun.quantity	depending VBG B-verb.motion	on IN 0	the DT 0	degree NN B-noun.communication	of IN 0	auditory_abnormality NN B-noun.group	, , 0	and CC 0	with IN 0	the DT 0	exception NN B-noun.act	of IN 0	two CD B-adj.all	cases NNS B-noun.person	no DT 0	further JJ B-adj.all	toxicity NN B-noun.attribute	was VBD 0	demonstrated VBN B-verb.perception	. . 0	. . 0
a3780846.s9	Haloperidol NNP B-noun.person	enhanced VBD B-verb.change	the DT 0	rigidity NN B-noun.attribute	in IN 0	the DT 0	A NNP 0	group NN 0	. . 0	. . 0
a8649546.s0	Improvement NN B-noun.state	of IN 0	levodopa NN B-noun.attribute	- : 0	induced VBN B-verb.creation	dyskinesia NN B-noun.process	by IN 0	propranolol NN B-noun.person	in IN 0	Parkinson's_disease NN 0	. . 0	. . 0
a1720453.s10	Severe JJ B-adj.all	toxicity NN B-noun.state	was VBD 0	correlated VBN B-verb.creation	with IN 0	the DT 0	higher RBR B-adj.all	cumulative JJ B-adj.all	dose NN B-noun.event	of IN 0	60 CD B-adj.all	g PRP 0	/ $ 0	m2 CD 0	of IN 0	ifosfamide NN 0	, , 0	a DT 0	younger JJR B-adj.all	age NN B-noun.time	( ( 0	less JJR B-noun.quantity	than IN 0	2 CD B-adj.all	1/2 CD 0	years NNS B-noun.time	old JJ B-adj.all	) ) 0	, , 0	and CC 0	a DT 0	predominance NN B-noun.person	of IN 0	vesicoprostatic JJ B-adj.all	tumor NN B-noun.relation	involvement NN I-noun.relation	. . 0	. . 0
a20667451.s10	Concomitant JJ B-adj.all	curcumin NN B-noun.person	administration NN B-noun.person	prevented VBD B-verb.communication	the DT 0	cognitive_impairment NN B-noun.artifact	and CC 0	decreased VBD B-verb.change	the DT 0	increased VBN B-verb.change	oxidative JJ B-adj.all	stress NN B-noun.communication	induced VBN B-verb.creation	by IN 0	these DT 0	antiepileptic JJ B-adj.all	drugs NNS B-noun.artifact	. . 0	. . 0
a17439425.s15	This DT 0	, , 0	together RB 0	with IN 0	our PRP$ 0	previous JJ B-adj.all	findings NNS B-noun.act	that WDT 0	allopurinol VBP 0	failed VBN B-verb.social	to TO 0	prevent VB B-verb.creation	adrenocorticotrophic JJ B-adj.all	hormone NN B-noun.communication	induced VBN B-verb.creation	hypertension NN 0	, , 0	suggests VBZ B-verb.communication	that IN 0	XO NNP 0	activity NN B-noun.process	is VBZ B-verb.stative	not RB I-verb.stative	a DT 0	major JJ B-adj.all	determinant NN B-noun.cognition	of IN 0	GC NNP 0	- : 0	HT NN 0	in IN 0	the DT 0	rat NN B-noun.artifact	. . 0	. . 0
a20722491.s0	Safety NN B-noun.person	of IN 0	capecitabine NN B-noun.location	, , 0	a DT 0	review NN B-noun.act	. . 0	. . 0
a11961407.s12	GLEPP1 JJ B-adj.all	expression NN B-noun.communication	may MD 0	be VB B-verb.stative	a DT 0	useful JJ B-adj.all	marker NN B-noun.person	of IN 0	podocyte NN B-noun.possession	injury NN B-noun.possession	. . 0	. . 0
a8558192.s6	RESULTS NNS B-noun.artifact	, , 0	Six CD 0	of IN 0	30 CD B-adj.all	patients NNS B-noun.person	( ( 0	20 CD B-adj.all	% NN 0	) ) 0	without IN 0	prior JJ B-adj.all	chemotherapy NN B-noun.communication	achieved VBD B-verb.stative	a DT 0	partial JJ B-adj.all	response NN B-noun.communication	( ( 0	PR NNP 0	) ) 0	( ( 0	95 CD 0	% NN 0	confidence NN B-noun.act	interval NN I-noun.act	[ '' 0	CI NNP 0	] # 0	, , 0	8 CD B-adj.all	% NN 0	to TO 0	39 CD 0	% NN 0	) ) 0	. . 0	. . 0
a12707296.s10	Systolic JJ B-adj.all	blood NN B-noun.group	pressure NN B-noun.person	was VBD 0	elevated VBN B-verb.social	by IN 0	an DT 0	average NN B-noun.act	of IN 0	7 CD B-adj.all	mm NN B-noun.quantity	Hg NNP 0	. . 0	. . 0
a9931093.s8	Little JJ 0	change NN 0	was VBD 0	observed VBN B-verb.perception	in IN 0	the DT 0	expression NN B-noun.communication	of IN 0	ECE-1 NNP B-noun.person	mRNA NNP I-noun.person	and CC 0	CNP NNP B-noun.person	mRNA NNP I-noun.person	. . 0	. . 0
a16428221.s2	Cerebral_vasculitis NN 0	associated VBN B-verb.cognition	with IN 0	amphetamine_abuse NN B-noun.act	is VBZ B-verb.stative	well RB 0	documented VBN 0	, , 0	and CC 0	in IN 0	rare JJ B-adj.all	cases NNS B-noun.artifact	ischaemic_stroke WDT 0	has VBZ 0	been VBN 0	reported VBN B-verb.communication	after IN 0	methylphenidate JJ B-adj.all	intake NN B-noun.person	in IN 0	children NNS B-noun.animal	. . 0	. . 0
a10365197.s3	The DT 0	prevalence NN B-noun.relation	rate NN B-noun.time	for IN 0	CIMD NNP B-noun.group	was VBD B-verb.stative	12 CD B-adj.all	% NN 0	at IN 0	baseline NN B-noun.location	. . 0	. . 0
a10669626.s2	The DT 0	first JJ B-adj.all	series NN B-noun.communication	of IN 0	experiments NNS B-noun.person	examined VBD B-verb.communication	the DT 0	influence NN B-noun.cognition	of IN 0	age NN B-noun.food	and CC 0	growth NN 0	status NN 0	on IN 0	artery_calcification NN B-noun.act	in IN 0	Warfarin NNP B-noun.location	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	. . 0	. . 0
a11379838.s3	Patients NNS B-noun.person	who WP 0	experienced VBD B-verb.perception	a DT 0	manic JJ B-adj.all	or CC 0	hypomanic JJ B-adj.all	switch NN B-noun.event	were VBD 0	compared VBN B-verb.change	with IN 0	those DT 0	who WP 0	did VBD 0	not RB B-adv.all	on IN 0	several JJ B-adj.all	variables NNS B-noun.cognition	including VBG B-verb.stative	age NN I-verb.stative	, , 0	sex NN B-noun.person	, , 0	diagnosis NN B-noun.person	( ( 0	DSM NNP 0	- : 0	IV_bipolar JJ B-noun.other	I PRP I-noun.other	vs. FW I-noun.other	bipolar_II NNP I-noun.other	) ) 0	, , 0	number NN B-noun.quantity	of IN 0	previous JJ B-adj.all	manic JJ B-adj.pert	episodes NNS B-noun.communication	, , 0	type NN B-noun.person	of IN 0	antidepressant JJ B-adj.all	therapy NN B-noun.person	used VBN B-verb.consumption	( ( 0	electroconvulsive JJ B-adj.all	therapy NN 0	vs. FW 0	antidepressant JJ B-adj.all	drugs NNS B-noun.artifact	and CC 0	, , 0	more RBR B-adv.all	particularly RB I-adv.all	, , 0	selective JJ B-adj.all	serotonin_reuptake_inhibitors NNS B-noun.person	[ POS 0	SSRIs NNP B-noun.group	] NNP I-noun.group	) ) 0	, , 0	use NN B-verb.consumption	and CC 0	type NN B-noun.person	of IN 0	mood NN B-noun.person	stabilizers NNS B-noun.person	( ( 0	lithium NN 0	vs. NN 0	anticonvulsants NNS B-noun.event	) ) 0	, , 0	and CC 0	temperament NN B-noun.attribute	of IN 0	the DT 0	patient NN B-noun.person	, , 0	assessed VBN B-verb.social	during IN 0	a DT 0	normothymic JJ B-adj.all	period NN B-noun.person	using VBG B-verb.consumption	the DT 0	hyperthymia NN B-noun.location	component NN B-noun.person	of IN 0	the DT 0	Semi NNP B-noun.person	- : 0	structured JJ B-noun.person	Affective NNP I-noun.person	Temperament NNP I-noun.person	Interview NNP I-noun.person	. . 0	. . 0
a9812111.s1	OBJECTIVE NNP B-noun.group	, , 0	The DT 0	goal NN B-noun.cognition	of IN 0	this DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	compare VB B-verb.stative	the DT 0	efficacy NN B-noun.person	and CC 0	side JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	two CD 0	doses NNS B-noun.quantity	of IN 0	haloperidol NN B-noun.person	and CC 0	placebo NN B-noun.person	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	psychosis NN B-noun.food	and CC 0	disruptive_behaviors NNS B-noun.person	in IN 0	patients NNS B-noun.person	with IN 0	Alzheimer's_disease NNP B-noun.person	. . 0	. . 0
a1147734.s0	Liver_disease NN 0	caused VBN B-verb.communication	by IN 0	propylthiouracil NN B-noun.person	. . 0	. . 0
a9406968.s3	The DT 0	Li SYM 0	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	produced VBD B-verb.creation	a DT 0	large JJ B-adj.all	volume NN B-noun.attribute	of IN 0	hypotonic JJ B-adj.all	urine NN B-noun.act	with IN 0	low JJ B-adj.all	ionic JJ B-adj.pert	concentrations NNS B-noun.attribute	. . 0	. . 0
a18020536.s7	Data NNS B-noun.cognition	on IN 0	use NN 0	of IN 0	BZDs NNP B-noun.other	/ NNP I-noun.other	RDs NNP I-noun.other	before IN 0	admission NN B-noun.time	, , 0	current JJ B-adj.all	medications NNS B-noun.person	and CC 0	discharge VB B-verb.possession	diagnoses NNS B-noun.person	were VBD 0	collected VBN B-verb.possession	from IN 0	medical JJ B-adj.all	records NNS B-noun.communication	. . 0	. . 0
a11250767.s7	A DT 0	literature NN B-noun.person	review NN B-noun.person	revealed VBD B-verb.perception	no DT 0	prior JJ B-adj.all	reports NNS B-noun.communication	of IN 0	pericarditis NN B-noun.food	in IN 0	anti NNS B-noun.person	- : 0	MPO NN B-noun.group	pANCA NN B-noun.attribute	- : 0	positive JJ B-adj.all	vasculitis NN B-noun.artifact	associated VBN B-verb.cognition	with IN 0	propylthio-_uracil NNP B-noun.person	therapy NN I-noun.person	. . 0	. . 0
a15737522.s7	After IN 0	cessation NN B-noun.time	of IN 0	the DT 0	treatment NN B-noun.communication	, , 0	pseudolithiasis NN B-noun.person	resolved VBN B-verb.communication	spontaneously RB B-adv.all	within IN 0	a DT 0	short JJ B-adj.all	period NN B-noun.time	. . 0	. . 0
a20196116.s2	Prospective JJ B-adj.all	studies NNS B-noun.artifact	on IN 0	ATT NNP B-noun.group	- : 0	ALF PRP 0	are VBP 0	lacking VBG B-verb.stative	. . 0	. . 0
a12063090.s3	metamizol NN B-noun.state	in IN 0	acutely RB B-adv.all	and CC 0	chronically RB B-adv.all	treated VBN B-verb.social	( ( 0	once RB B-adv.all	a DT 0	day NN B-noun.person	for IN 0	12 CD B-adj.all	days NNS B-noun.act	) ) 0	rats NNS B-noun.animal	. . 0	. . 0
a1720453.s11	This DT 0	low JJ B-adj.all	percentage NN B-noun.person	( ( 0	5 CD B-adj.all	% NN 0	) ) 0	of IN 0	TDFS NNP B-noun.group	must MD 0	be VB 0	evaluated VBN B-verb.cognition	with IN 0	respect NN B-noun.act	to TO 0	the DT 0	efficacy NN B-noun.phenomenon	of IN 0	ifosfamide NN B-noun.food	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	mesenchymal_tumors NNS B-noun.person	in IN 0	children NNS B-noun.animal	. . 0	. . 0
a15649445.s3	Reserpine JJ B-adj.all	injection NN B-noun.act	( ( 0	one CD 0	dose NN B-noun.event	of IN 0	1 CD 0	mg FW 0	/ FW 0	kg FW 0	s.c FW 0	. . 0	) ) 0	. . 0
a3827439.s3	We PRP 0	propose VBP B-verb.cognition	that IN 0	amphotericin NN B-noun.person	, , 0	in IN 0	the DT 0	setting NN B-noun.act	of IN 0	reduced VBN B-verb.change	effective JJ B-adj.all	arterial JJ B-adj.all	volume NN B-noun.artifact	, , 0	may MD 0	activate VB B-verb.stative	tubuloglomerular JJ B-adj.all	feedback NN B-noun.artifact	, , 0	thereby RB 0	contributing VBG 0	to TO 0	acute_renal_failure VB B-verb.stative	. . 0	. . 0
a11752354.s1	BACKGROUND NN 0	, , 0	An DT 0	association NN B-noun.cognition	between IN 0	the DT 0	use NN 0	of IN 0	oral_contraceptives NNS B-noun.plant	and CC 0	the DT 0	risk NN 0	of IN 0	myocardial_infarction NN B-noun.group	has VBZ 0	been VBN 0	found VBN B-verb.possession	in IN 0	some DT 0	, , 0	but CC 0	not RB 0	all DT 0	, , 0	studies NNS B-noun.person	. . 0	. . 0
a17879945.s8	Cells NNS B-noun.body	were VBD 0	then RB B-adv.all	treated VBN B-verb.change	with IN 0	30 CD 0	ng FW 0	/ FW 0	ml FW 0	ritonavir NN B-noun.person	or CC 0	vehicle NN B-noun.communication	in IN 0	the DT 0	presence NN B-noun.person	of IN 0	aggregated VBN B-verb.change	LDL NNP 0	for IN 0	24 CD B-adj.all	h. CD B-noun.quantity	Cell NNP B-noun.person	extracts NNS I-noun.person	were VBD 0	harvested VBN B-verb.consumption	, , 0	and CC 0	lipid NN B-noun.body	or CC 0	total JJ B-adj.all	RNA NNP 0	was VBD 0	isolated VBN B-verb.change	. . 0	. . 0
a18752389.s10	Ezetimibe NNP B-noun.person	undergoes VBZ B-verb.cognition	extensive JJ B-noun.phenomenon	glucuronidation NN I-noun.phenomenon	by IN 0	uridine_diphosphate JJ B-adj.all	glucoronosyltransferases NNS B-noun.attribute	( ( 0	UGT NNP 0	) ) 0	in IN 0	the DT 0	intestine NN B-noun.person	and CC 0	liver NN B-noun.person	and CC 0	may MD 0	have VB 0	inhibited VBN B-verb.change	the DT 0	glucuronidation NN B-noun.act	of IN 0	simvastatin_hydroxy_acid JJ B-adj.all	, , 0	resulting VBG B-verb.stative	in IN 0	increased VBN B-verb.change	simvastatin JJ B-adj.all	exposure NN B-noun.person	and CC 0	subsequent JJ B-adj.all	hepatotoxicity NN B-noun.attribute	. . 0	. . 0
a8387218.s4	Only RB B-adv.all	minor JJ B-adj.all	changes NNS B-noun.communication	in IN 0	CD4 CD 0	+ DT 0	lymphocyte NN B-noun.person	subset NN B-noun.person	count NN B-noun.person	were VBD 0	observed VBN B-verb.perception	in IN 0	AIDS NNP B-noun.group	patients NNS B-noun.person	, , 0	although IN 0	a DT 0	more RBR B-adv.all	significant JJ B-adj.all	rise NN B-noun.attribute	occurred VBD B-verb.stative	in IN 0	those DT 0	with IN 0	earlier JJR B-adj.all	stages NNS B-noun.state	of IN 0	disease NN B-noun.state	. . 0	. . 0
a16740173.s5	He PRP 0	bought VBD B-verb.contact	25 CD B-adj.all	g NN B-noun.quantity	of IN 0	carbachol NN 0	as IN 0	pure JJ B-adj.all	substance NN B-noun.state	in IN 0	a DT 0	pharmacy NN B-noun.time	, , 0	and CC 0	the DT 0	father NN B-noun.person	was VBD 0	administered VBN B-verb.creation	400 CD 0	to TO 0	500 CD 0	mg NN B-noun.quantity	. . 0	. . 0
a20667451.s6	Vehicle NNP B-noun.communication	/ POS 0	drugs NNS B-noun.artifact	were VBD 0	administered VBN B-verb.communication	daily RB B-adv.all	for IN 0	21days NNS B-noun.act	to TO 0	male NN B-noun.person	Wistar NNP I-noun.person	rats NNS I-noun.person	. . 0	. . 0
a20667451.s7	Passive JJ B-adj.all	avoidance NN B-noun.act	paradigm NN I-noun.act	and CC 0	elevated VBD B-verb.motion	plus CC 0	maze VB B-verb.change	test NN B-noun.person	were VBD 0	used VBN B-verb.consumption	to TO 0	assess VB B-verb.cognition	cognitive JJ B-adj.all	function NN B-noun.act	. . 0	. . 0
a6203452.s1	Five CD 0	patients NNS B-noun.person	with IN 0	carcinoma NN B-noun.group	developed VBD B-verb.creation	thrombotic_microangiopathy JJ 0	( ( 0	characterized VBN B-verb.communication	by IN 0	renal_insufficiency NN B-noun.person	, , 0	microangiopathic_hemolytic_anemia NNP B-noun.location	, , 0	and CC 0	usually RB B-adv.all	thrombocytopenia VBP B-verb.communication	) ) 0	after IN 0	treatment NN B-noun.plant	with IN 0	cisplatin NN B-noun.food	, , 0	bleomycin NN B-noun.person	, , 0	and CC 0	a DT 0	vinca_alkaloid JJ B-noun.plant	. . 0	. . 0
a8643971.s0	A DT 0	phase NN B-noun.time	I PRP 0	/ VBP 0	II NNP 0	study NN 0	of IN 0	paclitaxel NN B-noun.artifact	plus CC 0	cisplatin NN 0	as IN 0	first JJ B-noun.person	- : 0	line NN B-noun.act	therapy NN B-noun.act	for IN 0	head_and_neck_cancers NNS B-noun.person	, , 0	preliminary JJ B-adj.all	results NNS B-noun.communication	. . 0	. . 0
a16755009.s2	The DT 0	ethanolic JJ B-adj.all	extract_of_Daucus_carota_seeds NNS B-noun.group	( ( 0	DCE NNP 0	) ) 0	was VBD 0	administered VBN B-verb.possession	orally RB B-adv.all	in IN 0	three CD 0	doses NNS B-noun.quantity	( ( 0	100 CD 0	, , 0	200 CD 0	, , 0	400 CD 0	mg NN B-noun.quantity	/ : 0	kg LS 0	) ) 0	for IN 0	seven CD 0	successive JJ B-adj.all	days NNS B-noun.person	to TO 0	different JJ B-adj.all	groups NNS B-noun.group	of IN 0	young JJ B-adj.all	and CC 0	aged VBN B-verb.change	mice NNS I-verb.change	. . 0	. . 0
a16755009.s9	Furthermore RB B-adv.all	, , 0	DCE NNP B-noun.person	reversed VBD B-verb.change	the DT 0	amnesia NN B-noun.object	induced VBN B-verb.creation	by IN 0	scopolamine NN B-noun.person	( ( 0	0.4 CD 0	mg FW B-noun.quantity	/ FW 0	kg FW 0	, , 0	i.p NNP B-noun.person	. . 0	) ) 0	. . 0
a15515654.s3	All DT 0	patients NNS B-noun.person	were VBD B-verb.stative	on IN 0	a DT 0	regular JJ B-adj.all	transfusion NN B-noun.act	- : 0	chelation NN B-noun.act	program NN B-noun.person	maintaining VBG B-verb.consumption	a DT 0	mean JJ B-adj.all	hemoglobin NN B-noun.state	level NN B-noun.state	of IN 0	9.5 CD 0	gr FW 0	/ FW 0	dl FW 0	. . 0	. . 0
a11135224.s13	Nonhematologic JJ B-adj.all	toxicities NNS B-noun.state	were VBD B-verb.stative	mild JJ B-adj.all	. . 0	. . 0
a12369736.s10	In IN 0	other JJ 0	words NNS B-noun.animal	, , 0	the DT 0	present JJ B-adj.all	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	the DT 0	accumbal JJ B-adj.all	shell NN B-noun.person	5-HT1B JJ I-noun.person	receptors NNS I-noun.person	play VBP B-verb.creation	a DT 0	permissive JJ B-adj.all	role NN B-noun.attribute	in IN 0	the DT 0	behavioural JJ B-adj.all	response NN B-noun.communication	to TO 0	the DT 0	psychostimulant NN B-noun.person	. . 0	. . 0
a2224762.s9	Pharmacokinetic JJ B-adj.all	analyses NNS B-noun.act	in IN 0	21 CD B-adj.all	patients NNS B-noun.person	revealed VBD B-verb.communication	Pirarubicin NNP B-noun.person	plasma NN I-noun.person	T NNP 0	1/2 CD 0	alpha NN B-noun.quantity	( ( 0	+ FW 0	/- FW 0	SE NNP 0	) ) 0	of IN 0	2.5 CD 0	+ : 0	/- $ 0	0.85 CD 0	minutes NNS B-noun.time	, , 0	T NNP 0	beta JJ 0	1/2 CD 0	of IN 0	25.6 CD 0	+ : 0	/- $ 0	6.5 CD 0	minutes NNS B-noun.time	, , 0	and CC 0	T NNP 0	1/2 CD 0	gamma NN B-noun.act	of IN 0	23.6 CD 0	+ : 0	/- $ 0	7.6 CD 0	hours NNS B-noun.attribute	. . 0	. . 0
a15145918.s2	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	investigated VBD B-verb.communication	whether IN 0	this DT 0	effect NN B-noun.cognition	of IN 0	estrogen NN B-noun.communication	involves VBZ B-verb.creation	interaction NN I-verb.creation	with IN 0	alpha2- PDT B-noun.group	and/or CC I-noun.group	I1-receptors NNS I-noun.group	. . 0	. . 0
a15899738.s13	Clinicians NNS B-noun.person	must MD 0	be VB B-verb.stative	diligent NN B-noun.person	when WRB 0	interviewing VBG B-verb.communication	patients NNS B-noun.person	about IN 0	their PRP$ 0	drug NN 0	therapy NN 0	histories NNS B-noun.communication	and CC 0	include VBP B-verb.change	questions NNS B-noun.communication	about IN 0	their PRP$ 0	use NN 0	of IN 0	herbal JJ B-adj.pert	products NNS B-noun.person	and CC 0	dietary JJ B-adj.all	supplements NNS B-noun.person	. . 0	. . 0
a11752354.s2	We PRP 0	investigated VBD B-verb.communication	this DT 0	association NN B-noun.cognition	, , 0	according VBG 0	to TO 0	the DT 0	type NN B-noun.person	of IN 0	progestagen NN 0	included VBN B-verb.stative	in IN 0	third JJ B-noun.act	- : 0	generation NN B-noun.time	( ( 0	i.e. FW B-adv.all	, , 0	desogestrel NN B-noun.artifact	or CC 0	gestodene VB B-verb.social	) ) 0	and CC 0	second JJ B-adj.all	- : 0	generation NN B-noun.time	( ( 0	i.e. FW B-adv.all	, , 0	levonorgestrel NN B-noun.attribute	) ) 0	oral_contraceptives NNS B-noun.body	, , 0	the DT 0	dose NN B-noun.quantity	of IN 0	estrogen NN B-noun.food	, , 0	and CC 0	the DT 0	presence NN B-noun.person	or CC 0	absence NN B-noun.act	of IN 0	prothrombotic JJ B-adj.all	mutations NNS B-noun.group	METHODS NNS B-noun.attribute	, , 0	In IN 0	a DT 0	nationwide JJ B-noun.location	, , 0	population NN B-noun.person	- : 0	based VBN B-verb.cognition	, , 0	case NN B-noun.person	- : 0	control NN B-noun.act	study NN B-noun.artifact	, , 0	we PRP 0	identified VBD B-verb.cognition	and CC 0	enrolled VBD B-verb.social	248 CD 0	women NNS B-noun.person	18 CD 0	through IN 0	49 CD 0	years NNS B-noun.time	of IN 0	age NN B-noun.person	who WP 0	had VBD 0	had VBN B-verb.perception	a DT 0	first JJ B-adj.all	myocardial_infarction NN B-noun.act	between IN 0	1990 CD 0	and CC 0	1995 CD 0	and CC 0	925 CD 0	control NN B-noun.act	women NNS B-noun.person	who WP 0	had VBD 0	not RB 0	had VBD 0	a DT 0	myocardial_infarction NN B-noun.person	and CC 0	who WP 0	were VBD 0	matched VBN B-verb.contact	for IN 0	age NN B-noun.time	, , 0	calendar NN B-adj.all	year NN B-noun.time	of IN 0	the DT 0	index NN B-noun.communication	event NN B-adv.all	, , 0	and CC 0	area NN B-noun.cognition	of IN 0	residence NN B-noun.act	. . 0	. . 0
a2924746.s2	Carbamazepine NNP B-noun.person	( ( 0	CBZ NNP 0	) ) 0	, , 0	a DT 0	commonly RB B-adv.all	used VBN B-verb.consumption	AED NNP I-verb.consumption	, , 0	has VBZ 0	been VBN 0	implicated VBN B-verb.communication	in IN 0	some DT 0	clinical JJ B-adj.all	studies NNS B-noun.communication	. . 0	. . 0
a2234245.s9	Periodical JJ B-adj.all	audiovisual JJ B-adj.all	monitoring NN B-verb.perception	should MD 0	be VB 0	performed VBN B-verb.social	on IN 0	hemodialyzed VBN B-verb.cognition	patients NNS B-noun.person	receiving VBG B-verb.communication	the DT 0	drug NN B-noun.person	in IN 0	order NN 0	to TO 0	detect VB B-verb.cognition	adverse JJ B-adj.all	effects NNS B-noun.phenomenon	as IN 0	early RB 0	as IN 0	possible JJ B-adj.all	. . 0	. . 0
a11279304.s5	Cardiac NNP B-noun.person	functions NNS I-noun.person	were VBD 0	evaluated VBN B-verb.communication	with IN 0	radionuclide JJ 0	angiography NN 0	before IN 0	chemotherapies NNS B-noun.group	. . 0	. . 0
a19037603.s8	In IN 0	four CD 0	patients NNS B-noun.group	HBV NNP 0	DNA NNP 0	levels NNS B-noun.state	were VBD B-verb.stative	higher JJR B-adj.all	than IN 0	normal JJ B-adj.all	at IN 0	baseline NN B-noun.location	. . 0	. . 0
a11587867.s0	Fatal JJ B-adj.all	myeloencephalopathy JJ 0	due JJ 0	to TO 0	accidental JJ B-adj.all	intrathecal JJ B-adj.all	vincristin NN B-noun.person	administration NN B-noun.person	, , 0	a DT 0	report NN B-noun.person	of IN 0	two CD B-adj.all	cases NNS B-noun.person	. . 0	. . 0
a8595686.s2	In IN 0	a DT 0	randomized VBN B-verb.cognition	, , 0	double RB 0	- : 0	blind JJ B-adj.all	trial NN B-noun.act	, , 0	90 CD B-adj.all	women NNS B-noun.person	were VBD 0	allocated VBN B-verb.communication	to TO 0	receive VB B-verb.possession	one CD 0	of IN 0	three CD 0	treatments NNS B-noun.location	prior RB 0	to TO 0	induction NN B-noun.act	of IN 0	anaesthesia NN 0	with IN 0	propofol NN B-noun.person	. . 0	. . 0
a14513889.s3	Laboratory NN B-noun.body	evaluations NNS I-noun.body	, , 0	including VBG B-verb.communication	head NN I-verb.communication	CT NNP 0	scan JJ 0	, , 0	were VBD B-verb.stative	normal JJ B-adj.all	. . 0	. . 0
a18544179.s4	Patients NNS B-noun.person	were VBD 0	randomly RB B-adv.all	allocated VBN B-verb.communication	to TO 0	either CC 0	receive VB B-verb.communication	or CC 0	not RB B-adv.all	receive VB B-verb.possession	1 CD B-adj.all	1 CD 0	fentanyl NN 0	, , 0	while IN 0	a DT 0	third JJ B-adj.all	group NN B-noun.group	received VBD B-verb.possession	dexamethasone NN B-noun.person	in IN 0	addition NN 0	to TO 0	fentanyl NN B-noun.location	. . 0	. . 0
a17439425.s9	Thymus DT 0	weight NN B-noun.event	was VBD 0	used VBN B-verb.consumption	as IN 0	a DT 0	marker NN B-noun.person	of IN 0	glucocorticoid JJ B-adj.all	activity NN B-noun.process	, , 0	and CC 0	serum NN B-noun.body	urate NN 0	to TO 0	assess VB B-verb.cognition	XO NNP 0	inhibition NN 0	. . 0	. . 0
a18410508.s5	9 CD B-adj.all	( ( 0	2006 CD 0	) ) 0	, , 0	917 CD 0	] ) 0	recently RB B-adv.all	identified VBD B-verb.cognition	the DT 0	microglial JJ B-adj.all	- : 0	specific JJ B-adj.all	fractalkine NN B-noun.person	receptor NN B-noun.person	( ( 0	CX3CR1 NNP 0	) ) 0	as IN 0	an DT 0	important JJ B-adj.all	mediator NN B-noun.cognition	of_MPTP SYM I-noun.cognition	- : 0	induced_neurodegeneration NN B-noun.time	of IN 0	DA NNP 0	neurons NNS B-noun.artifact	. . 0	. . 0
a9727773.s2	The DT 0	importance NN B-noun.attribute	of IN 0	this DT 0	association NN B-noun.cognition	was VBD 0	evaluated VBN B-verb.change	in IN 0	Belgium NNP B-noun.location	while IN 0	this DT 0	country NN B-noun.attribute	still RB 0	had VBD 0	no DT 0	restriction NN B-noun.act	on IN 0	the DT 0	prescription NN B-noun.person	of IN 0	appetite_suppressants NNS B-noun.person	. . 0	. . 0
a11875660.s3	We PRP 0	observed VBD B-verb.perception	the DT 0	exencephaly NN B-noun.act	induced VBN B-verb.creation	by IN 0	5-azacytidine JJ 0	at IN 0	embryonic JJ B-adj.all	day NN 0	13.5 CD 0	( ( 0	E13.5 NN 0	) ) 0	, , 0	let VB B-verb.stative	the DT 0	embryos NNS B-noun.artifact	develop VBP B-verb.stative	exo NN I-verb.stative	utero NN B-noun.act	until IN 0	E18.5 NNP B-noun.person	, , 0	and CC 0	re SYM 0	- : 0	observed VBD B-verb.perception	the DT 0	same JJ B-adj.all	embryos NNS B-noun.person	at IN 0	E18.5 NNP B-noun.location	. . 0	. . 0
a11279304.s3	We PRP 0	measured VBD B-verb.cognition	the DT 0	plasma NN B-noun.plant	level NN B-noun.state	of IN 0	brain NN B-noun.food	natriuretic JJ B-adj.all	peptide NN B-noun.cognition	( ( 0	BNP NNP 0	) ) 0	to TO 0	determine VB B-verb.communication	whether IN 0	BNP NNP 0	might MD 0	serve VB B-verb.social	as IN 0	a DT 0	simple JJ B-adj.all	diagnostic JJ B-noun.person	indicator NN I-noun.person	of IN 0	anthracycline JJ B-noun.attribute	- : 0	induced VBN B-verb.creation	cardiotoxicity NN B-noun.process	in IN 0	patients NNS B-noun.person	with IN 0	acute_leukemia NNP B-noun.person	treated VBD B-verb.social	with IN 0	a DT 0	daunorubicin NN B-noun.person	( ( 0	DNR)-containing VBG 0	regimen NNS B-noun.person	. . 0	. . 0
a12707296.s7	L SYM 0	- : 0	arginine NN B-noun.person	uptake NN B-noun.person	was VBD 0	assessed VBN B-verb.cognition	in IN 0	mononuclear NN B-noun.body	cells NNS B-noun.body	incubated VBN B-verb.change	with IN 0	L SYM 0	- : 0	arginine NN B-noun.person	( ( 0	1 CD 0	to TO 0	300 CD 0	micromol NN B-noun.quantity	/ '' 0	L NNP 0	) ) 0	, , 0	incorporating VBG B-verb.stative	100 CD 0	nmol NN B-noun.quantity	/ '' 0	L NNP B-noun.quantity	[ : 0	3H]-l SYM 0	- : 0	arginine NN B-noun.person	for IN 0	a DT 0	period NN B-noun.time	of IN 0	5 CD B-adj.all	minutes NNS B-noun.time	at IN 0	37 CD 0	degrees NNS B-noun.communication	C. NNP B-noun.person	Forearm NNP I-noun.person	[ POS 0	3H]-L SYM 0	- : 0	arginine NN B-noun.person	extraction NN B-noun.person	was VBD 0	calculated VBN B-verb.cognition	after IN 0	infusion NN B-noun.time	of IN 0	[ : 0	3H]-L SYM 0	- : 0	arginine NN 0	into IN 0	the DT 0	brachial JJ B-adj.all	artery NN B-noun.shape	at IN 0	a DT 0	rate NN B-noun.time	of IN 0	100 CD 0	nCi CD 0	/ DT 0	min NN B-noun.quantity	for IN 0	80 CD B-adj.all	minutes NNS B-noun.time	. . 0	. . 0
a12198388.s5	We PRP 0	also RB B-adv.all	used VBN B-verb.consumption	microdialysis NN I-verb.consumption	to TO 0	measure VB B-verb.communication	basal NN B-noun.person	and CC 0	potassium NN B-noun.person	- : 0	stimulated VBD B-verb.communication	acetylcholine NN B-noun.person	( ( 0	ACh NNP 0	) ) 0	release NN B-noun.state	in IN 0	the DT 0	CA1 JJ B-adj.all	region NN B-noun.act	of IN 0	the DT 0	hippocampus NN B-noun.communication	. . 0	. . 0
a12584269.s0	Kidney NNP B-noun.person	function NN B-noun.act	and CC 0	morphology NN B-noun.person	after IN 0	short JJ B-noun.body	- : 0	term NN B-noun.time	combination NN 0	therapy NN 0	with IN 0	cyclosporine NN 0	A NNP 0	, , 0	tacrolimus NN B-noun.person	and CC 0	sirolimus NN B-noun.act	in IN 0	the DT 0	rat NN B-noun.artifact	. . 0	. . 0
a15130900.s5	In IN 0	the DT 0	cohort NN B-noun.communication	the DT 0	cumulative JJ B-adj.all	risk NN 0	of IN 0	bladder_cancer NN B-noun.person	after IN 0	Wegener's_granulomatosis NN B-noun.time	, , 0	and CC 0	the DT 0	relative JJ B-adj.all	prevalence NN B-noun.attribute	of IN 0	a DT 0	history NN B-noun.cognition	of IN 0	bladder_cancer NN B-noun.object	at IN 0	the DT 0	time NN B-noun.time	of IN 0	diagnosis NN B-noun.cognition	of IN 0	Wegener's_granulomatosis NN B-noun.food	, , 0	were VBD B-verb.stative	also RB B-adv.all	estimated VBN B-verb.cognition	. . 0	. . 0
a10901305.s6	Any DT 0	pain NN B-noun.cognition	during IN 0	the DT 0	reduction NN B-noun.person	was VBD 0	rated VBN B-verb.cognition	by IN 0	the DT 0	orthopaedic JJ B-adj.all	surgeon NN B-noun.person	treating VBG B-verb.change	the DT 0	patient NN B-noun.person	according VBG 0	to TO 0	the DT 0	Children NNP B-noun.person	's POS 0	Hospital NNP B-noun.other	of IN I-noun.other	Eastern NNP I-noun.other	Ontario NNP I-noun.other	Pain NNP I-noun.other	Scale NNP I-noun.other	( ( 0	CHEOPS NNP B-noun.group	) ) 0	. . 0	. . 0
a12584269.s8	RESULTS NNS B-noun.artifact	, , 0	CsA NNP B-noun.person	, , 0	FK506 NNP B-noun.person	and CC 0	SRL NNP 0	all DT 0	significantly RB B-adv.all	decreased VBD B-verb.change	the DT 0	GFR NNP B-noun.group	. . 0	. . 0
a3856631.s6	One CD 0	patient NN B-noun.person	had VBD B-verb.body	focal JJ B-adj.all	seizures NNS B-noun.body	and CC 0	transient_hemiparesis NN B-noun.body	but CC 0	recovered VBD B-verb.change	completely RB B-adv.all	. . 0	. . 0
a16787750.s5	We PRP 0	report VBP B-verb.stative	19 CD B-adj.all	patients NNS B-noun.person	with IN 0	VPA NNP B-noun.group	- : 0	associated VBN B-verb.cognition	encephalopathy JJ B-adj.all	in IN 0	Germany NNP 0	from IN 0	the DT 0	years NNS B-noun.time	1994 CD 0	to TO 0	2003 CD 0	, , 0	none NN 0	of IN 0	whom WP 0	had VBD 0	been VBN 0	published VBN B-verb.creation	previously RB B-adv.all	. . 0	. . 0
a12523465.s7	With IN 0	either DT 0	discontinuation NN B-noun.location	or CC 0	decreased VBN B-verb.change	dosage NN B-noun.quantity	of IN 0	the DT 0	drug NN B-noun.group	the DT 0	symptoms NNS B-noun.body	disappeared VBD B-verb.change	and CC 0	did VBD 0	not RB B-adv.all	recur VB B-verb.perception	. . 0	. . 0
a7504976.s2	METHODS NNS B-noun.attribute	, , 0	Retrospective JJ B-adj.all	review NN B-noun.act	of IN 0	medical JJ B-adj.all	records NNS B-noun.communication	of IN 0	236 CD 0	patients NNS B-noun.person	with IN 0	hyperthyroidism NN B-noun.feeling	admitted VBN B-verb.possession	in IN 0	our PRP$ 0	department NN B-noun.artifact	( ( 0	in- JJ 0	or CC 0	out RB 0	- : 0	patients NNS B-noun.person	) ) 0	from IN 0	1986 CD 0	to TO 0	1992 CD 0	. . 0	. . 0
a18308784.s10	This DT 0	effect NN B-noun.cognition	is VBZ B-verb.stative	NMDA NNP B-noun.person	receptor NN I-noun.person	dependent NN B-noun.person	. . 0	. . 0
a19884587.s0	Antibacterial JJ B-adj.all	medication NN B-noun.act	use NN 0	during IN 0	pregnancy NN B-noun.person	and CC 0	risk NN 0	of IN 0	birth_defects NNS B-noun.food	, , 0	National NNP B-noun.group	Birth_Defects NNPS I-noun.group	Prevention NNP I-noun.group	Study NNP I-noun.group	. . 0	. . 0
a14976857.s5	In IN 0	our PRP$ 0	case NN B-noun.state	this DT 0	interatrial JJ B-adj.all	shunt NN B-noun.artifact	was VBD B-verb.stative	very RB B-adv.all	accurately RB B-adv.all	detected VBN B-verb.perception	at IN 0	bubble JJ B-adj.all	contrast NN B-noun.act	echocardiography NN I-noun.act	. . 0	. . 0
a1720453.s5	The DT 0	most RBS 0	common JJ B-noun.person	primary JJ B-adj.all	tumor NN B-noun.phenomenon	site NN B-noun.location	was VBD B-verb.stative	the DT 0	head NN B-noun.location	and CC 0	neck NN B-noun.person	. . 0	. . 0
a7930386.s8	The DT 0	presence NN B-noun.person	of IN 0	REM NNP 0	sleep NN 0	was VBD 0	shown VBN B-verb.creation	not RB 0	to TO 0	be VB B-verb.stative	a DT 0	determining VBG B-verb.communication	factor NN B-noun.person	either CC 0	for IN 0	secretory JJ B-adj.all	pulse NN B-noun.person	amplitude NN B-noun.person	and CC 0	frequency NN B-noun.person	, , 0	as RB 0	, , 0	for IN 0	both DT 0	, , 0	mean VB B-verb.stative	nocturnal JJ B-adj.all	values NNS B-noun.attribute	were VBD B-verb.stative	similar JJ B-adj.all	with IN 0	and CC 0	without IN 0	prior JJ B-adj.all	clomipramine NN B-noun.phenomenon	ingestion NN B-noun.process	. . 0	. . 0
a227508.s6	As IN 0	naloxone NN 0	and CC 0	clonidine NN B-noun.person	do VBP 0	not RB B-adv.all	appear VB B-verb.change	to TO 0	interact VB B-verb.contact	with IN 0	the DT 0	same JJ B-adj.all	receptor NN B-noun.person	site NN 0	, , 0	the DT 0	observed JJ B-adj.all	functional JJ B-adj.all	antagonism NN B-noun.attribute	suggests VBZ B-verb.stative	the DT 0	release NN B-noun.state	of IN 0	an DT 0	endogenous JJ B-adj.all	opiate NN B-noun.person	by IN 0	clonidine NN B-noun.person	or CC 0	alpha NN B-noun.act	- : 0	methyldopa NN B-noun.person	and CC 0	the DT 0	possible JJ B-adj.all	role NN B-noun.attribute	of IN 0	the DT 0	opiate NN B-noun.person	in IN 0	the DT 0	central JJ B-noun.body	control NN I-noun.body	of IN 0	sympathetic JJ B-adj.all	tone NN B-noun.attribute	. . 0	. . 0
a18020536.s0	Associations NNS B-noun.person	between IN 0	use NN 0	of IN 0	benzodiazepines NNS B-noun.animal	or CC 0	related VBN B-verb.cognition	drugs NNS B-noun.artifact	and CC 0	health NN B-noun.person	, , 0	physical JJ B-noun.body	abilities NNS I-noun.body	and CC 0	cognitive JJ B-adj.all	function NN B-noun.act	, , 0	a DT 0	non NN B-noun.person	- : 0	randomised VBD B-verb.communication	clinical JJ B-adj.all	study NN B-noun.artifact	in IN 0	the DT 0	elderly JJ B-adj.all	. . 0	. . 0
a17608141.s6	Moreover RB B-adv.all	, , 0	systemic JJ B-adj.all	lipopolysaccharide NN B-noun.body	pretreatment NN B-noun.substance	( ( 0	1 CD 0	mg PRP 0	/ : 0	kg LS 0	) ) 0	attenuated VBD B-verb.stative	local JJ B-adj.all	methamphetamine NN B-noun.person	infusion NN B-noun.person	- : 0	produced VBN B-verb.creation	dopamine NN 0	and CC 0	3,4-dihydroxyphenylacetic_acid JJ B-noun.body	depletions NNS I-noun.body	in IN 0	the DT 0	striatum NN B-noun.artifact	, , 0	indicating VBG B-verb.communication	that IN 0	the DT 0	protective JJ B-adj.all	effect NN B-noun.cognition	of IN 0	lipopolysaccharide NN B-noun.animal	is VBZ B-verb.stative	less RBR B-adv.all	likely JJ B-adj.all	due JJ 0	to TO 0	interrupted JJ B-verb.communication	peripheral JJ B-adj.pert	distribution NN B-noun.act	or CC 0	metabolism NN B-noun.attribute	of IN 0	methamphetamine NN B-noun.attribute	. . 0	. . 0
a19269743.s12	The DT 0	data NNS B-noun.cognition	further RBR B-adv.all	suggest VB B-verb.communication	that IN 0	the DT 0	consolidation NN B-noun.act	of IN 0	this DT 0	memory NN B-noun.communication	is VBZ B-verb.stative	an DT 0	important JJ B-adj.all	interim JJ B-adj.all	stage NN B-noun.artifact	, , 0	and CC 0	may MD 0	take VB B-verb.cognition	up RP I-verb.cognition	to TO 0	one CD 0	day NN 0	. . 0	. . 0
a7083920.s3	Thirty CD 0	days NNS 0	after IN 0	amiodarone JJ B-adj.all	discontinuation NN B-noun.artifact	, , 0	His PRP$ 0	bundle NN B-noun.group	electrograms NNS B-noun.person	showed VBD B-verb.communication	atrial_flutter NN B-noun.person	without IN 0	intra NN B-noun.person	- : 0	Hisian JJ 0	or CC 0	infra NN B-noun.person	- : 0	Hisian JJ 0	delay NN 0	. . 0	. . 0
a2870085.s2	Flestolol NNP B-noun.person	is VBZ 0	metabolized VBN B-verb.change	by IN 0	plasma NN B-noun.substance	esterases NNS B-noun.artifact	and CC 0	has VBZ B-verb.possession	an DT 0	elimination NN B-noun.person	half NN B-noun.person	- : 0	life NN B-noun.time	of IN 0	approximately RB B-adv.all	6.5 CD 0	minutes NNS B-noun.time	. . 0	. . 0
a3560096.s4	In IN 0	all DT 0	of IN 0	them PRP 0	normal JJ B-adj.all	serum NN B-noun.phenomenon	potassium NN B-noun.phenomenon	levels NNS B-noun.attribute	reached VBD B-verb.stative	within IN 0	2 CD 0	to TO 0	4 CD B-adj.all	days NNS B-noun.time	of IN 0	stopping VBG B-verb.motion	sulindac NN 0	. . 0	. . 0
a983936.s3	Myocardial JJ B-adj.all	concentrations NNS B-noun.attribute	of IN 0	calcium NN B-noun.person	also RB B-adv.all	increased VBD B-verb.change	significantly RB B-adv.all	( ( 0	12.0 CD B-noun.other	vs. FW I-noun.other	5.0 CD I-noun.other	mg.per JJR I-noun.other	100 CD 0	Gm NNP 0	. . 0	. . 0
a18631865.s3	Whether IN 0	proteinuria NN B-noun.person	was VBD B-verb.stative	due JJ 0	to TO 0	sirolimus VB B-verb.perception	or CC 0	only RB B-adv.all	a DT 0	consequence NN B-noun.attribute	of IN 0	calcineurin NN B-noun.communication	inhibitors NNS B-noun.person	withdrawal NN B-noun.person	remained VBD B-verb.stative	unsolved JJ B-adj.all	until IN 0	high JJ B-adj.all	range NN B-noun.artifact	proteinuria NN B-noun.person	has VBZ 0	been VBN 0	observed VBN B-verb.perception	during IN 0	sirolimus NN 0	therapy NN 0	in IN 0	islet NN B-noun.animal	transplantation NN I-noun.animal	and CC 0	in IN 0	patients NNS B-noun.person	who WP 0	received VBD B-verb.possession	sirolimus NN B-noun.communication	de IN 0	novo NN B-noun.communication	. . 0	. . 0
a7802851.s0	Safety NN B-noun.person	and CC 0	side NN B-noun.body	- : 0	effects NNS B-noun.phenomenon	of IN 0	alprazolam NN B-noun.person	. . 0	Controlled VBN B-verb.social	study NN B-noun.artifact	in IN 0	agoraphobia NN 0	with IN 0	panic_disorder NN B-noun.person	. . 0	. . 0
a11334364.s6	Parameters NNS B-noun.person	of IN 0	study NN B-noun.artifact	included VBD B-verb.stative	analysis NN 0	of IN 0	serum NN B-noun.body	chemistry NN B-noun.cognition	( ( 0	ALT NNP 0	, , 0	BUN NNP 0	and CC 0	CPK NNP 0	) ) 0	, , 0	and CC 0	orderly JJ B-adj.all	fragmentation NN B-noun.person	of IN 0	genomic JJ 0	DNA NNP 0	( ( 0	both DT 0	endonuclease VBP B-verb.stative	- : 0	dependent JJ B-adj.all	and CC 0	independent JJ B-adj.all	) ) 0	in IN 0	addition NN 0	to TO 0	microscopic JJ B-adj.all	evaluation NN B-noun.act	of IN 0	damage NN B-noun.food	and/or CC 0	protection NN B-noun.possession	in IN 0	corresponding VBG B-verb.stative	PAS NNP 0	stained VBD B-verb.change	tissues NNS B-noun.artifact	. . 0	. . 0
a12653683.s4	We PRP 0	examined VBD B-verb.perception	the DT 0	abundance NN B-noun.act	of IN 0	ENaC NNP B-noun.other	subunit NN B-noun.artifact	mRNAs NNS I-noun.artifact	and CC 0	proteins NNS B-noun.person	in IN 0	puromycin_aminonucleoside JJ B-noun.other	( ( 0	PAN)-induced VBD B-verb.creation	nephrotic_syndrome JJ I-verb.creation	. . 0	. . 0
a15859940.s11	Other JJ 0	causes NNS B-noun.person	include VBP B-verb.stative	drug NN I-verb.stative	- : 0	related VBN B-verb.communication	( ( 0	cyclosporine NN B-noun.person	, , 0	tacrolimus NN 0	) ) 0	toxicity NN B-noun.quantity	, , 0	procoagulant JJ B-adj.all	status NN B-noun.state	, , 0	and CC 0	antibody NN B-noun.attribute	- : 0	mediated VBN B-verb.cognition	rejection NN I-verb.cognition	. . 0	. . 0
a17241784.s3	We PRP 0	investigated VBD B-verb.communication	the DT 0	muscle NN B-noun.body	pathology NN B-noun.attribute	in IN 0	8 CD B-adj.all	such JJ B-adj.all	cases NNS B-noun.person	. . 0	. . 0
a8387218.s11	Thirteen JJ B-adj.all	patients NNS B-noun.person	developed VBD B-verb.creation	a DT 0	raised VBN B-adj.all	serum NN B-noun.artifact	amylase NN I-noun.artifact	without IN 0	abdominal_pain NN B-noun.person	. . 0	. . 0
a9284778.s12	INTERPRETATION NN B-noun.artifact	, , 0	Repeated VBN B-verb.social	exposure NN B-noun.act	of IN 0	human JJ B-noun.animal	beings NNS I-noun.animal	to TO 0	HCFCs_123_and_124 NNS B-noun.person	can MD 0	result VB B-verb.stative	in IN 0	serious JJ B-adj.all	liver_injury NN B-noun.food	in IN 0	a DT 0	large JJ B-adj.all	proportion NN B-noun.shape	of IN 0	the DT 0	exposed VBN B-verb.perception	population NN I-verb.perception	. . 0	. . 0
a12905102.s4	Delirium NN B-noun.person	was VBD 0	diagnosed VBN B-verb.communication	in IN 0	14 CD B-adj.all	( ( 0	10.1 CD 0	% NN 0	incidence NN B-noun.attribute	, , 0	or CC 0	1.48 CD 0	cases NNS B-noun.quantity	/ POS 0	person NN B-noun.person	- : 0	years NNS B-noun.time	of IN 0	exposure NN B-noun.cognition	) ) 0	, , 0	71.4 CD 0	% NN 0	of IN 0	cases NNS B-noun.state	were VBD B-verb.stative	moderate JJ B-adj.all	or CC 0	severe JJ 0	. . 0	. . 0
a11928786.s4	8 CD B-adj.all	patients NNS B-noun.person	developed VBD B-verb.creation	symptoms NNS B-noun.communication	of IN 0	toxicity NN B-noun.attribute	. . 0	. . 0
a7930386.s3	Each DT 0	subject NN B-noun.artifact	received VBD B-verb.possession	a DT 0	single JJ B-adj.all	50 CD B-adj.all	mg NN B-noun.quantity	dose NN B-noun.quantity	of IN 0	clomipramine NN B-noun.phenomenon	given VBN B-verb.possession	orally RB B-adv.all	2 CD B-adj.all	hours NNS B-noun.artifact	before IN 0	blood NN B-noun.act	collection NN B-noun.act	. . 0	. . 0
a6640832.s12	Of IN 0	the DT 0	patients NNS B-noun.person	developing VBG B-verb.communication	one CD 0	or CC 0	more JJR B-noun.quantity	recurrences NNS B-noun.act	during IN 0	the DT 0	first JJ B-adj.all	year NN B-noun.time	, , 0	only RB B-adv.all	50 CD B-adj.all	% NN 0	presented VBN B-verb.communication	with IN 0	further JJ B-adj.all	recurrence NN B-adv.all	once RB I-adv.all	the DT 0	instillations NNS B-noun.artifact	were VBD 0	stopped VBN B-verb.motion	. . 0	. . 0
a18464113.s13	Comparison NNP B-noun.person	of IN 0	the DT 0	mean JJ B-adj.all	ALT NNP B-noun.group	values NNS B-noun.attribute	revealed VBD B-verb.perception	significantly RB B-adv.all	higher JJR B-adj.all	mean JJ B-adj.all	alanine JJ 0	aminotransferase NN 0	( ( 0	ALT NNP 0	) ) 0	values NNS B-noun.attribute	in IN 0	the DT 0	control NN B-noun.location	group NN 0	than IN 0	the DT 0	prophylactic JJ B-adj.all	lamivudine NN B-noun.location	group NN B-noun.person	, , 0	154,64 CD 0	( ( 0	p IN 0	< $ 0	0.32 CD 0	) ) 0	. . 0	. . 0
a8701950.s4	FK506-associated JJ B-adj.all	MAHA NNP B-noun.group	is VBZ B-verb.stative	probably RB B-adv.all	rare JJ B-adj.all	but CC 0	physicians NNS B-noun.person	must MD 0	be VB B-verb.stative	aware JJ B-adj.all	of IN 0	this DT 0	severe JJ B-adj.all	complication NN B-noun.person	. . 0	. . 0
a809711.s0	Reversal NN B-noun.person	by IN 0	phenylephrine NN B-noun.person	of IN 0	the DT 0	beneficial JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	intravenous JJ B-adj.all	nitroglycerin NN B-noun.person	in IN 0	patients NNS B-noun.person	with IN 0	acute_myocardial_infarction NN B-noun.act	. . 0	. . 0
a18951540.s1	In IN 0	a DT 0	placebo NN B-noun.person	- : 0	controlled VBN B-verb.social	, , 0	single JJ B-adj.all	- : 0	blinded VBD B-verb.communication	, , 0	crossover NN 0	study NN B-noun.artifact	, , 0	we PRP 0	assessed VBD B-verb.cognition	the DT 0	effect NN B-noun.cognition	of IN 0	" `` 0	real RB 0	" RB 0	repetitive JJ B-adj.all	transcranial JJ B-adj.all	magnetic JJ B-adj.all	stimulation NN B-noun.cognition	( ( 0	rTMS NNS B-noun.attribute	) ) 0	versus FW 0	" FW 0	sham FW 0	" . 0	rTMS NNS B-noun.attribute	( ( 0	placebo NN 0	) ) 0	on IN 0	peak NN B-noun.artifact	dose NN I-noun.artifact	dyskinesias NNS B-noun.artifact	in IN 0	patients NNS B-noun.person	with IN 0	Parkinson's_disease NNP B-noun.person	( ( 0	PD NNP 0	) ) 0	. . 0	. . 0
a10683478.s4	In IN 0	rats NNS B-noun.animal	, , 0	detection NN B-noun.act	of IN 0	apomorphine NN B-noun.person	- : 0	induced VBN B-verb.communication	hyperactivity NN B-noun.person	was VBD 0	facilitated VBN B-verb.communication	by IN 0	a DT 0	period NN B-noun.time	of IN 0	acclimatization NN 0	to TO 0	the DT 0	test NN B-adj.all	conditions NNS B-noun.cognition	. . 0	. . 0
a18217897.s3	Between IN 0	July NNP B-noun.person	2001 CD 0	and CC 0	April NNP B-noun.time	2004 CD 0	, , 0	24 CD B-adj.all	patients NNS B-noun.person	with IN 0	relapsed VBN B-verb.stative	/ : 0	refractory JJ B-adj.all	indolent NN B-noun.communication	lymphomas NNS B-noun.communication	received VBN B-verb.possession	thalidomide IN 0	200 CD 0	mg NN B-noun.quantity	daily RB 0	with IN 0	escalation NN B-noun.act	by IN 0	100 CD 0	mg NN B-noun.quantity	daily RB 0	every DT 0	1 CD B-adj.all	- : 0	2 CD B-adj.all	weeks NNS B-noun.time	as IN 0	tolerated VBN B-verb.communication	, , 0	up IN 0	to TO 0	a DT 0	maximum NN B-noun.person	of IN 0	800 CD 0	mg NN B-noun.quantity	daily RB B-adv.all	. . 0	. . 0
a1720453.s4	Ages NNS B-noun.person	ranged VBD B-verb.contact	from IN 0	4 CD B-adj.all	months NNS B-noun.person	to TO 0	17 CD B-adj.all	years NNS B-noun.time	, , 0	58 CD 0	patients NNS B-noun.person	were VBD B-verb.stative	males NNS B-noun.person	and CC 0	42 CD 0	females NNS B-noun.person	. . 0	. . 0
a20196116.s10	At IN 0	presentation NN B-noun.communication	, , 0	advanced VBD B-verb.communication	encephalopathy JJ B-noun.person	and CC 0	cerebral_edema NNP B-noun.location	were VBD B-verb.stative	present JJ B-adj.all	in IN 0	51 CD 0	( ( 0	76 CD 0	% NN 0	) ) 0	and CC 0	29 CD B-noun.quantity	( ( 0	41.4 CD 0	% NN 0	) ) 0	patients NNS B-noun.person	, , 0	respectively RB B-adv.all	. . 0	. . 0
a4812392.s3	Minimal JJ B-adj.all	cholestasis NN B-noun.cognition	was VBD 0	seen VBN B-verb.perception	in IN 0	two CD B-adj.all	cases NNS B-noun.person	and CC 0	portal JJ B-adj.all	fibrosis NN B-noun.cognition	of IN 0	a DT 0	reversible JJ B-adj.all	degree NN B-noun.communication	in IN 0	eight CD 0	. . 0	. . 0
a10091617.s6	RESULTS NNS B-noun.artifact	, , 0	Head NNP B-noun.person	- : 0	up IN 0	tilt NN B-noun.person	caused VBD B-verb.communication	systolic_orthostatic_hypotension NN B-noun.act	which WDT 0	was VBD 0	marked VBN B-verb.cognition	in IN 0	six CD 0	of IN 0	20 CD B-adj.all	PD NNP 0	patients NNS B-noun.artifact	on IN 0	selegiline NN B-noun.person	, , 0	one CD 0	of IN 0	whom WP 0	lost VBD B-verb.possession	consciousness NN B-noun.person	with IN 0	unrecordable JJ B-adj.all	blood NN B-noun.body	pressures NNS I-noun.body	. . 0	. . 0
a9931093.s10	The DT 0	administration NN B-noun.time	of IN 0	FR_139317 NNP B-noun.person	( ( 0	10 CD B-adj.all	mg NN B-noun.quantity	. . 0	. . 0
a10901305.s13	Minor JJ B-adj.all	side NN 0	effects NNS B-noun.phenomenon	included VBD B-verb.stative	nausea NN I-verb.stative	( ( 0	thirteen JJ 0	patients NNS B-noun.location	) ) 0	, , 0	emesis NN B-noun.cognition	( ( 0	eight CD 0	of IN 0	the DT 0	thirteen JJ B-adj.all	patients NNS B-noun.person	with IN 0	nausea NN B-noun.group	) ) 0	, , 0	clumsiness NN 0	( ( 0	evident JJ 0	as IN 0	ataxic_movements NNS B-noun.person	in IN 0	ten CD B-adj.all	patients NNS B-noun.location	) ) 0	, , 0	and CC 0	dysphoric_reaction NN B-noun.act	( ( 0	one CD 0	patient NN B-noun.location	) ) 0	. . 0	. . 0
a10706004.s4	To TO 0	assess VB B-verb.cognition	the DT 0	molecular JJ B-adj.all	basis NN B-noun.cognition	of IN 0	disturbances NNS B-noun.food	in IN 0	transmembraneous JJ B-adj.all	transport NN B-noun.event	of IN 0	Na+ NNP B-noun.person	, , 0	we PRP 0	studied VBD B-verb.cognition	the DT 0	response NN B-noun.communication	of IN 0	cardiac NN B-noun.substance	( ( 0	Na,,K)-ATPase UH 0	to TO 0	NO UH 0	- : 0	deficient NN B-verb.stative	hypertension NN 0	induced VBN B-verb.creation	in IN 0	rats NNS B-noun.animal	by IN 0	NO SYM 0	- : 0	synthase NN 0	inhibition NN 0	with IN 0	40 CD B-adj.all	mg NN B-noun.quantity	/ ) 0	kg RB 0	/ JJ 0	day NN 0	N(G)-nitro CD 0	- : 0	L SYM 0	- : 0	arginine_methyl_ester NN B-noun.person	( ( 0	L SYM 0	- : 0	NAME NN B-noun.group	) ) 0	for IN 0	4 CD B-adj.all	four CD B-noun.time	weeks NNS B-noun.time	. . 0	. . 0
a6534871.s0	Effects NNS B-noun.phenomenon	of IN 0	training NN B-verb.cognition	on IN 0	the DT 0	extent NN B-noun.attribute	of IN 0	experimental JJ B-adj.all	myocardial_infarction NN B-noun.act	in IN 0	aging VBG B-verb.competition	rats NNS I-verb.competition	. . 0	. . 0
a18020536.s17	CONCLUSIONS NNS B-noun.artifact	, , 0	Long RB 0	- DT 0	term NN B-noun.time	use NN 0	and CC 0	concomitant JJ B-adj.all	use NN 0	of IN 0	more JJR B-noun.quantity	than IN 0	one CD 0	BZD NNP 0	/ ( 0	RD NNP 0	were VBD B-verb.stative	common JJ B-noun.person	in IN 0	elderly JJ B-adj.all	patients NNS B-noun.person	hospitalised VBD B-verb.social	because IN 0	of IN 0	acute JJ B-adj.all	illnesses NNS B-noun.location	. . 0	. . 0
a10669626.s15	High JJ B-adj.all	levels NNS B-noun.attribute	of IN 0	matrix NNP B-noun.person	Gla NNP I-noun.person	protein NN I-noun.person	are VBP 0	found VBN B-verb.possession	at IN 0	sites NNS B-noun.location	of IN 0	artery_calcification NN B-noun.act	in IN 0	rats NNS B-noun.animal	treated VBN B-verb.change	with IN 0	vitamin NN 0	D NNP 0	plus CC 0	Warfarin NNP B-noun.location	, , 0	and CC 0	chemical NN B-noun.body	analysis NN B-noun.body	showed VBD B-verb.communication	that IN 0	the DT 0	protein NN B-noun.communication	that WDT 0	accumulated VBD B-verb.possession	was VBD 0	indeed RB 0	not RB 0	gamma NN B-noun.animal	- : 0	carboxylated VBD B-verb.communication	. . 0	. . 0
a15863244.s10	Decrease NNP B-noun.person	of IN 0	fetal JJ B-adj.all	length NN B-noun.person	was VBD B-verb.stative	the DT 0	only JJ B-adj.all	signs NNS B-noun.communication	of IN 0	the DT 0	DFU NNP B-noun.group	developmental JJ B-adj.all	toxicity NN B-noun.attribute	observed VBN B-verb.perception	in IN 0	pups NNS B-noun.body	exposed VBN B-verb.perception	to TO 0	the DT 0	highest JJS B-adj.all	compound NN B-noun.relation	dose NN I-noun.relation	. . 0	. . 0
a15804801.s3	The DT 0	patient NN B-noun.person	was VBD B-verb.stative	asymptomatic JJ B-adj.all	and CC 0	the DT 0	aneurysm NN B-noun.artifact	was VBD 0	detected VBN B-verb.perception	in IN 0	a DT 0	routine JJ B-adj.all	control NN B-noun.act	. . 0	. . 0
a6727060.s3	When WRB 0	the DT 0	metoclopramide JJ B-adj.all	administration NN B-noun.person	was VBD 0	discontinued VBN B-verb.stative	, , 0	the DT 0	abnormal_movements NNS B-noun.person	gradually RB B-adv.all	improved VBN B-verb.change	to TO 0	a DT 0	considerable JJ B-adj.all	extent NN B-noun.act	. . 0	. . 0
a12589964.s4	weekly RB B-adj.all	for IN 0	up RB 0	to TO 0	8 CD B-adj.all	weeks NNS B-noun.time	for IN 0	a DT 0	total JJ B-adj.all	cumulative JJ B-adj.all	dose NN B-noun.event	of IN 0	12 CD B-adj.all	mg NN B-noun.quantity	/ ( 0	kg IN 0	BW NNP 0	. . 0	. . 0
a16904497.s7	After IN 0	verifying VBG B-verb.social	the DT 0	epidural JJ B-adj.all	space NN B-noun.location	, , 0	bupivacaine NN B-noun.person	and CC 0	triamcinolone_diacetate NNP B-noun.person	were VBD 0	injected VBN B-verb.change	. . 0	. . 0
a18186898.s9	Fanconi_syndrome JJ 0	, , 0	as RB 0	well RB 0	as IN 0	myopathy JJ B-adj.all	, , 0	is VBZ B-verb.stative	well RB 0	recognized VBN B-verb.cognition	in IN 0	patients NNS B-noun.person	with IN 0	mitochondrial_disorders NNS B-noun.person	and CC 0	caused VBN B-verb.communication	by IN 0	depletion NN B-noun.act	of IN 0	mtDNA NNP B-noun.location	. . 0	. . 0
a12574103.s5	Six- CD 0	to TO 0	9-month JJ 0	old JJ B-adj.all	rats NNS B-noun.person	receiving VBG B-verb.communication	prenatal JJ B-adj.all	dexamethasone NN B-noun.person	on IN 0	days NNS B-noun.time	17 CD 0	and CC 0	18 CD B-adj.all	of IN 0	gestation NN B-noun.communication	had VBD 0	a DT 0	17 CD B-adj.all	% NN 0	reduction NN B-noun.act	in IN 0	glomeruli NNS 0	( ( 0	23 CD 0	380+/-587 NNP 0	) ) 0	compared VBN B-verb.stative	with IN 0	control NN B-noun.food	rats NNS B-noun.phenomenon	( ( 0	P<0.05 NN 0	) ) 0	. . 0	. . 0
a15572383.s3	Therefore RB 0	, , 0	we PRP 0	studied VBD B-verb.cognition	the DT 0	predictive JJ B-adj.all	effect NN B-noun.cognition	of IN 0	renal JJ B-adj.all	ACE NNP B-noun.group	activity NN B-noun.process	for IN 0	the DT 0	severity NN B-noun.attribute	of IN 0	renal_damage NN B-noun.act	induced VBN B-verb.creation	by IN 0	a DT 0	single JJ B-adj.all	injection NN B-noun.act	of IN 0	adriamycin NN B-noun.food	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a11007689.s0	Cyclosporine NNP B-noun.person	and CC 0	tacrolimus NN B-noun.person	- : 0	associated VBN B-verb.cognition	thrombotic_microangiopathy JJ 0	. . 0	. . 0
a18023325.s5	She PRP 0	was VBD B-verb.stative	not RB B-adv.all	an DT 0	alcoholic JJ B-adj.all	. . 0	. . 0
a11745184.s5	Amifostine NNP B-noun.person	subsequently RB I-noun.person	was VBD 0	shown VBN B-verb.perception	to TO 0	protect VB B-verb.change	normal JJ B-adj.all	tissues NNS B-noun.event	from IN 0	the DT 0	toxic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	alkylating_agents NNS B-noun.person	and CC 0	cisplatin NN B-noun.act	without IN 0	decreasing VBG B-verb.change	the DT 0	antitumor NN B-noun.location	effect NN 0	of IN 0	the DT 0	chemotherapy NN B-noun.communication	. . 0	. . 0
a16740173.s0	Case NN B-noun.state	report NN B-noun.communication	, , 0	acute JJ B-adj.all	unintentional JJ B-adj.all	carbachol NN B-noun.group	intoxication NN B-noun.act	. . 0	. . 0
a20520283.s6	Extrapyramidal_symptoms NNS B-noun.person	reported VBD B-verb.communication	as IN 0	AEs NNP B-noun.person	occurred VBD B-verb.cognition	in IN 0	15 CD B-adj.all	% NN 0	and CC 0	18 CD B-adj.all	% NN 0	, , 0	34 CD 0	% NN 0	, , 0	and CC 0	10 CD B-adj.all	% NN 0	of IN 0	the DT 0	asenapine NN B-noun.location	at IN 0	5 CD B-adj.all	and CC 0	10 CD B-adj.all	mg IN 0	BID NNP B-noun.group	, , 0	haloperidol NN B-noun.person	, , 0	and CC 0	placebo NN B-noun.plant	groups NNS B-noun.group	, , 0	respectively RB B-adv.all	. . 0	. . 0
a9931093.s6	kg-1 JJ 0	. . 0	. . 0
a11706060.s5	After IN 0	35 CD 0	days NNS B-noun.person	in IN 0	the DT 0	TG NNP 0	+ , 0	HAART NNP 0	cohort NN 0	, , 0	left VBD B-verb.stative	ventricular JJ B-adj.all	mass NN B-noun.act	increased VBD B-verb.change	160 CD 0	% NN 0	by IN 0	echocardiography NN B-noun.person	. . 0	. . 0
a8092427.s3	Skin NN B-noun.person	tests NNS B-noun.person	were VBD 0	performed VBN B-verb.social	with IN 0	benzylpenicilloyl NN B-noun.person	- : 0	poly RB B-adv.all	- : 0	L SYM 0	- : 0	lysine NN B-noun.person	( ( 0	BPO NNP 0	- : 0	PLL NNP 0	) ) 0	, , 0	benzylpenicilloate NN B-noun.person	, , 0	benzylpenicillin NN B-noun.person	( ( 0	PG NNP 0	) ) 0	, , 0	ampicillin NN B-noun.person	( ( 0	AMP NNP 0	) ) 0	, , 0	and CC 0	AX NNP 0	. . 0	. . 0
a9495837.s11	and_dicyclomine NN 0	( ( 0	2 CD 0	mg PRP$ 0	kg-1 JJ B-noun.person	i.p NNP I-noun.person	. . 0	) ) 0	. . 0
a17147461.s0	Sirolimus SYM 0	- : 0	associated VBN B-verb.cognition	proteinuria NN B-noun.person	and CC 0	renal_dysfunction NN B-noun.act	. . 0	. . 0
a18951540.s3	Direct JJ B-adj.all	comparison NN B-noun.relation	between IN 0	sham NN B-noun.person	and CC 0	real JJ B-adj.all	rTMS NNS B-noun.location	effects NNS B-noun.phenomenon	showed VBD B-verb.communication	no DT 0	significant JJ B-adj.all	difference NN B-noun.cognition	in IN 0	clinician JJ 0	- : 0	assessed VBN B-verb.cognition	dyskinesia NN 0	severity NN 0	. . 0	. . 0
a8437969.s4	This DT 0	is VBZ B-verb.stative	the DT 0	first JJ B-adj.all	reported VBN B-verb.communication	case NN B-noun.state	of IN 0	sinus_arrest JJS 0	associated VBN B-verb.cognition	with IN 0	continuous JJ B-adj.pert	- : 0	infusion NN 0	cimetidine NN 0	. . 0	. . 0
a14659530.s10	Platelet NN 0	serotonin NN 0	content NN B-noun.person	decreased VBD B-verb.change	significantly RB B-adv.all	( ( 0	P<0.01 NNP 0	) ) 0	after IN 0	nitroglycerin NN B-noun.person	in IN 0	subjects NNS B-noun.person	with IN 0	no DT 0	migraine NN B-noun.person	attack NN B-noun.person	but CC 0	no DT 0	consistent JJ B-adj.all	change NN B-noun.artifact	was VBD 0	observed VBN B-verb.perception	in IN 0	patients NNS B-noun.person	with IN 0	migraine JJ B-adj.all	attack NN B-noun.artifact	. . 0	. . 0
a6209318.s4	These DT 0	differences NNS B-noun.communication	were VBD 0	observed VBN B-verb.perception	even RB 0	though IN 0	the DT 0	serum NN B-noun.body	mexiletine NN B-noun.body	levels NNS B-noun.attribute	obtained VBN B-verb.change	in IN 0	this DT 0	study NN B-noun.artifact	were VBD 0	generally RB B-adv.all	lower JJR B-adj.all	than IN 0	those DT 0	observed VBN B-verb.perception	in IN 0	studies NNS B-noun.artifact	that WDT 0	have VBP 0	used VBN B-verb.consumption	the DT 0	regular JJ B-adj.all	form NN B-noun.attribute	of IN 0	the DT 0	drug NN B-noun.artifact	. . 0	. . 0
a17879945.s4	Furthermore RB B-adv.all	, , 0	peripheral JJ B-adj.pert	blood NN B-noun.location	monocytes NNS B-noun.person	isolated VBN B-verb.change	from IN 0	ritonavir NN B-noun.person	- : 0	treated VBN B-verb.communication	females NNS B-noun.person	had VBD B-verb.perception	less JJR B-verb.change	cholesteryl_ester JJ B-adj.all	accumulation NN I-adj.all	. . 0	. . 0
a17343925.s5	Newborns NNP B-noun.person	whose WP$ 0	mothers NNS B-noun.person	reported VBD B-verb.communication	smoking VBG B-verb.social	during IN 0	pregnancy NN B-noun.person	( ( 0	n=200 JJ 0	ears NNS B-noun.cognition	) ) 0	were VBD 0	compared VBN B-verb.change	to TO 0	a DT 0	control NN B-noun.act	group NN B-noun.act	of IN 0	newborns NNS B-noun.animal	( ( 0	n=200 JJ 0	ears NNS B-noun.cognition	) ) 0	, , 0	whose WP$ 0	mothers NNS B-noun.person	were VBD B-verb.stative	non RB B-adv.all	- : 0	smokers NNS B-noun.person	. . 0	. . 0
a20003049.s1	BACKGROUND NN 0	, , 0	Direct JJ 0	thrombin NN 0	inhibitors NNS B-noun.person	( ( 0	DTIs NNP B-noun.location	) ) 0	provide VBP B-verb.stative	an DT 0	alternative JJ B-adj.all	method NN B-noun.attribute	of IN 0	anticoagulation NN B-noun.attribute	for IN 0	patients NNS B-noun.person	with IN 0	a DT 0	history NN B-noun.cognition	of IN 0	heparin NN B-noun.person	- : 0	induced VBN B-verb.creation	thrombocytopenia NN 0	( ( 0	HIT NNP 0	) ) 0	or CC 0	HIT VBN 0	with IN 0	thrombosis NN B-noun.cognition	( ( 0	HITT NNP 0	) ) 0	undergoing VBG B-verb.cognition	cardiopulmonary JJ B-adj.all	bypass NN B-noun.person	( ( 0	CPB NNP 0	) ) 0	. . 0	. . 0
a18544179.s6	Antiemetic JJ B-adj.all	requirements NNS B-noun.object	were VBD 0	reduced VBN B-verb.change	from IN 0	24 CD B-adj.all	% NN 0	and CC 0	31 CD 0	% NN 0	to TO 0	7 CD B-adj.all	% NN 0	( ( 0	P UH 0	= SYM 0	0.0012 CD 0	) ) 0	. . 0	. . 0
a18410508.s12	We PRP 0	conclude VBP B-verb.cognition	from IN 0	these DT 0	studies NNS B-noun.communication	that IN 0	CX3CR1 JJ B-adj.all	signaling NN B-noun.communication	does VBZ 0	not RB B-adv.all	modulate_METH_neurotoxicity JJ B-adj.all	or CC 0	microglial JJ B-adj.all	activation NN B-noun.act	. . 0	. . 0
a1549199.s3	Following VBG 0	the DT 0	initial JJ B-adj.all	period NN B-noun.time	of IN 0	therapy NN B-noun.act	, , 0	emerging VBG B-verb.change	difficulties NNS B-noun.state	require VBP B-verb.stative	a DT 0	reassessment NN B-noun.person	of IN 0	therapeutic JJ B-adj.pert	approaches NNS B-noun.artifact	, , 0	such JJ 0	as IN 0	dosage NN B-noun.communication	adjustment NN B-noun.communication	or CC 0	introduction NN B-noun.act	of IN 0	a DT 0	dopamine NN B-noun.person	agonist NN B-noun.person	. . 0	. . 0
a15737522.s6	Comparison NNP B-noun.person	of IN 0	the DT 0	patients NNS B-noun.person	with IN 0	or CC 0	without IN 0	pseudolithiasis NN B-noun.person	revealed VBD B-verb.communication	no DT 0	significant JJ B-adj.all	difference NN B-noun.cognition	with IN 0	respect NN B-noun.act	to TO 0	age NN B-noun.person	, , 0	sex NN B-noun.person	, , 0	duration NN 0	of IN 0	the DT 0	treatment NN B-noun.plant	and CC 0	starvation NN B-noun.artifact	variables NNS B-noun.artifact	. . 0	. . 0
a11875660.s4	We PRP 0	confirmed VBD B-verb.cognition	several JJ B-adj.all	cases NNS B-noun.event	of IN 0	transformation NN B-noun.act	from IN 0	exencephaly JJ B-adj.all	to TO 0	anencephaly RB B-adv.all	. . 0	. . 0
a18752389.s3	We PRP 0	describe VBP B-verb.communication	a DT 0	70-year JJ 0	- : 0	old JJ B-adj.all	Hispanic JJ B-noun.person	woman NN B-noun.person	who WP 0	developed VBD B-verb.body	fulminant_hepatic_failure JJ 0	necessitating VBG B-verb.consumption	liver NN B-noun.food	transplantation NN B-noun.communication	10 CD B-adj.all	weeks NNS B-noun.time	after IN 0	conversion NN B-noun.person	from IN 0	simvastatin JJ B-adj.all	40 CD 0	mg RB 0	/ JJ 0	day NN 0	to TO 0	simvastatin_10_mg JJ B-noun.act	- : 0	ezetimibe_40_mg RB 0	/ DT 0	day NN B-noun.person	. . 0	. . 0
a9406968.s0	Upregulation NN 0	of IN 0	the DT 0	expression NN B-noun.communication	of IN 0	vasopressin JJ B-adj.all	gene NN B-noun.person	in IN 0	the DT 0	paraventricular NN B-noun.object	and CC 0	supraoptic JJ B-adj.all	nuclei NN B-noun.object	of IN 0	the DT 0	lithium NN B-noun.person	- : 0	induced VBN B-verb.creation	diabetes_insipidus NN B-noun.artifact	rat NN I-noun.artifact	. . 0	. . 0
a19729346.s0	Comparative JJ B-adj.all	cognitive NN B-noun.motive	and CC 0	subjective JJ B-adj.all	side NN B-noun.artifact	effects NNS B-noun.phenomenon	of IN 0	immediate JJ B-adj.all	- : 0	release NN B-verb.body	oxycodone NN 0	in IN 0	healthy JJ B-adj.all	middle NN B-noun.person	- : 0	aged VBN B-verb.communication	and CC 0	older JJR B-adj.all	adults NNS B-noun.animal	. . 0	. . 0
a12369736.s4	Systemic JJ 0	cocaine NN 0	( ( 0	10 CD 0	mg PRP 0	/ : 0	kg LS 0	) ) 0	significantly RB B-adv.all	increased VBD B-verb.change	the DT 0	locomotor NN B-noun.phenomenon	activity NN B-noun.process	of IN 0	rats NNS B-noun.animal	. . 0	. . 0
a11206082.s5	injections NNS B-noun.animal	. . 0	. . 0
a9088814.s2	The DT 0	patients NNS B-noun.person	were VBD B-verb.stative	randomly RB B-adv.all	allocated VBN B-verb.communication	to TO 0	one CD 0	of IN 0	three CD 0	groups NNS 0	, , 0	those DT 0	in IN 0	group NN 0	A DT 0	( ( 0	n UH 0	= $ 0	10 CD B-adj.all	) ) 0	were VBD 0	subjected VBN B-verb.perception	to TO 0	controlled JJ B-verb.social	hypotension NN 0	alone RB 0	, , 0	those DT 0	in IN 0	group NN 0	B NNP 0	( ( 0	n UH 0	= $ 0	10 CD B-adj.all	) ) 0	to TO 0	haemodilution VB 0	alone RB 0	and CC 0	those DT 0	in IN 0	group NN 0	C NNP 0	( ( 0	n UH 0	= $ 0	10 CD B-adj.all	) ) 0	to TO 0	both DT 0	controlled JJ B-adj.all	hypotension NN B-noun.person	and CC 0	haemodilution NN B-noun.act	. . 0	. . 0
a7890216.s0	Composition NN B-noun.person	of IN 0	gall_bladder_stones NNS B-noun.communication	associated VBN B-verb.cognition	with IN 0	octreotide NN 0	, , 0	response NN B-noun.communication	to TO 0	oral JJ B-adj.all	ursodeoxycholic_acid NN B-noun.location	. . 0	. . 0
a1835291.s6	These DT 0	results NNS B-noun.communication	show VBP B-verb.communication	that DT 0	ipratropium NN B-noun.person	is VBZ B-verb.stative	a DT 0	more RBR B-adv.all	potent JJ B-adj.all	bronchodilator NN B-noun.feeling	than IN 0	oral JJ B-adj.all	theophylline NN 0	in IN 0	patients NNS B-noun.person	with IN 0	chronic_airflow_obstruction NN B-noun.group	. . 0	. . 0
a18619688.s7	In IN 0	addition NN 0	, , 0	we PRP 0	analyzed VBD B-verb.cognition	the DT 0	expression NN B-noun.communication	of IN 0	autophagy NN B-noun.person	associated VBN B-verb.cognition	gene NN B-noun.person	, , 0	beclin IN 0	1 CD 0	using VBG B-verb.consumption	RT NNP 0	- : 0	PCR NNP B-noun.group	and CC 0	Western JJ 0	blotting VBG B-verb.change	in IN 0	an DT 0	animal NN B-adj.all	model NN B-noun.person	. . 0	. . 0
a9698967.s0	An DT 0	unusual JJ B-adj.all	toxic JJ B-adj.all	reaction NN B-noun.motive	to TO 0	axillary JJ B-adj.all	block NN B-noun.person	by IN 0	mepivacaine NN B-noun.person	with IN 0	adrenaline NN B-noun.person	. . 0	. . 0
a17879945.s10	Ritonavir NNP B-noun.person	increased VBD B-verb.change	the DT 0	expression NN B-noun.communication	of IN 0	the DT 0	scavenger NN B-noun.person	receptor NN B-noun.person	, , 0	CD36 JJ B-noun.person	mRNA NNP I-noun.person	, , 0	responsible JJ B-adj.all	for IN 0	the DT 0	uptake NN B-noun.location	of IN 0	LDL NNP B-noun.group	. . 0	. . 0
a18308784.s6	The DT 0	results NNS B-noun.communication	showed VBD B-verb.communication	that IN 0	rats NNS B-noun.person	treated VBN B-verb.social	with IN 0	Morphine NNP B-noun.person	/ POS 0	Rg1 NN 0	decreased VBD B-verb.change	escape NN B-noun.act	latency NN I-noun.act	and CC 0	increased VBD B-verb.change	the DT 0	time NN B-noun.time	spent VBN B-verb.stative	in IN 0	platform NN B-noun.animal	quadrant NN I-noun.animal	and CC 0	entering JJ B-adj.all	frequency NN B-noun.person	. . 0	. . 0
a18410508.s10	Striatal JJ B-adj.all	microglia NNS B-noun.person	expressing VBG B-verb.communication	eGFP NN I-verb.communication	constitutively RB B-adv.all	show VBP B-verb.communication	morphological JJ B-noun.phenomenon	changes NNS I-noun.phenomenon	after_METH IN 0	that DT 0	are VBP B-verb.stative	characteristic JJ B-adj.all	of IN 0	activation NN B-noun.act	. . 0	. . 0
a9672936.s1	A DT 0	healthy JJ B-adj.all	17-year JJ 0	- : 0	old JJ B-adj.all	male NN B-noun.person	received VBD B-verb.possession	standard JJ B-adj.all	intermittent NN B-noun.act	doses NNS B-noun.event	of IN 0	pethidine NN 0	via IN 0	a DT 0	patient NN B-noun.person	- : 0	controlled VBN B-verb.social	analgesia NN B-noun.animal	( ( 0	PCA NNP 0	) ) 0	pump NN B-noun.person	for IN 0	management NN B-noun.act	of IN 0	postoperative_pain JJ B-adj.all	control NN B-noun.act	. . 0	. . 0
a20588063.s9	By IN 0	day NN 0	4 CD 0	, , 0	foot NN B-noun.location	process NN B-noun.person	effacement NN B-noun.person	was VBD B-verb.stative	complete JJ B-adj.all	and CC 0	proteinuria NN B-noun.person	appeared VBD B-verb.social	in IN 0	parallel NN 0	with IN 0	signs NNS B-noun.communication	of IN 0	size NN B-noun.phenomenon	barrier NN B-noun.artifact	damage NN B-noun.person	. . 0	. . 0
a2304736.s0	Prazosin SYM 0	- : 0	induced VBN B-verb.creation	stress_incontinence NN B-noun.artifact	. . 0	. . 0
a18217897.s2	Its PRP$ 0	activity NN B-noun.process	is VBZ 0	believed VBN B-verb.stative	to TO 0	be VB B-verb.stative	due JJ B-adj.all	modulation NN B-noun.person	of IN 0	the DT 0	tumour NN B-noun.artifact	milieu NN I-noun.artifact	, , 0	including VBG B-verb.change	downregulation NN B-noun.act	of IN 0	angiogenesis NN B-noun.food	and CC 0	inflammatory JJ B-adj.all	cytokines NNS B-noun.communication	. . 0	. . 0
a9766615.s3	The DT 0	side NN B-noun.body	effect NN B-noun.phenomenon	profiles NNS B-noun.artifact	of IN 0	the DT 0	atypical JJ B-adj.all	antipsychotics NNS B-noun.person	are VBP B-verb.stative	more RBR B-adv.all	advantageous JJ B-adj.all	than IN 0	those DT 0	of IN 0	the DT 0	conventional JJ B-adj.all	neuroleptics NNS B-noun.person	. . 0	. . 0
a10721819.s9	These DT 0	results NNS B-noun.communication	show VBP B-verb.communication	that IN 0	15-day JJ 0	isoproterenol NN B-noun.substance	pretreatment NN B-noun.artifact	not RB B-adv.all	only RB B-adv.all	abolished JJ B-verb.contact	but CC 0	reversed VBD B-verb.change	bromocriptine NN B-noun.person	- : 0	induced VBN B-verb.creation	tachycardia NN 0	to TO 0	bradycardia NNS B-noun.location	, , 0	an DT 0	effect NN B-noun.cognition	that WDT 0	is VBZ B-verb.stative	mainly RB B-adv.all	related VBN B-verb.cognition	to TO 0	further JJ B-adj.all	cardiac NN B-noun.cognition	beta NN I-noun.cognition	- : 0	adrenoceptor NN B-noun.person	desensitization NN B-noun.person	rather RB 0	than IN 0	to TO 0	impairment NN B-noun.act	of IN 0	autonomic JJ B-adj.all	regulation NN B-noun.act	of IN 0	the DT 0	heart NN B-noun.body	. . 0	. . 0
a19356053.s7	Laboratory NN B-noun.person	results NNS I-noun.person	were VBD 0	compared VBN B-verb.change	between IN 0	prior RB B-adj.all	, , 0	during IN 0	and CC 0	following VBG 0	sirolimus JJ 0	use NN 0	. . 0	. . 0
a2445283.s5	From IN 0	these DT 0	results NNS B-noun.communication	, , 0	we PRP 0	conclude VBP B-verb.cognition	that DT 0	ribavirin NN B-noun.person	has VBZ B-verb.possession	an DT 0	antiviral JJ B-adj.all	effect NN B-noun.cognition	in IN 0	advanced JJ B-adj.all	cases NNS B-noun.person	of IN 0	AHF NNP B-noun.group	, , 0	and CC 0	that DT 0	anemia NN B-noun.state	, , 0	the DT 0	only JJ B-adj.all	secondary JJ B-adj.all	reaction NN B-noun.person	observed VBD B-verb.perception	, , 0	can MD 0	be VB 0	easily RB B-adv.all	managed VBN B-verb.social	. . 0	. . 0
a9869257.s4	In IN 0	the DT 0	same JJ B-adj.all	experimental JJ B-adj.all	conditions NNS B-noun.cognition	, , 0	PG-9 NN 0	( ( 0	5 CD 0	- : 0	20 CD B-adj.all	microg NN B-noun.quantity	per IN 0	mouse NN B-noun.animal	, , 0	i.c.v NNP B-noun.person	. . 0	) ) 0	. . 0
a17147461.s11	Further RB 0	long RB 0	- : 0	term NN B-noun.time	analysis NN 0	of IN 0	renal JJ B-adj.all	allograft NN B-noun.animal	studies NNS I-noun.animal	using VBG B-verb.consumption	sirolimus NN 0	as IN 0	de FW 0	novo FW 0	immunosuppression NN 0	along IN 0	with IN 0	clinical JJ B-adj.all	and CC 0	laboratory NN B-noun.artifact	studies NNS B-noun.group	will MD 0	refine VB B-verb.perception	these DT 0	issues NNS B-noun.attribute	in IN 0	the DT 0	future NN B-noun.attribute	. . 0	. . 0
a3409645.s4	Impotence NN B-noun.person	was VBD B-verb.stative	more JJR B-adv.all	common JJ B-adj.all	among IN 0	male NN 0	patients NNS B-noun.person	than IN 0	controls NNS B-noun.artifact	and CC 0	was VBD 0	found VBN B-verb.cognition	to TO 0	be VB 0	associated VBN B-verb.cognition	with IN 0	co SYM 0	- : 0	morbidity NN B-noun.motive	and CC 0	the DT 0	taking NN 0	of IN 0	methotrexate NN B-noun.food	. . 0	. . 0
a16858720.s11	A DT 0	significant JJ B-adj.all	proportion NN B-noun.attribute	of IN 0	warfarin NN B-noun.act	- : 0	related JJ B-adj.all	cerebral_haemorrhages NNS B-noun.artifact	might MD 0	have VB 0	been VBN 0	prevented VBN B-verb.communication	if IN 0	greater JJR B-adj.all	caution NN B-noun.person	had VBD 0	been VBN 0	taken VBN B-verb.consumption	when WRB 0	prescribing VBG B-verb.creation	drugs NNS B-noun.artifact	known VBN B-verb.cognition	to TO 0	interact VB B-verb.contact	with IN 0	warfarin NN B-noun.act	. . 0	. . 0
a12464714.s11	Recurrence NN B-noun.act	rates NNS B-noun.time	were VBD B-verb.stative	31.4 CD 0	% NN 0	with IN 0	rizatriptan JJ B-adj.all	and CC 0	15.3 CD 0	% NN 0	with IN 0	ergotamine NN 0	/ : 0	caffeine NN B-noun.person	. . 0	. . 0
a7265370.s2	The DT 0	stone NN B-noun.artifact	passed VBN B-verb.contact	spontaneously RB B-adv.all	and CC 0	was VBD 0	found VBN B-verb.cognition	to TO 0	contain VB B-verb.stative	a DT 0	triamterene NN B-noun.person	metabolite NN B-noun.attribute	admixed VBN B-verb.change	with IN 0	uric_acid_salts NNS B-noun.location	. . 0	. . 0
a6518066.s1	Cross NNP B-noun.person	- : 0	sectional JJ B-adj.all	echocardiography NN B-noun.person	was VBD 0	used VBN B-verb.consumption	to TO 0	evaluate VB B-verb.consumption	two CD 0	neonates NNS B-noun.person	whose WP$ 0	mothers NNS B-noun.person	ingested VBD B-verb.consumption	lithium NN B-noun.artifact	during IN 0	pregnancy NN B-noun.person	. . 0	. . 0
a1428568.s2	We PRP 0	performed VBD B-verb.social	a DT 0	preliminary JJ B-adj.all	study NN B-noun.artifact	in IN 0	order NN 0	to TO 0	determine VB B-verb.cognition	any DT 0	difference NN B-noun.cognition	between IN 0	a DT 0	non NN B-noun.person	selective JJ B-adj.all	beta NN B-noun.person	- : 0	blocker NN B-noun.person	( ( 0	timolol NN 0	) ) 0	and CC 0	a DT 0	selective JJ B-adj.all	beta NN B-noun.person	- : 0	blocker NN B-noun.person	( ( 0	betaxolol NN 0	) ) 0	regarding VBG B-verb.stative	CNS NNP 0	side NN 0	effects NNS B-noun.phenomenon	. . 0	. . 0
a9199746.s3	RESULTS NNS B-noun.artifact	, , 0	Endophthalmitis NNP B-noun.location	resolved VBD B-verb.communication	with IN 0	improvement NN B-noun.state	in IN 0	visual JJ B-adj.all	acuity NN B-noun.motive	to TO 0	6/24 CD 0	at IN 0	three CD 0	months NNS B-noun.person	. . 0	. . 0
a9245658.s0	The DT 0	role NN B-noun.attribute	of IN 0	nicotine NN B-noun.person	in IN 0	smoking NN B-verb.consumption	- : 0	related JJ B-adj.all	cardiovascular_disease NN B-noun.communication	. . 0	. . 0
a20619828.s5	Dopamine NNP B-noun.person	D2 POS I-noun.person	receptors NNS B-noun.person	were VBD 0	elevated VBN B-verb.social	in IN 0	the DT 0	striatum NN B-noun.artifact	, , 0	whereas IN 0	serotonin NN B-noun.person	2C '' 0	, , 0	but CC 0	not RB B-adv.all	serotonin VB B-verb.social	1A PRP 0	, , 0	receptors NNS B-noun.person	were VBD 0	elevated VBN B-verb.social	in IN 0	the DT 0	orbital JJ B-adj.all	frontal JJ B-adj.all	cortex NN B-noun.group	. . 0	. . 0
a9754849.s1	Choreatiform_hyperkinesias NNS 0	are VBP 0	known VBN B-verb.cognition	to TO 0	be VB B-verb.stative	occasional JJ B-adj.all	movement_abnormalities NNS B-noun.communication	during IN 0	intoxications NNS B-noun.person	with IN 0	cocaine NN B-noun.person	but CC 0	not RB B-adj.all	opiates NNS B-noun.person	. . 0	. . 0
a1549199.s4	Other JJ 0	possible JJ B-adj.all	adverse JJ B-adj.all	effects NNS B-noun.phenomenon	-- : 0	such JJ 0	as IN 0	gastrointestinal_disorders NNS B-noun.person	, , 0	orthostatic_hypotension NN 0	, , 0	levodopa NN B-noun.person	- : 0	induced VBN B-verb.communication	psychosis NN B-noun.person	, , 0	sleep_disturbances NNS B-noun.attribute	or CC 0	parasomnias NNS B-noun.artifact	, , 0	or CC 0	drug NN B-noun.act	interactions NNS I-noun.act	-- : 0	also RB B-adv.all	require VBP B-verb.communication	carefully RB B-adv.all	monitored VBN B-verb.body	individual JJ B-adj.all	treatment NN B-noun.plant	. . 0	. . 0
a18308784.s1	Rg1 LS 0	, , 0	as IN 0	a DT 0	ginsenoside NN 0	extracted VBN B-verb.change	from IN 0	Panax NNP B-noun.location	ginseng NN 0	, , 0	could MD 0	ameliorate VB B-verb.communication	spatial JJ B-adj.all	learning_impairment NN B-noun.act	. . 0	. . 0
a18791946.s9	Blood NNP B-noun.person	and CC 0	urine NN B-noun.act	cultures NNS B-noun.artifact	did VBD 0	not RB B-adv.all	show VB B-verb.change	any DT 0	bacterial JJ B-adj.all	growth NN B-noun.process	. . 0	. . 0
a11773892.s14	CONCLUSIONS NNS B-noun.artifact	, , 0	Patients NNPS B-noun.person	who WP 0	are VBP B-verb.stative	more JJR B-noun.quantity	than IN 0	10 CD B-adj.all	years NNS B-noun.time	post RB B-adv.all	- : 0	OLTX NNP B-noun.group	have VBP 0	CRF NNP 0	and CC 0	ESRD NNP B-noun.other	at IN 0	a DT 0	high JJ B-adj.all	rate NN B-noun.time	. . 0	. . 0
a9931093.s12	d-1 LS 0	) ) 0	prevented VBD B-verb.creation	FK_506-induced JJ B-adj.all	hypertension NN B-noun.person	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a8953972.s4	Epinephrine NN B-noun.person	has VBZ B-verb.possession	a DT 0	proven VBN B-verb.cognition	role NN B-noun.attribute	in IN 0	cardiac_arrest NN 0	in IN 0	prehospital JJ B-adj.all	care NN B-noun.group	, , 0	however RB 0	, , 0	use NN 0	by IN 0	paramedics NNS B-noun.person	in IN 0	patients NNS B-noun.person	with IN 0	suspected VBN B-verb.cognition	allergic_reaction NNP B-noun.person	and CC 0	severe JJ B-adj.all	hypertension NN B-noun.feeling	should MD 0	be VB 0	viewed VBN B-verb.social	with IN 0	caution NN B-noun.cognition	. . 0	. . 0
a8682684.s0	Acetaminophen SYM 0	- : 0	induced VBN B-verb.creation	hypotension NN 0	. . 0	. . 0
a18439803.s4	Pretreatment NN B-noun.person	with IN 0	either DT 0	VPU NNP 0	( ( 0	50 CD B-adj.all	and CC 0	100 CD 0	mg NN B-noun.quantity	/ : 0	kg LS 0	) ) 0	or CC 0	VPA NNP B-noun.group	( ( 0	300 CD 0	and CC 0	600 CD 0	mg PRP 0	/ : 0	kg LS 0	) ) 0	completely RB B-adv.all	abolished VBN B-verb.contact	pilocarpine NN B-noun.person	- : 0	evoked VBD B-verb.communication	increases NNS B-noun.person	in IN 0	extracellular JJ B-adj.all	glutamate NN B-noun.person	and CC 0	aspartate NN B-noun.person	. . 0	. . 0
a7420681.s6	Thus RB 0	, , 0	gentamicin NN B-noun.person	was VBD 0	associated VBN B-verb.cognition	with IN 0	renal_failure NN B-noun.act	more JJR B-noun.quantity	than IN 0	three CD 0	times NNS 0	as RB 0	often RB 0	as IN 0	was VBD B-verb.stative	tobramycin NN B-noun.person	. . 0	. . 0
a18619688.s10	CONCLUSION NN B-noun.group	, , 0	Autophagic NNP B-noun.person	cardiomyocyte NN I-noun.person	death NN B-noun.person	plays VBZ B-verb.social	an DT 0	important JJ B-adj.all	role NN B-noun.attribute	in IN 0	the DT 0	pathogenesis NN B-noun.location	of IN 0	heart_failure NN B-noun.food	in IN 0	rats NNS B-noun.animal	induced VBN B-verb.creation	by IN 0	adriamycin NN B-noun.person	. . 0	. . 0
a18726058.s0	Adverse JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	topical JJ B-adj.all	papaverine NN B-noun.person	on IN 0	auditory JJ B-adj.all	nerve NN B-noun.phenomenon	function NN B-noun.act	. . 0	. . 0
a18754075.s4	Urinary NNP B-noun.person	volume NN B-noun.artifact	and CC 0	serum NN B-noun.body	creatinine NN 0	levels NNS B-noun.attribute	recovered VBD B-verb.communication	to TO 0	the DT 0	normal JJ B-adj.all	range NN B-noun.location	, , 0	with IN 0	urinary JJ B-adj.all	protein NN B-noun.person	disappearing VBG B-verb.change	completely RB B-adv.all	within IN 0	40 CD B-adj.all	days NNS B-noun.person	. . 0	. . 0
a16867021.s23	Findings NNS B-noun.act	suggest VBP B-verb.communication	a DT 0	potential NN B-noun.person	for IN 0	H(3)-receptor NN 0	antagonists NNS B-noun.person	in IN 0	improving VBG B-verb.change	the DT 0	refractory JJ B-adj.all	cases NNS B-noun.person	of_schizophrenia NNP I-noun.person	. . 0	. . 0
a1867351.s0	Neuropsychiatric JJ B-adj.all	side NN B-noun.body	effects NNS B-noun.phenomenon	after IN 0	the DT 0	use NN 0	of IN 0	mefloquine NN B-noun.person	. . 0	. . 0
a17241784.s6	Progressive JJ B-adj.all	improvement NN B-noun.state	occurred VBD B-verb.stative	in IN 0	7 CD B-adj.all	cases NNS B-noun.artifact	after IN 0	commencement NN B-noun.person	of IN 0	prednisolone NN B-noun.person	and CC 0	methotrexate NN B-noun.person	, , 0	and CC 0	in IN 0	one CD 0	case NN 0	spontaneously RB B-adv.all	. . 0	. . 0
a20520283.s4	On IN 0	the DT 0	Positive JJ B-noun.other	and CC I-noun.other	Negative NNP I-noun.other	Syndrome NNP I-noun.other	Scale NNP I-noun.other	positive JJ B-adj.all	subscale NN B-noun.person	, , 0	all DT 0	treatments NNS B-noun.plant	were VBD B-verb.stative	superior JJ B-adj.all	to TO 0	placebo VB B-verb.cognition	with IN 0	LOCF NNP B-noun.group	and CC 0	MMRM NNP B-noun.group	, , 0	asenapine NN B-noun.person	at IN 0	5 CD 0	mg IN 0	BID NNP B-noun.group	was VBD B-verb.stative	superior JJ B-adj.all	to TO 0	placebo VB B-verb.cognition	on IN 0	the DT 0	negative JJ B-adj.all	subscale NN B-noun.person	with IN 0	MMRM NNP B-noun.group	and CC 0	on IN 0	the DT 0	general JJ B-adj.all	psychopathology NN B-noun.person	subscale NN B-noun.person	with IN 0	LOCF NNP B-noun.group	and CC 0	MMRM NNP B-noun.group	. . 0	. . 0
a12584269.s2	These DT 0	are VBP B-verb.stative	nephrotoxic JJ B-adj.all	, , 0	but CC 0	SRL NNP 0	seems VBZ B-verb.perception	to TO 0	act VB B-verb.social	differently RB B-adv.all	displaying VBG B-verb.change	only RB B-adv.all	minor JJ B-adj.all	nephrotoxic JJ B-adj.all	effects NNS B-noun.phenomenon	, , 0	although IN 0	this DT 0	question NN B-noun.communication	is VBZ B-verb.stative	still RB B-adv.all	open JJ B-adj.all	. . 0	. . 0
a1720453.s1	The DT 0	renal JJ B-adj.all	function NN B-noun.act	of IN 0	74 CD B-adj.all	children NNS B-noun.person	with IN 0	malignant_mesenchymal_tumors NNS B-noun.person	in IN 0	complete JJ B-adj.all	remission NN B-noun.communication	and CC 0	who WP 0	have VBP 0	received VBN B-verb.possession	the DT 0	same JJ B-adj.all	ifosfamide NN B-noun.person	chemotherapy NN B-noun.group	protocol NN B-noun.person	( ( 0	International NNP B-noun.other	Society NNP I-noun.other	of IN 0	Pediatric NNP B-noun.person	Oncology NNP I-noun.person	Malignant_Mesenchymal_Tumor NNP I-noun.person	Study NNP I-noun.person	84 CD 0	[ CD 0	SIOP NNP B-noun.group	MMT NNP 0	84 CD 0	] CD 0	) ) 0	were VBD 0	studied VBN B-verb.cognition	1 CD B-adj.all	year NN B-noun.time	after IN 0	the DT 0	completion NN B-noun.act	of IN 0	treatment NN B-noun.plant	. . 0	. . 0
a18809400.s1	The DT 0	study NN B-noun.artifact	investigates NNS B-noun.artifact	if IN 0	alpha NN B-noun.person	- : 0	lipoic_acid NN B-noun.time	is VBZ B-verb.stative	neuroprotective JJ 0	against IN 0	chemotherapy NN B-noun.communication	induced VBN B-verb.creation	neurotoxicity NN B-noun.attribute	, , 0	if IN 0	mitochondrial_damage NN 0	plays VBZ B-verb.creation	a DT 0	critical JJ B-adj.all	role NN B-noun.attribute	in IN 0	toxic_neurodegenerative_cascade NN 0	, , 0	and CC 0	if IN 0	neuroprotective JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	alpha NN B-noun.act	- : 0	lipoic_acid JJ B-adj.all	depend NN B-noun.event	on IN 0	mitochondria NN B-noun.animal	protection NN I-noun.animal	. . 0	. . 0
a8643971.s14	Eleven CD 0	responding VBG B-verb.communication	patients NNS B-noun.person	had VBD 0	subsequent JJ B-verb.possession	surgery NN B-noun.communication	/ : 0	radiotherapy NN B-noun.substance	or CC 0	radical JJ B-adj.all	radiotherapy NN B-noun.act	. . 0	. . 0
a2559236.s7	Chronic NNP B-adj.pert	enalapril NN B-noun.relation	treatment NN I-noun.relation	reduced VBN B-verb.change	blood NN B-noun.act	pressure NN B-noun.act	without IN 0	reducing VBG B-verb.change	albuminuria NNS B-noun.person	in IN 0	group NN 0	4 CD 0	. . 0	. . 0
a9390208.s16	Eight CD 0	patients NNS B-noun.person	were VBD B-verb.stative	dead JJ B-adj.all	in IN 0	the DT 0	last JJ B-adj.all	follow NN B-noun.person	- : 0	up RB B-adv.all	, , 0	two CD 0	of IN 0	them PRP 0	died VBD B-verb.change	of IN 0	treatment NN B-noun.communication	- : 0	related JJ B-adj.all	toxicity NN B-noun.attribute	. . 0	. . 0
a7292072.s2	Unusual JJ B-adj.all	features NNS B-noun.cognition	of IN 0	the DT 0	arrhythmia NN B-noun.communication	are VBP B-verb.stative	repetitive JJ B-adj.all	group NN B-noun.group	beating NN B-noun.group	, , 0	progressive JJ B-adj.all	shortening NN B-noun.act	of IN 0	the DT 0	R NNP 0	- : 0	R NN 0	interval NN 0	, , 0	progressive JJ B-adj.all	widening NN B-noun.process	of IN 0	the DT 0	QRS NNP 0	complex NN 0	with IN 0	eventual JJ B-adj.all	failure NN B-noun.person	of IN 0	intraventricular JJ B-adj.all	conduction NN B-noun.act	, , 0	and CC 0	changes NNS B-noun.artifact	in IN 0	direction NN B-noun.act	of IN 0	the DT 0	QRS NNP 0	axis NN 0	. . 0	. . 0
a15737522.s1	It PRP 0	is VBZ B-verb.stative	well RB 0	known VBN B-verb.cognition	that IN 0	ceftriaxone NN 0	leads VBZ B-verb.stative	to TO 0	pseudolithiasis NN B-noun.cognition	in IN 0	some DT 0	patients NNS B-noun.person	. . 0	. . 0
a16740173.s16	One CD 0	week NN 0	later RB B-adv.all	, , 0	the DT 0	patient NN B-noun.person	was VBD 0	again RB B-adv.all	extubated VBN B-verb.communication	and CC 0	3 CD B-adj.all	days NNS B-noun.phenomenon	later RB 0	was VBD 0	transferred VBN B-verb.social	to TO 0	a DT 0	peripheral JJ B-adj.pert	ward NN B-noun.state	. . 0	. . 0
a10835440.s13	For IN 0	low JJ B-adj.all	- : 0	dose NN B-noun.person	nimodipine NN B-noun.person	, , 0	the DT 0	results NNS B-noun.location	were VBD B-verb.stative	not RB B-adv.all	conclusive JJ B-adj.all	. . 0	. . 0
a18162529.s12	These DT 0	data NNS B-noun.cognition	show VBP B-verb.communication	that IN 0	GnRH JJ 0	pulse JJ B-adj.all	frequency NN B-noun.person	is VBZ 0	inhibited VBN B-verb.change	by IN 0	chronic JJ B-adj.all	hyperprolactinemia NN B-noun.state	in IN 0	a DT 0	steroid JJ B-adj.all	- : 0	dependent JJ B-adj.all	manner NN B-noun.person	. . 0	. . 0
a11279304.s7	Three CD 0	patients NNS B-noun.person	developed VBD B-verb.creation	congestive_heart_failure NN B-noun.act	after IN 0	the DT 0	completion NN B-noun.act	of IN 0	chemotherapy NN B-noun.communication	. . 0	. . 0
a16167916.s7	Relationship NN B-noun.state	between IN 0	those DT 0	markers NNS B-noun.person	and CC 0	demographic JJ B-adj.pert	characteristics NNS B-noun.person	were VBD 0	investigated VBN B-verb.communication	. . 0	. . 0
a150790.s1	A DT 0	3-year JJ 0	- : 0	old JJ B-adj.all	girl NN B-noun.person	had VBD B-verb.stative	behavioral_deterioration NN 0	, , 0	with IN 0	hyperkinesis NN B-noun.food	, , 0	irritability NN B-noun.person	, , 0	and CC 0	sleeping_difficulties NNS B-noun.communication	after IN 0	the DT 0	therapeutic JJ B-adj.pert	administration NN B-noun.time	of IN 0	isoniazid NN B-noun.feeling	. . 0	. . 0
a6538499.s0	Effect NN 0	of IN 0	polyethylene_glycol_400 NN 0	on IN 0	adriamycin NN B-noun.communication	toxicity NN B-noun.attribute	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a2385256.s4	While IN 0	she PRP 0	was VBD B-verb.stative	weak JJ B-adj.all	, , 0	2-Hz JJ B-adj.all	repetitive JJ B-adj.all	stimulation NN B-noun.artifact	revealed VBD B-verb.perception	a DT 0	decrement NN B-noun.time	without IN 0	significant JJ B-adj.all	facilitation NN B-noun.state	at IN 0	rapid JJ B-adj.all	rates NNS B-noun.time	or CC 0	after IN 0	exercise NN B-noun.act	, , 0	suggesting VBG B-verb.communication	postsynaptic_neuromuscular_blockade JJ I-verb.communication	. . 0	. . 0
a10193204.s6	In IN 0	the DT 0	vitro NN B-noun.plant	human JJ B-adj.all	platelet_aggregations NNS B-noun.shape	induced VBN B-verb.creation	by IN 0	the DT 0	agonists NNS B-noun.person	used VBN B-verb.consumption	in IN 0	tests NNS B-noun.cognition	, , 0	TET NNP B-noun.group	and CC 0	FAN NNP B-noun.person	showed VBD B-verb.communication	the DT 0	inhibitions NNS B-noun.artifact	dose VBP 0	dependently RB B-adv.all	. . 0	. . 0
a15338796.s10	Inter NNP B-noun.person	- : 0	observer NN B-noun.person	variability NN B-noun.person	was VBD 0	measured VBN B-verb.cognition	in IN 0	a DT 0	series NN B-noun.communication	of IN 0	10 CD B-adj.all	healthy JJ B-adj.all	subjects NNS B-noun.person	. . 0	. . 0
a8590259.s9	This DT 0	may MD 0	well RB 0	be VB B-verb.stative	a DT 0	particularly RB B-adv.all	notable JJ B-adj.all	finding NN B-noun.act	in IN 0	Asian JJ 0	people NNS 0	. . 0	. . 0
a11279304.s12	These DT 0	preliminary JJ B-adj.all	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	BNP NNP B-noun.group	may MD 0	be VB B-verb.stative	useful JJ 0	as IN 0	an DT 0	early JJ B-adj.all	and CC 0	sensitive JJ B-adj.all	indicator NN B-noun.person	of IN 0	anthracycline JJ B-noun.attribute	- : 0	induced VBN B-verb.creation	cardiotoxicity NN B-noun.feeling	. . 0	. . 0
a18162529.s6	Estradiol NN 0	is VBZ 0	known VBN B-verb.cognition	to TO 0	influence VB B-verb.change	expression NN B-noun.communication	of IN 0	the DT 0	long JJ B-adj.all	form NN B-noun.attribute	of IN 0	prolactin NN B-noun.person	receptors NNS B-noun.person	( ( 0	PRL NNP B-noun.person	- : 0	R NN 0	) ) 0	and CC 0	components NNS B-noun.person	of IN 0	prolactin NN B-noun.person	's POS 0	signaling NN B-noun.act	pathway NN B-noun.location	. . 0	. . 0
a2224762.s7	Less RBR B-adv.all	frequent JJ B-adj.all	toxic JJ B-adj.all	effects NNS B-noun.phenomenon	included VBD B-verb.stative	thrombocytopenia NN 0	, , 0	anemia NN B-noun.person	, , 0	nausea NN B-noun.person	, , 0	mild JJ B-adj.all	alopecia NNS B-noun.person	, , 0	phlebitis NN B-noun.person	, , 0	and CC 0	mucositis NN B-noun.act	. . 0	. . 0
a12684739.s6	RESULTS NNS B-noun.artifact	, , 0	Sub NNP B-noun.person	- : 0	chronic JJ B-adj.all	GVG NNP B-noun.group	exposure NN B-noun.communication	inhibited VBD B-verb.change	the DT 0	effect NN B-noun.cognition	of IN 0	cocaine NN 0	for IN 0	3 CD B-adj.all	days NNS B-noun.person	, , 0	which WDT 0	exceeded VBD B-verb.stative	in IN 0	magnitude NN B-noun.animal	and CC 0	duration NN 0	the DT 0	identical JJ B-adj.all	acute NN B-noun.person	dose NN B-noun.quantity	. . 0	. . 0
a2224762.s5	The DT 0	dose NN B-noun.act	- : 0	limiting VBG B-verb.social	toxic JJ B-adj.all	effect NN B-noun.cognition	was VBD B-verb.stative	transient JJ B-adj.all	noncumulative JJ B-adj.all	granulocytopenia NN B-noun.person	. . 0	. . 0
a3437726.s8	Analyses NNS B-noun.act	of IN 0	a DT 0	blood NN B-noun.person	sample NN B-noun.person	revealed VBD B-verb.communication	unusually RB B-adv.all	high JJ B-adj.all	plasma NN B-noun.plant	concentrations NNS B-noun.attribute	of IN 0	metoprolol NN B-noun.cognition	( ( 0	greater JJR B-adj.all	than IN 0	3000 CD 0	ng NN B-noun.quantity	/ : 0	ml LS 0	) ) 0	and CC 0	diltiazem NN B-noun.person	( ( 0	526 CD 0	ng IN 0	/ : 0	ml LS 0	) ) 0	. . 0	. . 0
a8170551.s4	Extracorporeal JJ 0	lithotripsy NN 0	successfully RB B-adv.all	removed VBN B-verb.change	a DT 0	renal_calculus NN B-noun.other	in IN 0	one CD 0	patient NN B-noun.person	and CC 0	surgery NN B-noun.person	removed VBD B-verb.change	a DT 0	staghorn JJ B-adj.all	calculus NN B-noun.person	in IN 0	another DT 0	, , 0	permitting VBG 0	continued VBN B-verb.stative	treatment NN 0	. . 0	. . 0
a2385256.s1	We PRP 0	studied VBD B-verb.cognition	a DT 0	patient NN B-noun.person	with IN 0	no DT 0	prior JJ B-adj.all	history NN B-noun.cognition	of IN 0	neuromuscular_disease NN B-noun.person	who WP 0	became VBD B-verb.stative	virtually RB B-adv.all	quadriplegic JJ 0	after IN 0	parenteral JJ B-adj.all	magnesium NN B-noun.person	administration NN B-noun.person	for IN 0	preeclampsia NN B-noun.person	. . 0	. . 0
a17439425.s3	2 LS 0	. . 0	. . 0
a17147461.s3	Its PRP$ 0	role NN B-noun.attribute	in IN 0	the DT 0	therapy NN B-noun.act	of IN 0	glomerulonephritis NN B-noun.food	, , 0	autoimmunity NN B-noun.person	, , 0	cystic_renal_diseases NNS B-noun.person	and CC 0	renal_cancer NN B-noun.person	is VBZ B-verb.stative	under IN 0	investigation NN B-noun.act	. . 0	. . 0
a19211690.s11	Testosterone NN 0	contributes VBZ B-verb.communication	to TO 0	the DT 0	development NN B-noun.process	of IN 0	hypertension NN B-noun.act	and CC 0	renal_injury NN B-noun.act	in IN 0	male NN 0	DS NNP 0	rats NNS B-noun.animal	on IN 0	HS NNP 0	diet NN 0	possibly RB 0	through IN 0	upregulation NN B-noun.act	of IN 0	the DT 0	intrarenal JJ B-adj.all	renin NN B-noun.act	- : 0	angiotensin NN 0	system NN B-noun.cognition	. . 0	. . 0
a12639165.s3	T SYM 0	- : 0	cell NN 0	stimulation NN 0	by IN 0	therapeutic JJ B-adj.all	concentration NN B-noun.event	of IN 0	ticlopidine NN B-noun.location	was VBD 0	demonstrated VBN B-verb.perception	in IN 0	vitro NN B-noun.food	in IN 0	the DT 0	patients NNS B-noun.person	, , 0	but CC 0	not RB B-adv.all	in IN 0	healthy JJ B-adj.all	controls NNS B-noun.group	. . 0	. . 0
a3403780.s1	A DT 0	case NN B-noun.state	of IN 0	metabolic_acidosis NN B-noun.food	, , 0	acute_renal_failure_and_hepatic_failure NN B-noun.person	following VBG B-verb.possession	paracetamol NN B-noun.possession	ingestion NN B-noun.act	is VBZ 0	presented VBN B-verb.possession	. . 0	. . 0
a19346865.s1	OBJECTIVE NNP B-noun.group	, , 0	This DT 0	is VBZ B-verb.stative	to TO 0	present VB B-verb.stative	reversible JJ B-adj.all	inferior_colliculus_lesions NNS B-noun.cognition	in IN 0	metronidazole NN B-noun.attribute	- : 0	induced VBN B-verb.creation	encephalopathy JJ B-adj.all	, , 0	to TO 0	focus VB B-verb.stative	on IN 0	the DT 0	diffusion NN B-noun.communication	- : 0	weighted JJ B-adj.all	imaging NN B-noun.attribute	( ( 0	DWI NNP 0	) ) 0	and CC 0	fluid NN B-noun.person	attenuated VBD B-verb.emotion	inversion NN I-verb.emotion	recovery NN B-noun.process	( ( 0	FLAIR NNP B-noun.group	) ) 0	imaging NN B-verb.creation	. . 0	. . 0
a9088814.s1	Combined VBN B-verb.creation	effects NNS B-noun.phenomenon	of IN 0	prolonged VBN B-verb.creation	prostaglandin_E1 NNP B-noun.person	( ( 0	PGE1)-induced JJ 0	hypotension NN B-noun.person	and CC 0	haemodilution NN B-noun.person	on IN 0	hepatic JJ B-adj.all	function NN B-noun.act	were VBD 0	studied VBN B-verb.cognition	in IN 0	30 CD B-adj.all	patients NNS B-noun.person	undergoing VBG B-verb.communication	hip NN I-verb.communication	surgery NN B-noun.artifact	. . 0	. . 0
a8092427.s12	None NN 0	of IN 0	the DT 0	sera NN B-noun.body	with IN 0	negative JJ B-adj.all	RAST NNP B-noun.group	for IN 0	AX NNP 0	were VBD B-verb.stative	positive JJ B-adj.all	to TO 0	BPO NNP 0	. . 0	. . 0
a2559236.s10	Reduction NN B-noun.person	in IN 0	GFR NNP 0	was VBD 0	associated VBN B-verb.cognition	with IN 0	the DT 0	development NN B-noun.process	of IN 0	glomerular_sclerosis NN B-noun.food	in IN 0	both DT 0	treated VBD B-verb.change	and CC 0	untreated JJ B-adj.all	rats.(ABSTRACT NN B-noun.other	TRUNCATED VBN I-noun.other	AT IN I-noun.other	250 CD I-noun.other	WORDS NNS I-noun.other	) ) 0	. . 0
a2924746.s0	Chronic NNP B-adj.pert	carbamazepine NN B-noun.communication	treatment NN B-noun.communication	in IN 0	the DT 0	rat NN B-noun.artifact	, , 0	efficacy NN B-noun.person	, , 0	toxicity NN B-noun.attribute	, , 0	and CC 0	effect NN B-noun.cognition	on IN 0	plasma NN B-noun.substance	and CC 0	tissue VB B-verb.body	folate JJ B-noun.body	concentrations NNS I-noun.body	. . 0	. . 0
a2484011.s0	Mouse NN 0	strain NN B-noun.communication	- : 0	dependent JJ B-adj.all	effect NN B-noun.cognition	of IN 0	amantadine NN B-noun.person	on IN 0	motility NN B-noun.motive	and CC 0	brain NN B-noun.plant	biogenic JJ B-adj.all	amines NNS B-noun.artifact	. . 0	. . 0
a12041669.s2	Bone NNP 0	marrow NN 0	recovery NN B-noun.act	and CC 0	peripheral JJ B-adj.pert	blood NN B-noun.act	recovery NN B-noun.act	were VBD B-verb.stative	complete JJ B-adj.all	1 CD B-adj.all	month NN B-noun.quantity	and CC 0	3 CD B-adj.all	months NNS B-noun.person	, , 0	respectively RB B-adv.all	, , 0	after IN 0	treatment NN B-noun.plant	, , 0	and CC 0	blood NN B-noun.act	transfusion NN B-noun.act	or CC 0	other JJ B-adj.all	therapies NNS B-noun.person	were VBD B-verb.stative	not RB B-adv.all	necessary JJ B-adj.all	in IN 0	a DT 0	follow NN B-noun.person	- : 0	up IN 0	period NN B-noun.time	of IN 0	more JJR B-noun.quantity	than IN 0	2 CD B-adj.all	years NNS B-noun.time	. . 0	. . 0
a10669626.s14	Because IN 0	Warfarin NNP B-noun.person	treatment NN I-noun.person	had VBD 0	no DT 0	effect NN B-noun.cognition	on IN 0	the DT 0	elevation NN B-noun.act	in IN 0	serum NN 0	calcium NN 0	produced VBN B-verb.creation	by IN 0	vitamin NN 0	D NNP 0	, , 0	the DT 0	synergy NN B-noun.attribute	between IN 0	Warfarin NNP B-noun.location	and CC 0	vitamin NN 0	D NNP 0	is VBZ B-verb.stative	probably RB B-adv.all	best RB B-adv.all	explained VBN B-verb.communication	by IN 0	the DT 0	hypothesis NN B-noun.cognition	that IN 0	Warfarin NNP B-noun.location	inhibits VBZ B-verb.stative	the DT 0	activity NN B-noun.process	of IN 0	matrix NNP B-noun.person	Gla NNP I-noun.person	protein NN I-noun.person	as IN 0	a DT 0	calcification NN B-noun.person	inhibitor NN B-noun.person	. . 0	. . 0
a10669626.s7	Although IN 0	the DT 0	explanation NN B-noun.communication	for IN 0	the DT 0	association NN B-noun.state	between IN 0	artery_calcification NN B-noun.act	and CC 0	growth NN 0	status NN 0	can MD 0	not RB B-adv.all	be VB 0	determined VBN B-verb.communication	from IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	, , 0	there EX 0	was VBD B-verb.stative	a DT 0	relationship NN B-noun.state	between IN 0	higher JJR B-adj.all	serum NN B-noun.person	phosphate NN B-noun.person	and CC 0	susceptibility NN 0	to TO 0	artery_calcification NN B-noun.act	, , 0	with IN 0	30 CD B-adj.all	% NN 0	higher JJR B-adj.all	levels NNS B-noun.attribute	of IN 0	serum NN B-noun.person	phosphate NN B-noun.person	in IN 0	young JJ B-adj.all	, , 0	ad NN 0	libitum NN 0	- : 0	fed VBN B-verb.stative	rats NNS 0	compared VBN B-verb.stative	with IN 0	either DT 0	of IN 0	the DT 0	groups NNS B-noun.group	that WDT 0	was VBD B-verb.stative	resistant JJ B-adj.all	to TO 0	Warfarin NNP B-noun.person	- : 0	induced VBN B-verb.creation	artery_calcification NN B-noun.act	, , 0	ie UH 0	, , 0	the DT 0	10-month JJ 0	- : 0	old JJ B-adj.all	rats NNS B-noun.person	and CC 0	the DT 0	restricted VBN B-verb.social	- : 0	diet NN B-noun.person	, , 0	growth NN B-noun.person	- : 0	inhibited JJ B-adj.all	young JJ B-adj.all	rats NNS B-noun.person	. . 0	. . 0
a6209318.s5	There EX 0	were VBD B-verb.stative	more JJR B-adj.all	deaths NNS B-noun.person	in IN 0	the DT 0	mexiletine NN B-noun.location	group NN 0	( ( 0	7.6 CD 0	% NN 0	) ) 0	than IN 0	in IN 0	the DT 0	placebo NN B-noun.location	group NN 0	( ( 0	4.8 CD 0	% NN 0	) ) 0	, , 0	the DT 0	difference NN B-noun.cognition	was VBD B-verb.stative	not RB B-adv.all	statistically RB B-adv.all	significant JJ B-adj.all	. . 0	. . 0
a11250767.s4	RESULTS NNS B-noun.artifact	, , 0	A DT 0	25-year JJ 0	- : 0	old JJ B-adj.all	woman NN B-noun.person	with IN 0	Graves'_disease NNP B-noun.person	had VBD B-verb.stative	a DT 0	febrile_illness NNP B-noun.person	and CC 0	evidence NN B-noun.attribute	of IN 0	pericarditis NN B-noun.person	, , 0	which WDT 0	was VBD 0	confirmed VBN B-verb.cognition	by IN 0	biopsy NN B-noun.cognition	. . 0	. . 0
a12716030.s2	We PRP 0	therefore RB B-adv.all	established VBD B-verb.creation	sensitive JJ B-adj.all	quantification NN B-noun.person	methods NNS B-noun.person	and CC 0	provided VBD B-verb.communication	a DT 0	rat NN B-noun.person	ICH NNP I-noun.person	model NN B-noun.person	for IN 0	detection NN B-noun.act	of IN 0	ICH NNP 0	deterioration NN B-noun.process	. . 0	. . 0
a88336.s4	The DT 0	fourth JJ B-adj.all	patient NN B-noun.person	who WP 0	was VBD B-verb.stative	unconscious JJ B-adj.all	after IN 0	chlormethiazole JJ B-adj.all	administration NN B-noun.person	exhibite NN B-noun.person	generalized VBD B-verb.communication	non RB B-adv.all	- : 0	reactive JJ B-adj.all	activity NN B-noun.process	in IN 0	the DT 0	slow JJ B-adj.all	beta JJ B-noun.body	range NN I-noun.body	. . 0	. . 0
a1664218.s6	Grade NNP B-noun.person	less JJR I-noun.person	than IN 0	or CC 0	equal JJ B-adj.all	to TO 0	2 CD B-adj.all	nausea NN B-noun.quantity	and CC 0	vomiting NN B-noun.act	occurred VBD B-verb.change	in IN 0	66 CD 0	% NN 0	courses NNS B-noun.act	and CC 0	phlebitis NN B-noun.person	in IN 0	the DT 0	infusion NN 0	arm NN 0	in IN 0	37 CD 0	% NN 0	. . 0	. . 0
a12464714.s8	Almost RB 0	36 CD 0	% NN 0	of IN 0	patients NNS B-noun.person	taking VBG B-verb.social	rizatriptan JJ I-verb.social	were VBD B-verb.stative	pain JJ B-adj.all	free JJ B-noun.person	at IN 0	2 CD B-adj.all	h NN B-noun.quantity	and CC 0	had VBD B-verb.perception	no DT 0	recurrence NN B-noun.act	or CC 0	need VB B-verb.consumption	for IN 0	additional JJ B-adj.all	medication NN B-noun.act	within IN 0	24 CD B-adj.all	h NN B-noun.quantity	, , 0	compared VBN B-verb.cognition	to TO 0	20 CD B-adj.all	% NN 0	of IN 0	patients NNS B-noun.person	on IN 0	ergotamine NN 0	/ : 0	caffeine NN B-noun.substance	( ( 0	p UH 0	< : 0	or CC 0	= $ 0	0.001 CD 0	) ) 0	. . 0	. . 0
a11426838.s6	Moreover RB B-adv.all	, , 0	post NN B-noun.person	- : 0	treatment NN B-noun.plant	with IN 0	LR132 NNP B-noun.person	prevented VBD B-verb.communication	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	lethality NN B-noun.attribute	in IN 0	a DT 0	significant JJ B-adj.all	proportion NN B-noun.attribute	of IN 0	animals NNS B-noun.food	. . 0	. . 0
a11279304.s6	The DT 0	plasma NN B-noun.plant	levels NNS B-noun.state	of IN 0	atrial JJ B-adj.all	natriuretic JJ B-adj.all	peptide NN B-noun.cognition	( ( 0	ANP NNP 0	) ) 0	and CC 0	BNP NNP B-noun.group	were VBD 0	measured VBN B-verb.cognition	at IN 0	the DT 0	time NN B-noun.time	of IN 0	radionuclide NN 0	angiography NN 0	. . 0	. . 0
a19884587.s5	RESULTS NNS B-noun.artifact	, , 0	The DT 0	reported VBN B-verb.communication	use NN 0	of IN 0	antibacterials NNS B-noun.food	increased VBN B-verb.change	during IN 0	pregnancy NN B-noun.person	, , 0	peaking VBG B-verb.social	during IN 0	the DT 0	third JJ B-adj.all	month NN B-noun.person	. . 0	. . 0
a19299179.s2	However RB 0	, , 0	treatment NN B-noun.communication	is VBZ B-verb.stative	often RB B-adv.all	limited VBN B-verb.change	by IN 0	adverse JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a16938416.s2	METHODS NNS B-noun.attribute	, , 0	In IN 0	a DT 0	population NN B-noun.person	- : 0	based VBN B-verb.cognition	study NN B-noun.artifact	in IN 0	513 CD 0	naturally RB B-adv.all	postmenopausal JJ B-adj.all	women NNS B-noun.person	aged VBN B-verb.consumption	54 CD 0	- : 0	67 CD 0	years NNS B-noun.time	, , 0	we PRP 0	studied VBD B-verb.cognition	the DT 0	association NN B-noun.state	between IN 0	self PRP 0	- : 0	reported VBD B-verb.communication	intramuscularly RB B-adv.all	administered VBN B-verb.perception	high JJ B-adj.all	- : 0	dose NN 0	estrogen NN 0	- : 0	testosterone NN 0	therapy NN 0	( ( 0	estradiol-_and_testosterone_esters NNS B-noun.other	) ) 0	and CC 0	aortic JJ B-adj.all	atherosclerosis NN B-noun.communication	. . 0	. . 0
a8864707.s9	However RB 0	, , 0	multiple JJ B-adj.all	regression NN B-noun.act	for IN 0	the DT 0	daily JJ B-adj.pert	dosage NN B-noun.food	, , 0	duration NN 0	of IN 0	phenytoin NN B-noun.animal	treatment NN I-noun.animal	and CC 0	cerebellar JJ B-adj.all	volume NN B-noun.artifact	revealed VBD B-verb.perception	a DT 0	correlation NN B-noun.cognition	of IN 0	these DT 0	parameters NNS B-noun.person	. . 0	. . 0
a7988234.s0	Angioedema NNP B-noun.person	following VBG B-verb.stative	the DT 0	intravenous JJ B-adj.all	administration NN B-noun.time	of IN 0	metoprolol NN B-noun.food	. . 0	. . 0
a18791946.s6	An DT 0	accurate JJ B-adj.all	autopsy NN B-noun.person	revealed VBD B-verb.perception	most JJS 0	organs NNS 0	with IN 0	diffuse NN B-noun.food	petechial JJ B-adj.all	haemorrhages NNS B-noun.person	. . 0	. . 0
a7919560.s4	The DT 0	patient NN B-noun.person	was VBD 0	treated VBN B-verb.change	with IN 0	methylprednisolone NN B-noun.attribute	and CC 0	gradually RB B-adv.all	improved VBN B-verb.change	. . 0	. . 0
a10791295.s0	Development NN B-noun.process	of IN 0	apomorphine NN B-noun.person	- : 0	induced VBN B-verb.creation	aggressive_behavior JJ B-noun.feeling	, , 0	comparison NN B-noun.person	of IN 0	adult NN B-noun.person	male NN B-noun.person	and CC 0	female JJ B-noun.person	Wistar NNP I-noun.person	rats NNS I-noun.person	. . 0	. . 0
a17919553.s5	Admission NN B-noun.person	laboratory NN B-noun.person	tests NNS B-noun.person	were VBD B-verb.stative	as IN 0	follows VBZ B-verb.stative	, , 0	alanine JJ B-adj.all	aminotransferase NN B-noun.artifact	, , 0	67 CD 0	U NNP 0	/ NNP 0	L NNP 0	( ( 0	reference NN B-adv.all	range NN I-adv.all	, , 0	10 CD B-adj.all	- : 0	37 CD 0	U NNP 0	/ NNP 0	L NNP 0	) ) 0	, , 0	aspartate JJ B-adj.all	aminotransferase NN B-noun.person	, , 0	98 CD 0	U NNP 0	/ NNP 0	L NNP 0	( ( 0	10 CD B-adj.all	- : 0	40 CD B-adj.all	U NNP 0	/ NNP 0	L NNP 0	) ) 0	, , 0	alkaline JJ B-adj.all	phosphatase NN B-noun.artifact	, , 0	513 CD 0	U NNP 0	/ NNP 0	L NNP 0	( ( 0	0 CD B-noun.quantity	- : 0	270 CD 0	U NNP 0	/ NNP 0	L NNP 0	) ) 0	, , 0	gamma NN B-noun.act	- : 0	glutamyltransferase NN B-noun.person	, , 0	32 CD 0	U NNP 0	/ NNP 0	L NNP 0	( ( 0	7 CD 0	- : 0	49 CD 0	U NNP 0	/ NNP 0	L NNP 0	) ) 0	, , 0	amylase NN B-noun.person	, , 0	46 CD 0	U NNP 0	/ NNP 0	L NNP 0	( ( 0	0 CD B-noun.quantity	- : 0	220 CD 0	U NNP 0	/ NNP 0	L NNP 0	) ) 0	, , 0	total JJ B-adj.all	bilirubin NN B-noun.possession	, , 0	20.1 CD 0	mg PRP B-noun.quantity	/ : 0	dL PRP 0	( ( 0	0.2 CD 0	- : 0	1.0 CD 0	mg PRP 0	/ : 0	dL LS 0	) ) 0	, , 0	direct JJ 0	bilirubin NN 0	, , 0	14.8 CD 0	mg PRP B-noun.quantity	/ : 0	dL PRP 0	( ( 0	0 CD B-noun.quantity	- : 0	0.3 CD 0	mg PRP 0	/ : 0	dL LS 0	) ) 0	, , 0	and CC 0	albumin NN B-noun.person	, , 0	4.7 CD 0	mg PRP B-noun.quantity	/ : 0	dL PRP 0	( ( 0	3.5 CD 0	- : 0	5.4 CD 0	mg PRP B-noun.quantity	/ : 0	dL LS 0	) ) 0	. . 0	. . 0
a2396046.s0	No DT 0	enhancement NN B-noun.person	by IN 0	phenobarbital NN B-noun.time	of IN 0	the DT 0	hepatocarcinogenicity NN B-noun.attribute	of IN 0	a DT 0	choline NN B-noun.person	- : 0	devoid JJ B-adj.all	diet NN B-noun.person	in IN 0	the DT 0	rat NN B-noun.artifact	. . 0	. . 0
a15863244.s8	The DT 0	pooled VBN B-adj.all	statistical JJ B-adj.all	analysis NN B-noun.act	for IN 0	ventricular_septal_(VSD)_and_midline_(MD)_defects NNS B-noun.location	was VBD 0	performed VBN B-verb.social	for IN 0	rat NN 0	fetuses NNS 0	exposed VBN B-verb.perception	to TO 0	piroxicam VB B-verb.contact	, , 0	selective JJ B-adj.all	and CC 0	non NN B-noun.person	- : 0	selective JJ B-adj.all	COX-2 NN B-noun.other	inhibitor NN B-noun.artifact	based VBN B-verb.cognition	on IN 0	present JJ B-adj.all	and CC 0	historic JJ B-adj.pert	data NNS B-noun.cognition	. . 0	. . 0
a14659530.s4	Blood NNP B-noun.person	was VBD 0	collected VBN B-verb.possession	from IN 0	the DT 0	antecubital JJ B-adj.all	vein NN B-noun.communication	four CD B-adj.all	times NNS B-noun.event	, , 0	60 CD B-adj.all	min NN B-noun.quantity	before RB 0	and CC 0	after IN 0	the DT 0	nitroglycerin NN B-adj.all	application NN B-noun.act	, , 0	and CC 0	60 CD B-adj.all	and CC 0	120 CD 0	min NN 0	after IN 0	the DT 0	beginning NN B-noun.cognition	of IN 0	the DT 0	migraine NN B-noun.artifact	attack NN B-noun.artifact	( ( 0	mean VB B-verb.stative	344 CD 0	and CC 0	404 CD 0	min NN 0	, , 0	12 CD B-adj.all	subjects NNS B-noun.artifact	) ) 0	. . 0	. . 0
a12707296.s8	Deep JJ B-adj.all	forearm NN B-noun.body	venous JJ I-noun.body	samples NNS B-noun.cognition	were VBD 0	collected VBN B-verb.contact	for IN 0	determination NN B-noun.cognition	of IN 0	L NNP 0	- : 0	arginine NN B-verb.communication	extraction NN B-noun.act	. . 0	. . 0
a17919553.s4	He PRP 0	had VBD 0	been VBN 0	prescribed VBN B-verb.communication	telithromycin NN B-noun.communication	400 CD 0	mg PRP 0	/ ( 0	d IN 0	PO NNP 0	to TO 0	treat VB B-verb.social	an DT 0	upper_respiratory_tract_infection NN B-noun.communication	7 CD B-adj.all	days NNS B-noun.act	prior RB 0	. . 0	. . 0
a11773892.s18	New JJ B-adj.all	strategies NNS B-noun.state	for IN 0	long RB 0	- : 0	term NN B-noun.time	immunosuppression NN B-noun.act	may MD 0	be VB 0	needed VBN B-verb.consumption	to TO 0	decrease VB B-verb.cognition	this DT 0	complication NN B-noun.communication	. . 0	. . 0
a7352670.s7	This DT 0	study NN B-noun.communication	indicates VBZ B-verb.communication	that IN 0	with IN 0	stable JJ B-adj.all	halothane NN B-noun.person	anesthesia NN B-noun.person	, , 0	the DT 0	partial JJ B-adj.all	recovery NN B-noun.process	of IN 0	blood NN B-noun.act	pressure NN B-noun.act	during IN 0	SNP NNP 0	infusion NN 0	and CC 0	the DT 0	post NN B-noun.act	- : 0	SNP NN 0	rebound NN 0	of IN 0	blood NN B-noun.group	pressure NN B-noun.person	can MD 0	be VB B-verb.stative	completely RB B-adv.all	blocked VBN B-verb.contact	by IN 0	saralasin NN B-noun.person	. . 0	. . 0
a10835440.s6	Nimodipine CD 0	treatment NN B-noun.communication	resulted VBD B-verb.stative	in IN 0	a DT 0	statistically RB B-adv.all	significant JJ B-adj.all	reduction_in_systolic_BP NNP B-noun.group	( ( 0	SBP NNP 0	) ) 0	and CC 0	diastolic JJ B-adj.all	BP NNP 0	( ( 0	DBP NNP 0	) ) 0	from IN 0	baseline NN B-noun.person	compared VBN B-verb.possession	with IN 0	placebo NN 0	during IN 0	the DT 0	first JJ B-adj.all	few JJ B-noun.animal	days NNS I-noun.animal	. . 0	. . 0
a17615423.s4	Laboratory NN B-noun.artifact	evaluation NN I-noun.artifact	revealed VBD B-verb.perception	66,680 CD 0	U NNP 0	/ NNP 0	L NNP 0	creatine NN 0	kinase NN 0	, , 0	93 CD 0	mg NN B-noun.quantity	/ : 0	dL SYM B-adv.all	blood_urea_nitrogen NN I-adv.all	, , 0	4.6 CD 0	mg FW 0	/ FW 0	dL FW 0	creatinine NN 0	, , 0	1579 CD 0	U NNP 0	/ NNP 0	L NNP 0	aspartate JJ B-adj.all	aminotransferase NN B-noun.person	, , 0	and CC 0	738 CD 0	U NNP 0	/ NNP 0	L NNP 0	alanine JJ 0	aminotransferase NN 0	. . 0	. . 0
a18329269.s3	in IN 0	the DT 0	rat NN 0	haloperidol NN B-noun.person	- : 0	induced VBN B-verb.creation	catalepsy NN B-noun.artifact	model NN B-noun.person	for IN 0	Parkinson's_disease NN B-noun.act	. . 0	. . 0
a322550.s2	Before IN 0	nitroprusside JJ B-adj.all	infusion NN B-noun.cognition	, , 0	5 CD 0	cm IN 0	H2O NNP B-noun.group	CPAP NNP I-noun.group	significantly RB B-adv.all	, , 0	P NNP 0	less JJR 0	than IN 0	.05 CD 0	, , 0	decreased VBD B-verb.change	arterial JJ B-adj.all	blood NN B-noun.act	pressure NN B-noun.act	, , 0	but CC 0	did VBD 0	not RB B-adv.all	significantly RB B-adv.all	alter VB B-verb.change	heart NN B-noun.body	rate NN B-noun.time	, , 0	cardiac JJ 0	output NN 0	, , 0	systemic JJ B-adj.all	vascular JJ B-adj.all	resistance NN B-noun.phenomenon	, , 0	or CC 0	QS NNP 0	/ NNP 0	QT NNP 0	. . 0	. . 0
